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RESUMO 
Os oceanos compreendem uma imensa diversidade de organismos vivos, ainda 
pouco explorados quando comparados com os organismos terrestres. As algas são parte 
dessa diversidade, constituindo um dos mais importantes grupos de organismos, tanto em 
número como em variedade de espécies. Atendendo à pesquisa constante de compostos 
bioativos, as algas atraíram a atenção dos cientistas e tornaram-se objeto de muitos 
estudos nas últimas décadas. Portugal tem uma localização geográfica privilegiada, com 
uma vasta área costeira e uma gama de temperatura e exposição solar propícias ao 
desenvolvimento de várias espécies de algas. Com o objetivo de valorizar este recurso 
natural, dezoito espécies de algas colhidas na costa oeste Portuguesa pertencentes a três 
filos diferentes (Chlorophyta, Rhodophyta e Phaeophyta), foram exploradas no que 
respeita à sua composição química e atividade biológica. 
O perfil de esteróis das amostras foi analisado por HPLC-DAD, permitindo a 
identificação e quantificação de 7 compostos: desmosterol, ergosterol, fucosterol, 
colesterol, campesterol, estigmasterol e β-sitosterol. As espécies pertencentes aos filos 
Chlorophyta e Phaeophyta caracterizaram-se pela presença maioritária de esteróis C29, 
sendo o isofucosterol/fucosterol os principais compostos, respectivamente, enquanto as 
espécies do filo Rhodophyta se caracterizaram pela sua abundância em colesterol. As 
espécies dos filos Chlorophyta e Phaeophyta apresentaram o maior teor de esteróis, sendo 
a alga castanha Cystoseira tamariscifolia Hudson Papenfuss a espécie mais rica. 
Considerando os efeitos benéficos dos esteróis para a saúde humana, e tendo em conta o 
perfil qualitativo e quantitativo apresentado pelas espécies em estudo, as pertencentes aos 
filos Chlorophyta e Phaeophyta revelaram-se mais promissoras. 
As espécies de algas de Phaeophyta foram analisadas relativamente ao seu teor total 
em florotaninos, determinado num extrato purificado pelo método específico do 
dimetoxibenzaldeído. A espécie Fucus spiralis Linnaeus apresentou a maior quantidade 
destes compostos, seguida pelas espécies do género Cystoseira. Foram avaliadas as 
atividades anti-inflamatória, antimicrobiana e a capacidade de sequestro do óxido nítrico 
(NO) dos extratos purificados de florotaninos. A ação anti-inflamatória foi estudada 
através da avaliação da capacidade dos extratos para reduzir o NO produzido pela linha 
celular de macrófagos RAW 264.7. A espécie C. tamariscifolia apresentou a melhor 
atividade, sem toxicidade nas concentrações testadas. A atividade sequestrante para o NO 
foi avaliada também num sistema não celular, tendo os melhores resultados sido obtidos 
com o extrato de F. spiralis. A atividade antimicrobiana dos extratos foi avaliada 
relativamente a uma vasta gama de bactérias e fungos patogénicos, sendo mais ativos 
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contra bactérias Gram+ e dermatófitos, com destaque para as espécies F. spiralis e 
Cystoseira nodicaulis (Withering) M. Roberts. 
O perfil de florotaninos das algas mais promissoras, ou seja, aquelas com maiores 
quantidades de florotaninos e melhores atividades biológicas, foi analisado por HPLC-
DAD-ESI/MSn. Foram caracterizados 22 florotaninos nas espécies estudadas, 
pertencentes às classes ecol e fucofloroetol: 8 em C. nodicaulis, 2 em C. tamariscifolia, 4 
em Cystoseira usneoides (Linnaeus) M. Roberts e 8 em F. spiralis. A capacidade dos 
extratos de florotaninos destas espécies para sequestrar o radical anião superóxido, para 
inibir a peroxidação lipídica e para prevenir a degradação do ácido hialurónico, por meio 
da inibição da hialuronidase, foi determinada. Todas as espécies estudadas apresentaram 
resultados promissores, sendo a F. spiralis a mais ativa. 
Tendo em conta o aparecimento crescente de resistências a antifúngicos, a atividade 
antifúngica de extratos purificados de florotaninos foi aprofundada, relativamente a uma 
variedade mais alargada de leveduras e dermatófitos, demonstrando atividade fungistática 
contra leveduras e fungicida contra dermatófitos. O mecanismo de ação dos extratos 
purificados de florotaninos foi também avaliado, usando a levedura Candida albicans e o 
dermatófito Trichophytom rubrum como modelos, e baseou-se no seu efeito sobre os 
alvos mais comuns dos fungos. Embora os florotaninos não apresentem um efeito claro 
sobre os componentes da membrana e parede celular dos fungos, o seu efeito sobre a rede 
metabólica dos microorganismos é notório. Adicionalmente, a espécie F. spiralis 
apresentou resultados promissores na inibição do fator de virulência de C. albicans. 
Dado o potencial químico e biológico da espécie F. spiralis, o seu estudo foi 
aprofundado e prosseguiu-se com o isolamento de compostos. Dois monogalactosil 
diacilgliceróis (MGDGs) e um monoacilglicerol foram isolados por métodos 
cromatográficos e as suas estruturas foram elucidadas por meio de espectroscopia (RMN e 
MS) e por comparação com a literatura. O monoacilglicerol, composto por glicerol ligado a 
ácido oleico (C18:1 Ω9) e os MGDGs, compostos por uma porção de glicerol ligado a uma 
unidade de galactose e de ácido eicosapentaenoico (C20:5 Ω3) combinado com o ácido 
linolénico (C18:3 Ω3) ou ácido octadecatetraenoico (C18:4 Ω3), respetivamente, foram 
testados quanto à sua atividade citotóxica e anti -inflamatória em macrófagos RAW 264.7, 
apresentando capacidade para inibir a produção de NO em concentrações não citotóxicas. 
As algas estudadas apresentaram características biológicas interessantes, sendo as 
espécies do género Cystoseira e o F. spiralis particularmente promissoras para o possível 
desenvolvimento de formulações farmacêuticas e de alimentos funcionais. 
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ABSTRACT 
Oceans comprise an immense diversity of living organisms, still underexplored if 
compared with terrestrial ones. Seaweeds are part of this diversity, constituting one of the 
most important groups of organisms, in both number and variety of species. Considering 
the constant search for new bioactive compounds, seaweeds have attracted scientists’ 
attention and became the subject of many studies in the last decades. Portugal has a 
privileged geographical location, with a wide coastal area and a range of temperature and 
sun exposition propitious to the development of various species of seaweeds. With the aim 
of valuing this natural resource, seaweeds species belonging to three different phyla 
(Chlorophyta, Rhodophyta and Phaeophyta) were analyzed and explored for their 
chemical composition and biological activities. 
The sterols profile of eighteen seaweeds was analyzed by HPLC-DAD, allowing the 
identification and quantification of 7 compounds: desmosterol, ergosterol, fucosterol, 
cholesterol, campesterol, stigmasterol and β-sitosterol. Species belonging to Chlorophyta 
and Phaeophyta contained mainly C29 sterols, isofucosterol/fucosterol being the major 
compounds, respectively, while the ones of Rhodophyta where characterized by their 
abundance in cholesterol. Chlorophyta and Phaeophyta presented the highest total sterols 
content, the brown seaweed Cystoseira tamariscifolia Hudson Papenfuss being the 
richest species. Considering the sterols health effects and the qualitative and quantitative 
profile presented by the studied seaweeds, Chlorophyta and Phaeophyta represent the 
most promising groups. 
Phaeophyta species were analyzed for their total phlorotannins content by their 
quantification in a purified phlorotannins extract using the dimethoxybenzaldehyde 
specific assay. Of the studied species, Fucus spiralis Linnaeus presented the highest total 
phlorotannins amount, followed by the Cystoseira species. The anti-inflammatory, 
antimicrobial and NO scavenging activity of the purified extracts was analyzed. The anti-
inflammatory capacity was studied by evaluating the capacity of the extracts to reduce the 
NO produced by RAW 264.7 macrophage cells, C. tamariscifolia presenting the best 
activity, with no citotoxicity under the tested concentrations. The NO scavenging activity 
was evaluated on a cell-free system, F. spiralis presenting the best results. The 
antimicrobial activity was evaluated over a wide range of pathogenic Gram+ and Gram─ 
bacteria and fungi. In a general way, phlorotannins extracts were more active against 
Gram+ bacteria and, among fungi, against dermatophytes, with emphasis on F. spiralis 
and Cystoseira nodicaulis (Withering) M. Roberts. 
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The phlorotannins profile of the most promising seaweeds, i.e., the ones with higher 
phlorotannins amounts and better biological activities, was analyzed by HPLC-DAD-
ESI/MSn. Twenty two different phlorotannins belonging to eckol and fucophlorethol main 
groups were characterized in the studied seaweeds: 8 in C. nodicaulis, 2 in C. 
tamariscifolia, 4 in Cystoseira usneoides (Linnaeus) M. Roberts and 8 in F. spiralis. The 
capacity of the phlorotannins extracts of these species to sequester superoxide anion 
radical, to inhibit lipid peroxidation and to prevent the degradation of hyaluronic acid, by 
the inhibition of hyaluronidase, was determined. All of the studied species presented 
promising results; nevertheless, F. spiralis was, by far, the most active species. 
Taking into account the emergence of resistance to antifungal drugs, the antifungal 
activity of purified phlorotannins extracts was extended to a larger number of yeasts and 
dermatophytes, demonstrating fungistatic activity against yeast and fungicidal capacity 
against dermatophytes. The mechanism of action of purified phlorotannins extracts was 
also evaluated, using the yeast Candida albicans and the dermatophyte Trichophytom 
rubrum as models. The effect of purified phlorotannins extracts was evaluated over the 
most common fungal targets. Although phlorotannins did not present a clear effect on 
fungal cell membrane and cell wall, they clearly interacted with the microorganism’s 
metabolic network. Additionally, F. spiralis presented promising results on the inhibition 
of C. albicans virulence factor. 
Considering the potential of the seaweed species F. spiralis, the studies were 
deepened and continued with the isolation of compounds. Two monogalactosyl 
diacylglicerols (MGDGs) and one monoacylglycerol were isolated by chromatographic 
methods and their structures were elucidated by spectroscopic means (NMR and MS) and 
by comparison with the literature. The monoacylglycerol was composed of a glycerol 
moiety linked to oleic acid (C18:1 Ω9) and the MGDGs contained a glycerol moiety linked 
to a galactose unit and eicosapentaenoic acid (C20:5 Ω3) combined with linolenic acid 
(C18:3 Ω3) or octadecatetraenoic acid (C18:4 Ω3), respectively. The isolated compounds 
were tested for their cytotoxic and anti-inflammatory activity in RAW 264.7 macrophage 
cells, presenting the capacity to inhibit NO production at non-cytotoxic concentrations. 
The studied seaweeds demonstrated interesting nutritional and biological features, 
Cystoseira species and F. spiralis being particularly promising for the possible 
development of pharmaceutical formulations and functional food products. 
Keywords: Anti-inflammatory activity; antimicrobial activity; antioxidant activity; 
glycerolipids; phlorotannins; sterols; seaweeds. 
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1. GENERAL STRUCTURE OF THE DISSERTATION 
 
This dissertation is divided into five main parts: 
 
PART I – Introduction and aims of the dissertation 
This part contains an introduction to the topics that have been studied in this 
dissertation. Each topic is covered in a general way, with the exception of those which are 
most important for the interpretation of the results. The main goals of this dissertation are 
listed at the end of this part. 
PART II – Experimental section 
This part provides information regarding sampling and the experimental procedures 
used in the evaluation of the parameters under study. 
PART III – Results and discussion 
This part presents the results of the different studies and attempts to correlate them 
with the existing works addressing similar issues. 
PART IV – Conclusions 
The conclusions reached with this dissertation are summarized in this part. 
PART V – References 
This last part contains the literature required for the elaboration of this dissertation. 
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2. INTRODUCTION 
2.1. Generalities 
Facing the oceans and its fauna and flora as a source of bioactive metabolites has 
revolutionized the scientific world and brighten a new hope to the scientific community. 
Marine organisms have shown to constitute a rich source of bioactive compounds with a 
diversified use in several areas, such as agriculture, food, textile and pharmaceutical 
industries. They have been intensively studied in the last few decades because of their 
promising bioactive molecules, perceived by the scientific community as good candidates 
for the development of new and innovative drugs (1). Marine organisms produce a large 
amount of secondary metabolites that are not found in terrestrial ones. In part, due to the 
extreme environmental conditions to which they are exposed, both marine animals and 
algae have developed defense strategies that resulted in a significant level of structural and 
chemical diversity of compounds. These compounds are originated from different 
metabolic pathways and are structurally different from those produced by terrestrial 
plants (2). The exploitation of these organisms for pharmaceutical purposes has revealed 
important chemical prototypes for the discovery of new agents, stimulating compounds 
isolation and syntheses of new related compounds with biomedical application.  
Recent surveys of drugs from natural sources have shown that algae are promising 
organisms that provide new biochemically active compounds, with beneficial effects on 
human health and nutrition. Chemical research on algae products has been intensified 
during the last years and over 15000 primary and secondary metabolites from different 
metabolic pathways were reported (1). Scientists have focused their attention on 
secondary metabolism, which leads to a high structural diversity of compounds, due to 
modifications and combinations of reactions from the primary metabolic pathways. 
Nevertheless, both types of metabolites are of extreme importance and can be related to 
remarkable positive effects on human organism. In addition to bioactive compounds 
isolation, more recently, algae farming and controlled algae cultivation with the objective 
of producing valuable new compounds in a large scale has gained ground (3). 
The bioactivity of seaweeds’ extracts and isolated compounds constituted a great 
deal of research in recent years. This increasing interest is justified by the promising 
biological activities of their compounds, from both metabolic and pharmacological points 
of view. In order to valorize the Portuguese algal flora and extend its application for food 
and pharmaceutical industries, this dissertation will focus the study of bioactive 
compounds from seaweeds, and their role in health promotion and disease prevention. 
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2.2. Seaweeds 
Algae are considered a big group of autotrophic organisms, ranging from unicellular 
to multicellular forms. These organisms can be found in both marine and fresh waters, 
and are divided according to their size in microalgae and macroalgae or seaweeds (4). 
Microalgae constitute a polyphyletic group of prokaryotic and eukaryotic microscopic 
organisms with a simple cellular structure. This group of unicellular microorganisms live 
individually or in groups and is known as phytoplankton. Among the most common 
microalgae are the Cyanophyceae (blue green algae), Bacillariophyceae (diatoms) and 
Chrysophyceae (golden algae). Among these, diatoms are the dominant life form in 
phytoplankton and represent the largest group of biomass producers on earth (5). 
Macroalgae can be defined as photosynthetic multicellular eukaryotic organisms, 
with a wide variety of cell morphologies and life cycles. These organisms are found in a 
multiple variety of habitats and their morphological diversity results from their 
polyphyletic origin within the eukaryotic tree of life. In their natural environment, 
macroalgae grow on rocky substrates and form stable, multi-layered, perennial vegetation 
(6). A wide range of specific requirements, such as nutrients, salinity, temperature, light, 
depth and currents, are determinant factors that affect macroalgae growth and nutrients 
production. Nevertheless, the fact of being fixed on a substrate enhances macroalgae 
growth and productivity, contrary to what happens with phytoplankton (6, 7). These 
organisms are of extreme importance as primary producers; they play a key role in the 
productivity of oceans and constitute the basis of the marine food chain. Additionally to 
the organic material they produce through sun light, carbon dioxide (CO2) and water 
(H2O), macroalgae are one of the major responsible for oxygen production on earth (8).  
Several classifications have been proposed over the years (8). Nowadays, macroalgae 
are divided into three main groups according to the distribution and occurrence of several 
photosynthetic pigments, which are the main features for algae classification. As so, they 
are normally divided into green algae (Phylum Chlorophyta), red algae (Phylum 
Rhodophyta) and brown algae (Phylum Heterokontophyta, Class Phaeophyceae). With the 
exception of the green and red algae that belong to kingdom Plantae, brown algae belong 
to the kingdom Chromista (9, 10).  
Both “macroalgae” and “seaweed” terminology have been used when referring to 
these organisms, although the second respects to macroalgae living in marine waters. 
Along this dissertation, the term “macroalgae” will be used in a generalized context and 
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the term “seaweed” will be confined to macroalgae species exclusive or collected in marine 
waters. 
2.2.1. Chlorophyta 
Chlorophyta are considered to be the ancient of terrestrial plants and, due to their 
similarities with them, they are grouped in the kingdom Plantae (11). This phylum is better 
represented in fresh water (90%) than in the sea (10%) and counts more than 7000 known 
species (12, 13). Contrary to fresh water species, which have a cosmopolitan distribution, 
Chlorophyta species belonging to the marine environment from northern and southern 
hemispheres present clear differences (14). 
In this phylum, the chloroplasts contain chlorophyll a and b, β-carotene and 
xanthophylls in a proportion resembling terrestrial plants. Lutein is the main carotenoid. 
Their major photosynthetic pigment, responsible for their green color, is chlorophyll b, 
although, some tropical species are pigmented by siphonoxanthin and siphonein (15). 
Concerning storage products obtained from photosynthesis, Chlorophyta differs from 
other eukaryotic macroalgae since they reserve starch in organelles called pyrenoids, 
within chloroplasts, instead of cytoplasm. The cell walls of these organisms are composed 
by cellulose as the major polysaccharide, although xylans and manans can replace 
cellulose in some species (14). 
Among the full diversity of green algae, species belonging to the Ulvaceae family are 
specially disseminated (10). Ulvaceae species can tolerate a wide range of temperatures 
and survive to drying at low tide. Ulva lactuca Linnaeus is an edible macroalgae 
commonly found in Portuguese waters. It growths attached to rocks, crustaceous or other 
algae species (Figure 1 A), without a stipe, in the middle to low intertidal zone and has 
the appearance of a lettuce, thus being called sea lettuce or green laver. This species has a 
delicate and translucent thallus sheet like and its color varies from dark to light green 
(Figure 1 B and C). This opportunistic algae is capable of rapid colonization and growth 
when conditions are favorable. It has a fast growth rate and capacity to store and respond 
to enhanced nutrient supply (16). It is mainly composed by sugars and proteins, being 
commonly consumed in salads or used in soups (17). 
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Figure 1. Ulva lactuca growing on rocks and attached to other seaweeds species (A); Color 
variations among U. lactuca (B and C). (Photographs of Graciliana Lopes). 
2.2.2. Rhodophyta 
Rhodophyta, one of the oldest eukaryotic algae, are thought to be descendent from a 
cyanome in the Glaucophyta. More than 6000 species have been identified to date, of 
which only a few are found in fresh water (10, 18). Rhodophyta can occur at all latitudes, 
but predominantly from equator to colder seas. Few Rhodophyta are found in polar and 
sub-polar regions, where green and brown algae are predominant, contrary to what 
happens in temperate and tropical regions where this phylum prevails. Members from this 
phylum share a combination of characters that do not occur together in any other 
eukaryote, such as the complete lack of flagellated stages and the absence of centrioles 
(14). 
These species contain a variety of pigments, including chlorophyll a, 
phycobiliproteins, red phycoerythrin, blue phycocyanin, carotenes, lutein and zeaxanthin. 
The most important pigment is phycoerythrin, which provides the algae's red 
pigmentation by reflecting red light and absorbing blue light. Red algae with little of this 
pigment may appear more green or blue than red due to the presence of other pigments. 
Unlike other algae phyla, and thanks to their photosynthetic pigments that absorb light in 
the wavelength corresponding to blue color, red algae have the ability to live below 200 m 
depth in the ocean (19). These photosynthetic reserves are stored in plastids as floridean 
starch grains (14). 
Several species from this phylum are important food crops, particularly in Asian 
countries, where members of the genus Porphyria are highly consumed (20). In Portugal, 
algae are consumed in trace quantities, the consumption of red algae being almost limited 
to the species Osmundea pinnatifida (Hudson) Stackhouse, also known as pepper grass, 
particularly in Azores Islands (21). 
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One of the most popular red seaweed species in Portuguese coasts is certainly 
Asparagopsis armata Harvey. Despite being native of southern hemisphere, this species 
is now globally distributed; in the north-eastern Europe it is more noticeable between 
June and September. A. armata appears as a pale purplish-red species, irregularly 
branched (with short branches alternating with longer ones) and with harpoon-like barbs 
(Figure 2 A) (21). This endemic species has a great capacity for growth and invasion, 
colonizing the habitat in which it lies and hindering the development of other species, 
such as algae and marine animals (Figure 2 B) (22). 
 
 
 
 
 
 
Figure 2. Asparagopsis armata (A) as invasive species (B). (Photographs of Graciliana Lopes). 
 
2.2.3. Phaeophyta 
Brown algae belong to the phylum Heterokontophyta (12) or Phaeophyta (23), 
according to the taxonomic classifications. As a matter of standardization, brown algae 
will be referred as Phaeophyta along this dissertation. 
Phaeophyta mainly consists of macroscopic organisms inhabiting marine waters. Of 
the approximately 2000 known species, less than 1% colonizes fresh water habitats (24). 
These species have adapted to a great variety of marine ecological niches, including the 
tidal zone, rock pools, all intertidal zone and relatively deep waters near the coast. A large 
number of Phaeophyta are found in the intertidal or upper littoral area, where the waters 
are predominantly cool and the currents of nutrient-filled cold waters inflow the land (14). 
Species belonging to this phylum present a wide range of sizes and forms, varying from 
groups of threadlike cells with few centimeters to giant kelps with dozens of meters. These 
species grow so profusely that they form offshore kelp forests, very efficient at capturing 
sunlight and serving as home to a diverse group of marine animals. In a general way, 
brown algae species are composed by a holdfast (root like structure) (Figure 3 A), thallus 
(twig), stipe, lamina and pneumatocyst (also known as gas bladder, a floating structure 
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containing gas). Pneumatocysts are found only in brown algae and exert an upward force 
that allows the organism to receive more sunlight for photosynthesis (Figure 3 B) (25). 
 
 
 
 
 
 
Figure 3. Brown algae species Saccorhiza polyschides (A) and Fucus (B). Evidencing the holdfast 
(A) and pneumatocysts (B). (Photographs of Graciliana Lopes). 
 
Members of Phaeophyta are distinguished by their brown or yellow brown color, 
resulting from their main carotenoid fucoxanthin. Along with fucoxanthin, the main 
photosynthetic pigments of brown algae are chlorophylls a, c1 and c2, β-carotene, 
violaxanthin and diatoxanthin. Their brown color is also influenced by the presence of 
phlorotannins stored in vesicles called physodes (26). Contrary to Chlorophyta and 
Rhodophyta, their main photosynthetic storage product is not starch but laminarin, a 
water soluble β-(1→3)-glucan. Their cell walls are composed of cellulose, alginic acid and 
sulfated polysaccharides, produced in high quantities in some marine species and 
harvested for commercial purposes (27). 
In fact, some Phaeophyta species are of sufficient commercial importance and have 
become subjects of extensive research. The alginates of some brown algae are harvested 
for commercial use as thickening agents in the textile, cosmetic and food industries. For 
many years macroalgae were also the source of iodine, a trace nutrient required in thyroid 
disorders (28). Despite the interest of the pharmaceutical industry regarding the search 
for new bioactive compounds, brown seaweeds are particularly attractive for cosmetics, 
where their bioactive ingredients show benefits beyond the traditional cosmetics, such as 
creams, lotions and ointments (29). Nowadays, the use of brown seaweeds does not have 
much visibility in Portugal. However, a few decades ago, the harvesting of seaweeds 
stirred the local economy. The "sargaço", also known as "argaço" or "limos", a set of 
diverse seaweeds (predominantly consisting of brown species from the genus Saccorhiza, 
Laminaria and Fucus, and also some red ones from the genus Codium, Palmaria, 
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Chondrus and Gelidium) growing on the cliffs of the Portuguese continental shelf was 
harvested and used to fertilize the soil and to improve its structure and capacity to 
increase H2O retention (30). 
2.3. Chemical composition 
Since ancient times, seaweeds play an important role in Asian population diet, 
where they are also widely used by food industries because of their rich chemical 
composition and high content of fiber, minerals, vitamins and different antioxidants 
(Figure 4) (31). H2O makes up 70 to 90% of the weight of fresh seaweeds. The 
composition of the dry seaweed varies with the species, but the approximate proportions 
are 45-75% of carbohydrates and fiber, 7-35% proteins and less than 5% fats. The main 
sugars are mannitol in brown seaweeds, sorbitol in red and saccharose in green. The 
primary mineral components are iodine, calcium (Ca2+), phosphorous, magnesium, iron, 
sodium, potassium and chlorine. Concerning vitamins, seaweeds do not have vitamin D, 
but are rich in vitamin A, vitamins from B complex (B1, B2, B3, B6 and B12) and vitamin 
C. Taurin is an important amino acid present in seaweeds, as it is essential for the 
formation of bile salts (32). 
 
 
 
 
 
 
 
Figure 4. Main classes of compounds found in seaweeds with highlight on those that were studied 
in this dissertation. 
 
Some of the secondary metabolites of seaweeds arose further attention, not only for 
their commercial application, but also for their biological activities and interesting health 
effects (Figure 4). Among them, polysaccharides like agar, carrageenans and alginate can 
be highlighted, as they are, by far, the seaweeds most economically important compounds. 
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These polysaccharides of high molecular weight are the main structural components of 
seaweeds cell walls and, despite some biological activities have been reported, they are 
important because of their extensive use in food and cosmetic industries, thanks to their 
gelling, viscosifying and emulsifying properties (33).  
Of great importance are also carotenoids. These 40-carbon atoms structures are 
essential constituents of the photosynthetic apparatus, being responsible for light 
harvesting during photosynthesis. They also act as protein stabilizers and antioxidants. 
Carotenoids consist of a carbon skeleton derived from the polymerization of isoprene units 
that may undergo cyclization in one or both ends. The formed ring can be additionally 
substituted by oxo, hydroxyl (OH) or epoxy groups, originating different xanthophylls (34, 
35).  
Fatty acids are essential for cell function and have entered the biomedical and 
nutraceutical areas as result of their biological roles in clinical conditions, such as obesity 
and cardiovascular diseases (36). These compounds consist of a carboxyl group linked to a 
saturated or unsaturated aliphatic chain and play key roles in cellular and tissue 
metabolism, membrane fluidity, electron and oxygen transport and thermal adaptation. 
Seaweeds are rich in long chain polyunsaturated fatty acids, which are considered to be 
the most benefic for human health (37).  
Halogenated compounds, mainly produced by red and brown seaweeds, comprise a 
vast and heterogeneous group of molecules dispersed in several different classes of 
primary and secondary metabolites, including indoles, terpenes, acetogenins, phenols and 
volatile hydrocarbons. The halogens present in these compounds are mainly bromine and 
chlorine and the antibacterial and antitumor activities are those of most pharmacological 
interest (38).  
Polyketides and lectins are also interesting secondary metabolites present in 
seaweeds: polyketides, like macrolides, for their antibiotic application and lectins for their 
carbohydrate binding specificity, useful in immunological and histochemical studies (39, 
40). 
Mostly because of their rich and diverse chemical composition, seaweeds 
importance increased in such a way that in the past few decades the emphasis has moved 
from wild harvest to farming and controlled cultivation, in order to produce valuable and 
profitable new products in a large scale (41). This dissertation highlights the seaweeds 
composition in terms of phytosterols, phlorotannins and glycerolipids, and explores the 
biological activities of the most promising compounds. 
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2.3.1. Phytosterols 
Phytosterols constitute a class of cholesterol-like molecules that are not 
endogenously synthesized by humans and are mainly found in the cellular membranes of 
plants and algae (Figure 5). These essential constituents of all eukaryotic membranes 
play important functions in the control of membrane fluidity and permeability and also in 
signal transduction, as hormones or hormonal precursors (42, 43). Beyond that, 
phytosterols represent a unique group that can be used as a chemotaxonomic biomarker 
for distinguishing members of the three main algal phyla (44). 
 
 
 
 
 
 
 
 
 
 
 
Figure 5: Phytosterols basic structure and chemical structures of the most common sterols found 
in seaweeds; * isomers at C-24: isofucosterol (Z) and fucosterol (E) (adapted from (44)). 
 
Phytosterols are structurally similar and functionally analogous to cholesterol of 
vertebrate animals, differing only in the substitution on the sterol side chain, at the C-24 
position. Therefore, whereas the cholesterol side chain comprises eight carbon atoms, 
most phytosterols side chains consist of nine or ten carbons (Figure 5) (42). The sterol 
nucleus contains four rings (A, B, C and D), OH group at C-3 and a side chain. Rings A and 
D are of particular importance for sterols function. The OH group at C-3 of ring A 
contributes for hydrogen-bond interactions. On the other hand, the conformation and 
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length of the side chain and the stereochemistry of the C-24 alkyl group in ring D are 
crucial for intermolecular interactions (Figure 5) (45). The alkyl substitution at C-24 in 
phytosterols is added by the enzyme sterol methyltransferase (SMT), which is not 
necessary in cholesterol and in the other C27 sterols biosynthesis. The activity of SMT 
controls the levels of cholesterol in photosynthetic organisms (46). Seaweeds phytosterols 
can be found either in their free form or conjugated with different molecules, like fatty 
acids and sugars and, in this situation, the OH group on the A ring is covalently bound to 
another molecule (44). Although it is more common to find algae phytosterols esterified 
with fatty acids, they can also appear conjugated with sugars by a 1-O-β-glycosidic bond 
between the 3-OH group and a hexose (commonly glucose) (47).  
Sterols pattern tend to be quite stable among different algae groups; nevertheless, 
the ecological differences, geographical origin and developmental stage of the organisms 
can contribute to different phytosterols profiles (48). In a general way, C29 sterols, namely 
fucosterol and isofucosterol (Figure 5), are the major compounds in brown and green 
algae, respectively. Red algae, on the other hand, are richer in cholesterol. All of them 
possess β-sitosterol, campesterol and stigmasterol (Figure 5), which are the most 
frequent phytosterols in nature and in human diet (43). 
 
The complexity of phytosterols is further increased by steric features concerning the 
size and direction of the substituent at C-24, which is a phylogenetic indicator. 24-β-
Methyl sterols predominate in primitive organisms, while 24-α-ethyl sterols are typical of 
more advanced ones (49). Seaweeds belonging to Chlorophyceae division present more 
complex sterols with an asymmetric carbon at C-24, similar to the ones found in higher 
plants. Moreover, the proportion of C29 sterols in this group is high, in comparison with 
C27 and C28, which supports green seaweeds as the ancestors of land plants (11). 
2.3.1.1. Biosynthesis 
Isoprenoids represent one of the most diverse families of compounds, some of them 
used in pharmaceutical and food industries for their considerable health benefits. As 
plants, algae utilize two distinct and separate compartmentalized pathways to build up the 
basic building blocks of isoprenoids, which take place in different cellular compartments: 
the cytosol and the plastids (Figure 6) (50).  
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Figure 6. MVA and the DOXP/MEP pathways overview (44) 
All isoprenoids biosynthesis starts with two basic units of five carbons: the 
isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP). In the classical 
cytosolic pathway, known as mevalonate (MVA) pathway, IPP is formed from the 
condensation of three molecules of acetyl-coenzyme A (Ac-CoA). On the other hand, on 
the second non-MVA pathway for IPP/DMAPP biosynthesis, operating in the chloroplasts, 
IPP/DMAPP are formed from the intermediates pyruvate and D-glyceraldehyde-3-
phosphate (GAP), to yield 1-deoxy-D-xylulose-5-phosphate (DOXP), followed by 
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intramolecular rearrangement and reduction to 2-C-methyl-D-erythritol-4-phosphate 
(MEP) (44). With the exception of green algae, which are devoid of MVA pathway and 
exclusively use the DOXP/MEP one for sterol formation, all photosynthetic organisms 
possess both biosynthetic pathways (51). 
MVA Pathway 
The MVA-dependent IPP/DMAPP biosynthesis takes place in the cytosolic 
compartment of algae cells and starts with the condensation of two units of Ac-CoA into 
acetoacetyl-CoA via a Claisen-type reaction, in which acetoacetyl-CoA thiolase acts as 
catalyst. Then, acetoacetyl-CoA and Ac-CoA condense to form 3-(S)-hydroxy-3-
methylglutaryl-CoA (HMG-CoA), by the action of 3-hydroxy-3-methylglutaryl coenzyme A 
synthase. HMG-CoA is then converted into 3-(R)-mevalonate through a nicotinamide 
adenine dinucleotide phosphate (NADPH)-dependent reductive deacylation, catalyzed by 
HMG-CoA reductase. The remaining steps for IPP biosynthesis comprise two 
phosphorylation reactions to convert MVA to mevalonate-5-diphosphate (MVADP), 
catalysed by mevalonate kinase (MK) and phosphomevalonate kinase (PMK), and 
followed by an adenosine triphosphate (ATP)-dependent MVADP decarboxylation 
catalysed by mevalonate-5-diphosphate-decarboxylase (PPMD). Finally, isopentenyl-
diphosphate isomerase (IDI) catalyses the formation of DMAPP, which is the chemically 
active isoprene unit that starts isoprenoid biossynthesis (44). 
DOXP/MEP Pathway 
The DOXP/MEP alternative pathway is initiated by a transketolase catalysed 
condensation of GAP with pyruvate. The enzyme responsible for this condensation, 1-
deoxy-D-xylulose-5-phosphate synthase (DXS), yields the first product, DOXP. 
Subsequently, DOXP is transformed into the intermediate MEP in two steps catalysed by 
the DOXP reductoisomerase (DXR, also known as MEP synthase). An intramolecular 
rearrangement leads thereby to the formation of the enzyme-bound intermediate MEP, 
which is concomitantly reduced via a NADPH-dependent reduction. MEP is then 
converted into 4-diphosphocytidyl-2-C-methyl-D-erythritol (CDP-ME), which is 
phosphorylated yielding 4-diphosphocytidyl-2-C-methyl-D-erythritol-2-phosphate (CDP-
MEP). These conversions are carried out by CDP-ME synthase, also referred to as MEP 
cytidyl transferase (MCT) and CDP-ME kinase (CMK), respectively. Next, CDP-MEP is 
converted into 2-C-methyl-D-erythritol-2,4-cyclodiphosphate (MEcPP) by ME-cPP 
synthase (MDS). This compound is then reduced by 1-hydroxy-2-methyl-2-(E)-butenyl-4-
diphosphate synthase (HMBPP synthase) to yield 1-hydroxy-2-methyl-2-(E)-butenyl-4-
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diphosphate (HMBPP). In the final step, HMBPP is converted by the HMBPP reductase, 
HDR, into IPP and DMAPP. IPP and DMAPP become the basic building blocks of 
polyisoprenoid biosynthesis in the stroma of plastids. All MEP-derived isoprenoids are 
considered as typical and exclusive plastidial isoprenoids (44).  
2.3.1.2. Sterols in seaweeds 
The possibility of several biosynthetic pathways for sterols byosinthesis and the 
variability concerning the side chain provide a wide range of structural types of sterols in 
algae, which has long been recognized. These structures also provide strong evidence for 
particular phylogenetic affiliations in some algae taxa, since, unlike higher plants, 24-β 
alkyl sterols are dominant in algae. It is clear that sterols can play an important role in 
determining the relationships between algae and in their evolutionary relationships with 
other organisms. Thus, most of the algal divisions can be easily characterized on the basis 
of their sterol composition (52).  
Rhodophyta is the unique phylum containing primarily cholesterol or related C27 
sterols. They also produce small amounts of C28 and C29 sterols, C28 ones normaly being 
present in higher quantities (53). Desmosterol, the biosynthetic precursor of cholesterol, 
can also be found in red algae; nevertheless, it predominates in the evolutionary lower red 
algae (54). Some evolutionary higher red algae that are able to alkylate sterols contain 24-
methylenecholesterol, which is a precursor of C-24 alkylated sterols. These sterols, 
together with the ones with a double bond at C-22, are found in low concentrations (55). 
Green algae appear to be more variable in terms of sterols, suggesting some 
phylogenetic relationships (56, 57). In lower green algae, the alkylation of 24-
methylenecholesterol leads to the production of an isomer of fucosterol, called 
isofucosterol. On the other hand, in the evolutionary advanced green algae and in higher 
plants, alkylation is followed by a reduction of the C-24 double bond, giving origin to the 
accumulation of sitosterol (54). Thus, in a general way, green algae have media 
percentages of C29 sterols that are high relative to their C27 and C28 sterols. In all green 
algae, sterols relative abundance follows the order C27 < C28 < C29, while in all red algae, 
this pattern is reversed (57). 
Brown algae present a sterols pattern different from the reds and more constant 
than the greens. This phylum almost exclusively contains fucosterol, which is 
biosynthesized through the alkylation of 24-methylenecholesterol. The fucosterol 
biosynthetic precursor, desmosterol, can be also present in brown algae, but usually at low 
concentration. Comparing with Rhodophyta, the desmosterol amounts in this phylum are 
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significantly lower. Generally, brown algae mainly contain C29 sterols and very low 
concentrations of phytosterols with less than 29 carbon atoms, presenting a high 
fucosterol:cholesterol ratio (54, 58). 
2.3.1.3. Sterols bioactivities 
Phytosterols are increasingly regarded as beneficial to human health, in such a way 
that they are also being included in several pharmaceutical formulations. The cholesterol 
lowering capacity of phytosterols is perhaps their main and most important property. 
Several studies have been performed to evaluate the extent of diet’s phytosterols 
absorption (59, 60) and the cholesterol lowering properties displayed by them (61-66). In 
fact, phytosterols can lead to an additional significant reduction of serum cholesterol 
concentrations compared to that obtained with a low fat diet alone (47). These compounds 
have the ability to incorporate into membranes and to replace cholesterol molecules, 
inhibiting its absorption and attenuating the high-cholesterol diet effects (64). They 
primarily act at the intestinal lumen, where they compete with cholesterol for the 
incorporation in bile salts and phospholipid micelles. The competition of phytosterols with 
cholesterol for the uptake into intestinal epithelium leads to a reduction in cholesterol 
absorption by the intestinal cells, resulting from a displacement of cholesterol from the 
phospholipidic micelles (67). The recirculation of biliary cholesterol is another way of 
cholesterol absorption in the intestine, which can be reduced by phytosterols, once they 
can prevent the esterification of free cholesterol into cholesterol esters and, thus, its 
assembly into the chylomicrons (68). 
Together with their cholesterol-lowering properties, phytosterols are also recognized 
as important molecules for the reduction of low density lipoproteins (LDL)-cholesterol 
and cardiovascular heart disease (CHD). Phytosterols have been shown to reduce LDL-
cholesterol without relevant effects on high density lipoproteins (HDL) and triglycerides 
(68). Elevated LDL blood cholesterol is one recognized risk factor for CHD, an important 
cause of mortality and morbidity. Lowering LDL-cholesterol by dietary intervention is 
beneficial to human health, as it has been shown to reduce the risk of CHD. Untill now, 
there are no human studies demonstrating that plant sterols reduce the risk of CHD. 
However, both epidemiological studies and randomized controlled clinical trials have 
indicated a causal relationship between elevated LDL-cholesterol and CHD (69-71). To 
support this, the Eupean Food Safety Authority claims that there is evidence that the risk 
of CHD is reduced by cholesterol-lowering therapy, including dietary intervention 
strategies (72). 
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Apart from these activities, phytosterols also have an important role in reducing 
atherosclerosis, which increases with increasing levels of LDL-cholesterol, being reduced 
with increasing levels of HDL-cholesterol (73). They also display anticancer properties 
against human cancer cell lines, suggesting a protective effect of these compounds against 
colon, prostate and breast cancer (74, 75). According to all these studies, there is evidence 
for the exploitation of phytosterols rich matrices, in which seaweeds are included. 
2.3.1.4. Extraction and purification 
As mentioned above, algae sterols can occur is their free form, esterified with fatty 
acids or, in minor concentrations, involved in glycosylated conjugates. For this reason, the 
analysis of algae phytosterols requires not only the extraction of free and conjugated 
phytosterols, but also the hydrolysis of phytosterols conjugates, in order to convert the 
esterified phytosterols to their free form (47). 
Sterols are usually extracted from algae material by solid/liquid extraction. Several 
solvents and solvent mixtures can be used in order to establish the most suitable 
extraction conditions (chloroform-methanol (MeOH), hexane, methylene chloride and 
acetone have been reported, among others) (76). After extraction, a saponification step 
(usually with ethanolic potassium hydroxide (KOH)) should be performed to enable the 
cleavage of ester bonds of phytosterol conjugates. Nevertheless, a combination of acid and 
alkaline hydrolysis is necessary to determine the total amount of phytosterols in the 
sample (including free, esterified, and glycosylated forms). After saponification, the free 
sterols can be removed from the extract by using solid-phase extraction (SPE) or simply by 
extraction with an organic solvent (normally n-hexane or diethyl ether) (77). To obtain the 
free purified compounds, the fraction containing sterols can be cleaned-up by preparative 
thin-layer chromatography (TLC) and column chromatography (CC), usually using silica 
gel stationary phases (78). 
The main drawback of the sterols purification step is that it involves extensive and 
time/solvent-consuming procedures before phytosterols determination, which leads to a 
massive analysis time and also a significant lost of compounds (78).  
2.3.1.5. Characterization by high-performance liquid chromatography 
(HPLC) with diode array detection (DAD) 
HPLC coupled to DAD is a valuable tool for the separation of phytosterols, providing 
good repeatability and efficiency, short analysis time and reduced consumption of mobile 
phase (79). 
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Column packing and mobile phase 
Separation by HPLC is performed in columns packed with microparticles of 
diameter comprised between 3 and 10 µm, called stationary phase. Columns packaging is 
achieved with high-pressure to ensure their stability during use. These smaller particles 
provide a higher surface of contact with the mobile phase, where individual components of 
the sample are moved. Because of the strong packaging of the stationary phase, the solvent 
(mobile phase) must be forced to flow through the column by a pump. The process of 
retention of the analytes is determined by the choice of the column packing and the 
selection of the mobile phase to push the analytes through the packed column. For this 
reason, the correct selection of the column packing and the mobile phase are the most 
important factor for a successful separation. The stationary phase can be of two types: 
normal or reverse. In reversed phase, the column packing is non-polar (normally C18), 
and the mobile phase solvents are H2O and organic solvents miscible with H2O (MeOH, 
acetonitrile). In normal phase, the column packing is polar (normally silica) and the 
mobile phase solvents are non-polar (hexane, isoctane, ethyl acetate (ETOAc)). In reverse 
phase columns, unlike the normal phase, polar compounds elute more quickly than non 
polar ones. This mode is used in more than 90% of the analysis (80). 
For the separation of similar compounds in the samples there is a need for the use of 
mobile phases with solvent mixtures or systems in gradient. There are two basic methods 
for separation of compounds in HPLC, according to the composition of the mobile phase: 
isocratic and gradient. In isocratic mode, the mobile phase solvent composition remains 
constant with time, being the best mode for simple separations. In the gradient mode, the 
amount of one of the solvents increases with the time, being the best choice for the 
analysis of complex samples and unknown mixtures. Although gradients are adjusted 
according to the analytes, linear gradients are more common (81). 
Thus, the separation is based on the affinity of the different compounds between the 
stationary phase and the mobile phase. The analysis of phytosterols is normally performed 
in reversed-phase columns (C18), and using an isocratic mode with solvent mixtures of 
MeOH:acetonotrile. As non-polar compounds, phytosterols attach to the column, and the 
elution is held according to the analytes polarity. Therefore, the more non-polar 
phytosterols are retained in the column for longer time (80, 81). 
Detection 
The universal detector for this type of compounds is the ultraviolet (UV). Because it 
is not destructive, it constitutes an advantage when there is the need to use another 
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subsequent detection system to acquire more information, or when there is the intention 
to isolate the compounds. The availability of DAD increases the possibility of identifying 
compounds as it registers the chromatograms at different wavelengths with a single 
injection: this detector provides the UV spectrum of each compound eluted, together with 
its retention time, which are two important parameters in the process of identifying 
compounds. The identification of phytosterols is possible by comparison of their retention 
time and UV spectrum with the retention times and spectra of the respective standards. In 
terms of quantification of each individual phytosterol, the most desirable is the relation to 
the area of the peak chromatographically obtained. However, the lack of reference 
substances, which allow the definition of the absorption characteristics of the compound, 
is a limiting factor (80, 82). 
2.3.2. Phlorotannins 
Phlorotannins are marine algae polyphenols with a wide range of molecular sizes. 
Although they have typically 10-100 kDa, their range can span from as small as 126 Da to 
as large as 650 kDa. Phlorotannins are also thought to polymerize as they age and thereby, 
go larger (83). These compounds are specific from brown seaweeds and have been 
reported from almost all brown algae orders (84). 
These secondary metabolites are formed by the polymerization of phloroglucinol 
(1,3,5-trihydroxybenzene) units (Figure 7).  
 
 
 
 
 
 
Figure 7. Phloroglucinol (1, 3, 5 – trihydroxybenzene). 
 
Six different phlorotannins groups were found until now, based upon variations in 
their assemblage from the polymerization of phloroglucinol and the distribution of OH 
groups: phlorethols, fuhalols, fucols, fucophlorethols, eckols and carmalols (Figure 8) 
(85). 
Phlorotannins with ether linkages: This subclass comprises phlorethols (Figure 8 
A) and fuhalols (Figure 8 B), in which phloroglucinol monomers are linked by aryl ether 
bonds. Fuhalols differ from phlorethols because in this subclass phloroglucinol units are 
connected by aryl ether bonds in a regular sequence of para- and ortho- ether bridges. 
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Fuhalols are also characterized by the presence of one additional OH group in every third 
ring and by the lack of one or more OH groups in the whole molecule (86). 
Phlorotannins with phenyl linkages: This subclass comprises fucols (Figure 8 C), 
which consist of phloroglucinol units linked by aryl-aryl bonds (86). 
Phlorotannins with ether and phenyl linkages: This subclass comprises 
fucophlorethols (Figure 8 D), which contain both aryl-ether and aryl-aryl bonds (86). 
Phlorotannins with dibenzodioxin linkages: This subclass comprises eckols (Figure 
8 E) and carmalols (Figure 8 F). Eckols are usually of low molecular size. This subclass is 
composed of molecules with a dibenzodioxin unit substituted by a phenoxyl group at C4. 
Carmalols have a dibenzodioxin unit and are derived from phlorethols. Both subclasse can 
present additional OH groups (86). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8. Phlorotannins groups structures: phloretol (A), fuhalol (B) , fucol (C), fucophloretol 
(D), eckol (E) and carmalol (F). 
 
2.3.2.1. Biosynthesis 
The exact biosynthetic pathway by which phloroglucinol gives origin to 
phlorotannins is not yet fully known, in part because of the difficulty in establishing 
methodologies to monitor phlorotannins synthesis at genetic and enzymatic levels (87). 
Nevertheless, it is known that the aromatic precursor of phlorotannins is biosynthesised 
by the acetate-malonate pathway, also known as polyketide pathway, in a process 
involving polyketide synthases-type enzyme complexes (Figure 9) (83, 84, 88).  
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Figure 9. Phlorotannins biosynthetic pathway (adapted from (89)). 
In the early steps of phlorotannin biosynthesis, Ac-CoA is converted into malonyl 
CoA through the addition of CO2. This changes the acetyl methyl group into a highly 
reactive methylene, leading to a polymerization process, which occurs without a high 
investment of energy. During further synthesis steps, the CO2, which was added as an 
activator, is lost (Figure 9) (89). 
As a result of the polymerization process, a polyketide chain consisting of an acid 
moiety is formed, and the co-enzyme is lost. The polyketide chain is transformed by 
intermolecular ring closure and elimination of H2O, producing a hexacyclic ring. The 
cyclization product is a triketide, which is not stable and, thus, undergoes transformation 
(tautomerisation) into its thermodynamically more stable aromatic form, phloroglucinol, 
consisting of three phenolic OH groups (Figure 9)(89). 
2.3.2.2. Role in seaweeds 
Phlorotannins are accumulated among the vegetative cells of the outer cortical layer 
of brown algae, regardless of the variety of tissue, stage of growth or organ (90). These 
compounds are stored in physodes, which can be recognized in meristodermic and 
promeristematic cells. Physodes accumulate at the zygote periphery early in development, 
being secreted into the primary zygote wall. These phenolic compounds are thought to 
prevent multiple fertilizations, by inhibiting spermatozoid movement, as they are also 
found on the surface of recently fertilized zygotes (91, 92). Nevertheless, in some species of 
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brown algae, phlorotannins tend to be concentrated within the outer cortical layers and 
the mitotic meristematic and meiotic sporogeneous tissues (84). Physodes containing 
phlorotannins can also contribute to the development of the algae cell walls. When 
physodes fuse with the cell membrane, and the phlorotannins are secreted from cells, they 
complex with alginic acid by means of hydrophobic, hydrogen, ionic and covalent bonds 
(92, 93). Despite the multifunction of phlorotannins in algae, their herbivore deterrent 
capacity and cell wall and antioxidant roles should undoubtedly be highlighted. For this, 
the location of these compounds is of central importance. Due to their peripheral 
localization they can absorb at short wavelengths and display a photoprotective role 
against UV radiation, attenuating the inhibition of photosynthesis and deoxyribonucleic 
acid (DNA) damage, which are two major detrimental effects of UV radiation (94). 
For some years it was thought that brown algae could release phlorotannins to the 
sea water (84, 91), under the stimuli of external and environmental factors. Nevertheless, 
exudation of phloroglucinol and phlorotannins was confirmed to take place only after 
algae cell death. Hereupon, whilst the algae are alive, polymeric phlorotannins are strictly 
kept within the algal body, not being released into the sea water (95). 
Several biological activities have been attributed to phlorotannins over the years. 
The UV protection against photo-oxidative stress (96), antioxidant (97-103), antimicrobial 
(102, 104-109), anti-allergic (110) and anti-inflammatory (111-114) are among the most 
important ones. 
Of these, only the antimicrobial, anti-inflammatory and anti-allergic/anti-aging 
activities will be explored along this dissertation. 
2.3.2.3. Extraction and purification 
The procedures used for phlorotannins extraction are widely variable and include 
aqueous mixtures of ethanol and acetone. Acetone is believed to inhibit the interactions 
between phlorotannins and proteins during extraction and also to break hydrogen bonds 
between phlorotannin-protein complexes, increasing the total yield of extraction (84, 115, 
116). Phenolic compounds are usually easily soluble in solvents less polar than H2O and, in 
a general way, the efficiency of the solvent increases with increasing polarity (117). The 
most suitable solvent for phlorotannins extraction was studied by Koivikko and co-
workers, who found the mixture acetone: H2O (7:3) as the most efficient one. This 
research group also evaluated the number of consecutive solvent treatments in 
phlorotannins extraction and described that more than 80% of these compounds are 
released during the first treatment and that four treatments allowed the release of more 
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than 90% of soluble phlorotannins present in brown algae powdered samples. On the 
other hand, for the release of cell wall bound phlorotannins it is necessary to subject the 
sample to an alkaline degradation (118). As free phlorotannins are prone to rapid 
oxidation, in studies involving isolated compounds, acetylation with acetic anhydride-
pyridine is used to protect them from oxidation (86). The conversion of peracetylated 
phlorotannins into their free form can be achieved by reductive ester cleavage, using 
lithium aluminium hydride with tetrahydrofuran as solvent (119). The addition of ascorbic 
acid has also been used to prevent oxidation of phlorotannins extracts, as it increases the 
stability of these compounds (120). 
In order to obtain a phlorotannins rich extract, the mixture resulting from 
acetone:H2O extraction can be purified, taking advantage of the phlorotannins features. As 
these polyphenols have a great adherence capacity to cellulose, the cellulose powder can 
be used to selectively remove phlorotannins from solution. The different affinities of these 
compounds to the solvent and the cellulose will allow their separation and subsequent 
purification from the other extracted compounds (121). 
2.3.2.4. Quantitative analysis of phlorotannins  
Since brown algae are known to contain no other phenolics than phlorotannins (84), 
colorimetric methods for total phenolics quantification seem to be a reliable tool. 
Nevertheless, the colorimetric quantification of these polyphenols has some limitations, as 
there is no selective method to degrade phlorotannins into its basic unit, phloroglucinol 
(84, 87, 121). Additionally, the colorimetric methodologies for phlorotannins 
quantification measure reactive phenolics, which correspond to the extractable physode-
bound phlorotannins. Contrary to what happens with the cell wall-bound phlorotannins, 
the ones in physodes are reactive and they possess the characteristics of effective 
polyphenolic defences. On the other hand, phlorotannins which have been deposited at 
the cell wall, oxidized by peroxidases and complexed with alginic acid can not be 
extractable or detectable by these commonly used colorimetric assays (122). 
The basis of colorimetric methods for polyphenols measurement relies on the 
quantification of total phenolic OH groups present in an extract, independently of the 
molecules in which they occur. Additionally, the chemical reactions in colorimetric assays 
do not always follow the stechiometry and the yield obtained represents an approximation 
of the compounds group under investigation (123). 
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Dimethoxybenzaldehyde (DMBA) assay 
The DMBA assay is specific to quantify phenolic compounds substituted at positions 
1,3 and 1,3,5. The reagent 2,4-dimethoxybenzaldehyde reacts with the OH groups at these 
specific positions and originates a pink colored product, which can be 
spectrophotometrically measured. This methodology is the most appropriated for 
phlorotannins colorimetric quantification, since these polyphenols are hydroxylated at 
positions 1, 3 and 5. Phloroglucinol is used as the monomer standard for phlorotannins 
quantification (87). The main advantage of this method is its insensitivity to interference; 
for example, it does not react with tannic acid containing only ortho and para hydroxyl-
substituted phenolics (124).  
In the reaction between DMBA reagent and phlorotannins there is an electrophilic 
attack by the aldehyde in a strongly acidic solution. The intensity of the color produced 
depends, in part, on the structure of the aldehyde formed, and the variation in reactivity 
depends on the differences in the chemical structures of phlorotannins. The main 
disadvantage of this assay is that it can form chromophores with some non-polar 
metabolites; nevertheless, this situation can be avoided if the colorimetric quantification is 
performed with purified fractions of phlorotannins (124, 125). 
2.3.2.5. Characterization by liquid chromatography-mass 
spectrometry (LC-MS) 
The availability of standards in the market allows the characterization of compounds 
present in a sample by comparison of their chemical characteristics with those of the 
respective standards. Thus, compounds which absorb in the UV-Vis are easily identified, 
after chromatographic separation, by comparing their retention time and absorption 
spectrum with the respective standard. Nevertheless, despite phloroglucinol, to date no 
phlorotannins standards are available. This constitutes a limitation to the identification of 
these molecules, as they exhibit different retention times and UV spectrum, depending on 
the degree of polymerization (which increases with age) and the nature of connections 
their basic units establish between each other. Some approaches to separate phlorotannins 
by HPLC have been performed in the past few years; nevertheless, the studies were 
focused on a phlorotannins profile without identifying or quantifying the individual 
compounds (120, 126, 127). For these reasons, HPLC-DAD is far from ideal for 
characterizing these compounds and more specific methods are required to separate, 
identify and quantify individual phlorotannins, in order to make possible the assignment 
of specific biological activities and pharmacological effects to specific compounds. 
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LC-MS is an advantageous technique, which combines the chromatographic 
separation by liquid chromatography with the detection by mass spectrometry (MS). In a 
general way, the molecules present on the sample are converted into a gas phase ionic 
species by the addition or removal of electrons or protons (Figure 10) (128).  
 
 
 
 
 
 
 
 
 
 
Figure 10. Schematic representation of a sample analysis by MS, operating in positive ion mode. 
These ionic species consist of atoms, molecules or fragments of molecules carrying 
one or more positive or negative electrical charges. One of the most common ion 
formation techniques consists in bombarding the gas phase sample with a beam of 
electrons. During this procedure, an electron (e-) is removed from the highest occupied 
molecular orbit of the molecule (M), forming a positively charged molecular ion 
(equation 1) (128). 
M + e- →M+• + 2e-                                                          (1) 
Nevertheless, depending on the mode of ionization, a variety of ion types can be 
formed, for instance: 
[M+H]+ - positively charged ion/protonated molecule; 
[M-H]- - negatively charged ion/deprotonated molecule; 
[M]•+ - positive radical ion, formed by the removal of an electron from a molecule; 
[M]- - negative molecular ion, formed by the addition of an electron to a molecule; 
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[M+Na]+, [M+Cl]-, [M+NH4]+- adduct ions, formed by the addition of an 
ionizing species to a molecule. 
The molecular ions are separated in the mass analyzer, according to their mass-to-
charge (m/z) ratio (Figure 10). The separated ions are then passed to the detector 
system, which measures their concentration, and the result is finally displayed in the form 
of a mass spectrum (128). Since the ions on the gas phase are very reactive (susceptible to 
collisions and interactions) and short living, their formation and manipulation normally 
occurs under high vacuum (129). 
Thus, despite the vacuum system (responsible for maintaining the low pressure in 
the mass spectrometer) the detector (which stores, processes and displays the data) and 
the inlet system (responsible for transferring the sample into the ion source, HPLC and 
gas chromatography (GC) being the most common), a mass spectrometer comprises 
fundamentally two important components: 
1. Ion source - where the samples are ionized prior to their analysis in the mass 
spectrometer. There are a variety of ionization techniques, which convert the neutral 
molecules into gas-phase ions. The ion sources can be a liquid-phase or solid-state. In the 
liquid-phase, the analyte is introduced by nebulization into the source where ions are 
produced at atmospheric pressure and directed to the mass spectrometer through some 
vacuum pumping stages. Electron spray ionization (ESI), atmospheric pressure chemical 
ionization (APCI) and atmospheric pressure photo-ionization (APPI) correspond to this 
type. In the solid state ion sources, the analyte is in the form of a deposit, which is then 
irradiated by energic particles or photons that desorb ions from the surface of the deposit. 
Of this is example the matrix-assisted laser desorption ionization (MALDY). Generally, the 
ion source is kept at atmospheric pressure and continuous pressure and voltage gradients 
are used from the source to the detector in order to pump out the ions through the 
analyzer (128-130). 
2. Mass analyzer – this component is considered the heart of the mass spectrometer 
and is responsible for the separation and analysis of the ionic species according to m/z. As 
examples of mass analyzers are the magnetic/electric sector, the linear quadrupole ion 
trap (LIT), three-dimensional quadrupole ion trap (QIT), the orbitrap, the  time of flight 
(TOF) and cyclotron resonance (ICR); they can be selected according to their resolution, 
mass range, scan rate and detection limits (129). 
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ESI 
ESI consists in a soft ionization technique to ionize intact chemical species by 
multiple charging. Thus, a very little residual energy is retained by the analyte and few or 
no fragmentation occurs (131). ESI is produced by the application of a strong electric field 
(under atmospheric pressure), over a solution passing through a capillary tube, under a 
weak flux. A charge accumulation will be induced at the liquid surface allowing the 
formation of highly charged droplets. The droplets will pass through a steam of a heated 
inert gas, which removes the lasting solvent molecules. After solvent evaporation, the 
droplets shrink and their charge per unit volume increase (129, 132, 133). 
The major advantage of ESI is the possibility to produce multiple charged ions from 
large molecules, which improves the sensitivity at the detector and allows the analysis of 
high molecular weight molecules, as is the case of phlorotannins (83, 129). Due to its 
characteristics, ESI shows a good response over analytes with ionizable acid/basic polar 
functional groups. Due to the advantages of this instrumentation and due to the 
limitations of DAD for the characterization of phlorotannins, HPLC has been coupled with 
ESI-MS for the molecular fractionation prior to MS analysis. HPLC-ESI/MS has become a 
very powerful technique capable of analyzing both small and large molecules of various 
polarities in complex biological samples (134). 
Mass spectrum 
In HPLC/LC-MS, data is presented in form of a chromatogram, a mass spectrum 
being displayed for each analytical signal. In a mass spectrum there is a molecular ion 
region, corresponding to the ion formed by the removal of one or more electrons, and a 
fragment ion region, where the molecule-related fragments can be found (Figure 10). 
Thus, the molecular mass of the analyte is often represented by the peak with the highest 
m/z value of the mass spectrum. This peak corresponds to the molecular ion ([M]•+) or to 
the protonated molecule ([M+H]+). The base peak is the most intense peak in the 
spectrum and represents the most stable ion resulting from the ionization process. The 
intensities of all other ions are normalized in accordance to the base peak. Fragment ions 
appear with masses lower than the molecular mass and reflect the amount of energy 
added to the molecules during ionization (higher the energy, higher the decomposition of 
the molecular ion) (Figure 10). In a general way, the ions resulting from ESI are multiple 
charged and the analyte remains intact (135). 
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Mode of ionization 
MS has traditionally deal with positively charged ions, this being the ions polarity 
more commonly formed. Nevertheless, instruments are designed to handle in both 
positive ion mode (PIM) and negative ion mode (NIM), according to the extent of 
protonation and deprotonation of the analytes. The extent of protonation and 
deprotonation of the molecules contained in the analyte depends on various factors, 
including the nature and structure of those molecules. Substances having basic groups, 
such as amines, amides and esters, are usually analyzed in PIM, since they are easily 
protonated. On the other hand, substances with acidic functions like carboxylic acids and 
phenols are easily deprotonated and, therefore, negatively analyzed. The nature of the 
solvent and pH are also important in generating positive and negative ions, as the charged 
droplets are formed by the solvent. When the solution containing the analyte is pumped 
through the capillar, an electrochemical reaction occurs and the solvent suffers oxidation 
(PIM) or reduction (NIM), which will supply positive or negative ions in the solution. The 
positive ions are analyzed in solvents with low pH, while negative ions are produced from 
solutions of chloroform and high pH values. In a general way, polar solvents like H2O, 
MeOH and acetonitrile are commonly used in ESI because of their facility to undergo 
electrochemical reactions (136, 137). 
As so, in ESI, the ionization can occur in PIM or NIM. In PIM, the spraying needle is 
maintained at positive potential and the charging occurs via protonation. In NIM, a 
negative potential is kept and charging occurs by deprotonation of the analyte. This makes 
the detected ionic species not corresponding to the true ion but the protonated or 
deprotonated molecules (138). The way to find the mass of the analyte by its mass 
spectrum is based on the Mathematical Charge Deconvolution, that extracts the 
molecular mass information from spectra showing sequences of peaks due to ions with 
varying number of charges, being nowadays part of ESI/MS instruments (131, 139, 140). 
Despite the foregoing, the ionization mode is commonly chosen according to the best 
molecular ionization. 
The fragments and molecular ions obtained in a mass spectrum are specific of each 
compound and function as a compound fingerprint. Thus, concerning phlorotannins, it is 
common to find fragments with m/z corresponding to 126, which is the molecular weight 
of their basic unit phloroglucinol (126 g/mol). Moreover, by the m/z of the molecular ion it 
is possible to know how many molecules of phloroglucinol constitute the polymer. With a 
more detailed analysis, it is also possible to predict the kind of linkages established 
between the phloroglucinol units since, according to the chemical linkages, the molecules 
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will break and produce different kinds of fragments. Thus, this first analysis of the LC-MS 
data gives much more information about these compounds than the analysis of the data 
resulting from HPLC-DAD (141). 
In the absence of commercially available standards, an effective way to obtain 
accurate information about a compound is through its isolation (142). Once the compound 
has been isolated and its structure has been assigned (by other methodologies of analysis, 
for instance, nuclear magnetic resonance (NMR), correlation spectroscopy (COSY) and 
heteronuclear multiple Quantum correlation (HMBC), it is possible to assign it a mass 
spectrum and to construct a library. 
2.3.2.6. Compounds isolation 
The isolation of compounds is in the basis of discovery, development and 
manufacture of drugs. For achieving it, and in order to obtain enough quantity for 
chemical characterization and structure elucidation, huge amounts of samples are 
necessary, together with a wide array of solvents with variable polarities. Diverse 
chromatographic techniques are in the basis of compounds isolation, the affinities 
between the stationary and mobile phase being critical for that. 
Column chromatography 
Column chromatography allows the separation of compounds from a mixture, for 
example, in crude extracts, or the isolation of products resulting from chemical reactions 
from synthesis. Column chromatography uses a stationary phase, normally packed in glass 
columns. The mixture of compounds is applied at the top of the column and the mobile 
phase is allowed to flow through the stationary phase. The mobile phase can flow through 
the stationary phase by gravity or with the application of positive pressure, which is used 
to force the eluent down the column at a faster rate; in this situation, the technique is 
called vacuum liquid chromatography (VLC). In column chromatography, each 
component of the mixture will exhibit different interactions with the stationary and 
mobile phases, which will depend on the chemical structure and geometry of each 
molecule. This allows each component of the mixture to be carried down the column at 
variable rates so that separation can be achieved (143). 
Normal vs reversed phase chromatography 
There are basically two types of solid/liquid column chromatography, the normal-
phase (NP) chromatography and the reversed phase (RP) chromatography. In NP 
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A B
chromatography, the stationary phase is more polar than the mobile phase. Several types 
of stationary phases can be used, silica gel being the most common. It provides optimum 
and reproducible compounds purification and is available in a variety of shapes and sizes 
(e.g. Silica Gel 60, which means a pore diameter of the silica particles of 60 Å). This polar 
stationary phase composed of silanol groups (Figure 11 A) allows the less polar molecules 
to elute first (as polar molecules experiment a greater degree of retention than non-polar 
ones) (143). 
 
 
 
 
 
 
Figure 11. Schematic representation of silica used in normal phase (A) and reversed phase 
chromatography (B). 
Contrarily, in RP chromatography the stationary phase is non-polar. The non-polar 
stationary phase can be produced by covering the polar surface of the silica gel with a non-
polar layer of alkanes (Figure 11 B). The mobile phase is generally a binary mixture of 
H2O and a miscible polar organic solvent, like MeOH, acetonitrile or tetrahydrofuran 
(143). 
Compounds separation can be achieved in isocratic conditions, where the mobile 
phase is not changed during separation. On the other hand, a gradient separation is more 
commonly used and, in this situation, the composition of the mobile phase is changed 
during separation (143). 
TLC 
TLC is a chromatographic technic commonly used to monitor compounds separation 
during the isolation process. It is performed in a thin support, generally aluminum or 
glass, covered by a thin-layer of stationary phase, generally silica. The mixtures to be 
separated are applied in a spot at about 1 cm from the bottom of the TLC plate. The 
solvent is allowed to evaporate and the plate is placed on a transparent separation 
chamber containing the mobile phase. The mobile phase goes up the plate by capillary 
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action, allowing compounds separation. The separation is enhanced by varying the 
content of the mobile phase, which is performed according to the coating of the TLC plate 
(144). 
After complete elution, the TLC place is analyzed. The components of the mixture 
are separated and give origin to spots with different retention factors (Rf). As the 
compounds present in the mixture can give origin to colorless spots, it is necessary the use 
of additional methods for their viewing. Thus, the spots can be visualized under UV light, 
at 254 nm. If they are not visible this way, the TLC plates can be revealed by spraying the 
plates with TLC visualization reagents. p-Anisaldehyde reagent is a preparation of p-
anisaldehyde in glacial acetic acid and sulfuric acid. This reagent is sensitive to most 
functional groups, especially the strongly and weakly nucleophilic, and tendentiously 
insensitive to alkenes, alkynes and aromatic compounds. The revelation of the TLC 
sprayed with p-anisaldehyde reagent requires heating to 110 ºC. p-Anisaldehyde tends to 
stain the TLC plate itself to a light pink color, while other functional groups tend to vary 
with respect to coloration (144, 145). 
2.3.3. Glycerolipids 
Glyceroglycolipids are the most widespread group of lipids in nature. They are 
synthesized by all eukaryotic and prokaryotic organisms and constitute important 
membrane lipids with a key role in energy storage, membrane formation and fluidity and 
in chemical interactions with the environment (146, 147). This group consists of 
amphipathic molecules formed by the joint of fatty acids and glycerol by ester bonds. The 
glycerol molecule can be mono-, di- or tri-substituted by fatty acids, originating mono-, di- 
or triglycerides, respectively. Beyond fatty acids, the glycerol molecule can establish 
glycosidic linkages with one or more sugar residues, which, together with the fatty acids, 
originate glycosilglycerols, commonly found in plant membranes (147, 148) (Figure 12).  
Of them, the ones with galactose in their composition constitute the main part of 
plant membranes, monogalactosyldiacylglycerols (MGDGs) and 
digalactosyldiacylglycerols (DGDGs) being the most common (148). Brown seaweeds play 
an important role in Asian countries’ diets, in part because they contain valuable nutrients 
and bioactive components, some of which have not been found in terrestrial plants. 
Especially the species grown in temperate or subarctic areas can accumulate Ω-3 and Ω-6 
polyunsaturated fatty acids (PUFAs), eicosapentaenoic acid (EPA, 20:5 Ω-3), stearidonic 
acid (SDA, 18:4 Ω-3) and α-linolenic acid (LNA, 18:3 Ω-3) being the major Ω-3 and 
arachidonic acid (ARA, C20:4 Ω-6) the major Ω-6 PUFA (149, 150). 
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Figure 12. Structures of triglycerides, diglycerides, monoglycerides, MGDGs and DGDGs. 
Galactose – A, oleic acid – B. 
Contrarily to what happens in animals and yeasts, glycoglycerolipids are the major 
membrane lipids of brown seaweeds, having a special importance in photosynthetic 
membranes (151, 152). The high contents of PUFAs in brown seaweed lipids are attributed 
to the high levels of these PUFAs in glycoglycerolipids, as they constitute the major brown 
seaweed lipids class (149). Most brown seaweed lipids have higher contents of Ω-3 PUFAs, 
which can constitute an advantage for the increment of the Ω-6/Ω-3 ratio, considering 
brown seaweeds incorporation into food products (153). Excessive amounts of Ω-6 PUFAs 
and a very high Ω-6/Ω-3 ratio is found in Western diets, which promotes the pathogenesis 
of many diseases, including cardiovascular disease, cancer and inflammatory and 
autoimmune diseases, whereas increased levels of Ω-3 PUFAs exert suppressive effects 
(154).  
Only the anti-inflammatory activity of glycerolipids will be explored along this 
dissertation. 
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2.4. Biological activities 
As referred above, there are numerous biological activities attributed to secondary 
metabolites from marine origin, where macroalgae hold a special place (155). The 
biological activities assigned to these organisms are related to both extracts and isolated 
compounds (107, 108). Among them, the antimicrobial, anti-inflammatory and anti-
allergic activities are especially important, since there is a search for new biological 
compounds with potential to replace those used in therapeutics for which there are 
already many resistances (156, 157). The antioxidant activity is, by far, the most explored, 
in part because the oxidative stress is a condition present in most of the pathologies (158, 
159). 
2.4.1. Antioxidant activity 
For its general importance and relationship with numerous pathologies, the 
antioxidant potential of crude and purified extracts or isolated compounds is assessed by 
almost all researchers in biological studies. As so, during the last decades, research on 
oxidative stress has been subject of a rapid progression and antioxidants have gained 
growing notoriety among the scientific community and general public (160). 
2.4.1.1. Oxidative stress 
Oxidative stress can be defined as a biological condition occurring from the 
imbalance between the production of reactive species and their detoxification through 
biological systems (enzymatic and non-enzymatic) that remove or repair the damage they 
cause. All living organisms have biological systems responsible for removing and repairing 
the damage caused by free radicals, existing a balance between them and the molecules 
responsible for their neutralization. Every time this redox balance is disturbed, and there 
is an increment in the production of reactive species, there will be damage in all cellular 
components, including proteins, lipids and DNA, resulting in a state of oxidative stress 
(161). Thus, the maintenance of the equilibrium between the production of reactive species 
and antioxidant defenses is an essential condition for normal organism functioning. 
Nevertheless, despite their association with several diseases and pathological conditions, 
such as neurological diseases and inflammatory states, and with the aging process, 
reactive species can be beneficial to the organism when used by the immune system to 
destroy the pathogens, or when acting as messenger molecules in cell signaling pathways 
(162, 163). 
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Oxidative stress may result from natural causes, like situations of extreme exercise 
or inflammation, and from non-natural causes, such as the presence of xenobiotics in the 
body (164). There is a continuous need for the inactivation of oxidants formed as a normal 
product of aerobic metabolism. The intake of dietary antioxidants may help to maintain an 
adequate antioxidant status. Moreover, it is recognized that antioxidants other than 
vitamins can constitute a major factor responsible for such protective effects (165). 
2.4.1.2. Reactive species 
There are several reactive species directly involved in the establishment of oxidative 
stress. Nevertheless, the most common are the reactive oxygen species (ROS) and the 
reactive nitrogen species (RNS) (166, 167). 
Oxygen molecule has low reactivity; however, due to its electronic configuration, it 
can be activated or reduced, leading to the formation of toxic molecules (166). ROS 
include radical and non-radical species derived from oxygen and represent the most 
important class of reactive species generated in living systems. Among the radical species, 
hydroxyl (•OH), peroxyl (ROO•), alkoxyl (RO•) and superoxide anion (O2•-) are the most 
representative. In turn, the non-radical ones include hydrogen peroxide (H2O2), singlet 
oxygen (1O2) and hypochlorous acid (HOCl) (167). O2 •- is formed by reduction of triplet 
molecular oxygen (3O2), in a process mediated by enzymes, such as NADPH oxidases and 
xanthine oxidase (XO) or, non-enzymatically, by redox-reactive compounds like the semi-
ubiquinone compound of the mitochondrial electron transport chain (Figure 13). 
Superoxide dismutase (SOD) is responsible for the conversion of superoxide into 
hydrogen peroxide (168). In biological tissues, O2•- can also be converted non-
enzymatically into the non-radical species H2O2 and 1O2 (169). In the presence of reduced 
transition metals, such as ferrous or cuprous ions, H2O2 can be converted into the highly 
reactive •OH, or into H2O, by the enzymes catalase (CAT) or glutathione peroxidase (GPx) 
(Figure 13) (170). O2•- is the primary ROS produced in cells. Due to the various 
conversions that O2•- might be targeted, most of the effects observed in cellular and non-
cellular systems are indeed not directly mediated by O2•-, but rather by its derived ROS. Of 
those, the reactions with cellular lipids, proteins and DNA may be highlighted, since they 
can lead to cell damage and death (171). 
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Figure 13. Schematic representation of the generation of several ROS and RNS. NADPH - 
nicotinamide adenine dinucleotide phosphate reduced form; O2•- - superoxide radical; SOD – 
superoxide dismutase; H2O2 – hydrogen peroxide; GPx – glutathione peroxidase; •OH – hydroxyl 
radical; PUFAs – polyunsaturated fatty acids; ROO• - peroxyl radicals; RO• - alkoxyl radicals; NO – 
nitric oxide; ONOO- - peroxynitrite; GABA – ɣ-aminobutiric acid. 
Among RNS, the nitric oxide radical (•NO) and the non-radical reactive species 
peroxynitrous acid (ONOOH) and peroxynitrite (ONOO-) can be highlighted, the last ones 
being extremely harmful for the central nervous system (CNS) (172). •NO is produced in 
higher organisms by the oxidation of L-arginine, in a process catalyzed by the enzyme 
nitric oxide synthase (NOS) (173, 174). Depending on the microenvironment, NO can be 
converted to various other RNS, such as nitrosonium cation (NO+), nitroxyl anion (NO-) or 
ONOO- (175). •NO toxicity is predominantly linked to its ability to combine with 
superoxide anions (Figure 13 and equation 2): 
•NO + O2•- → ONOO-                                                             (2) 
The half-time of •NO lasts only a few seconds in an aqueous environment and its 
stability is higher under low oxygen concentrations. However, since it is soluble in both 
aqueous and lipid media, it readily diffuses through the cytoplasm and plasma 
membranes, affecting neuronal transmission in CNS. In extracellular medium, •NO reacts 
with oxygen and H2O to form nitrate and nitrite anions (176). When the generation of RNS 
in a system exceeds the system's ability to neutralize and eliminate them, a situation of 
nitrosative stress occurs. 
The role of NO in biological systems and its relation with pathological states will be 
further explored in the section concerning inflammation. 
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2.4.1.3. Antioxidants 
Antioxidants can be defined as substances that delay or prevent the oxidation of an 
oxidizable substrate (177). Defense against free radicals-induced oxidative stress involves 
preventive and repair mechanisms and physical and antioxidant defenses. The antioxidant 
defenses can be exogenous or endogenous and, within the last, enzymatic and non-
enzymatic. Enzymatic antioxidant defenses include SOD, GPx and CAT, while non-
enzymatic ones are represented by ascorbic acid (Vitamin C), α-tocopherol (Vitamin E), 
glutathione (GSH), carotenoids, flavonoids, among other antioxidants. Under normal 
conditions, there is a balance between both the activities and the intracellular levels of 
these antioxidants, which is essential for organisms’ homeostasis (177, 178). Antioxidants 
can act in vivo or in vitro by inhibiting the generation of reactive species, or by direct 
sequestration of these species. In vivo, an antioxidant can also act indirectly and increase 
the endogenous antioxidant defenses, by increasing the expression of genes encoding for 
SOD, CAT or GPx, which prevent the formation of reactive species. The various defenses 
complement each other and act on different oxidizing agents or cellular compartments 
(164).  
2.4.1.4. Evaluation of the antioxidant potential 
The evaluation of the antioxidant capacity of natural extracts or compounds can be 
easily evaluated by spectrophotometric methods. However, this screening does not reflect 
the physiological conditions, but constitutes a first approach to the biological potential of 
extracts and compounds (179). 
Macroalgae have been deeply explored in the last decades and, apart from the 
isolation of compounds from different chemical groups, several kinds of extracts have 
been evaluated for their capacity to scavenge free radicals. Because macroalgae are 
photosynthetic organisms, they are exposed to sun’s radiation and to high concentrations 
of oxygen, which promotes the formation of free radicals. The absence of structural 
damage in these organisms indicates a good protection against oxidation and, for this 
reason, these organisms are a good source of secondary metabolites with antioxidant 
potential. 
The evaluation of the antioxidant activity of macroalgae extracts has been a constant 
over times (98, 99, 180, 181). Several kinds of crude extracts, purified extracts and isolated 
compounds have been screened in order to find the main compounds or groups of 
compounds responsible for the antioxidant activity in each phylum. Alongside the 
enormous antioxidant capacity of carotenoids, one of the main responsible for the 
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antioxidant activity attributed to brown macroalgae are polyphenols (100). This capacity 
has been proved by the in vitro evaluation of extracts and isolated compounds using 
human cell lines (101, 182). Recently, Parthiban and co-workers evaluated the antioxidant 
capacity of ethanolic and acetonic macroalgae extracts and verified that the antioxidant 
potential was directly proportional to the amount of polyphenols present in the extract 
(98). Since phlorotannins are the unique polyphenols of brown algae (84), the antioxidant 
activity of these organisms can be mainly attributed to these compounds. Fujii and 
colleagues (183) isolated phlorotannins from the brown algae Eisenia bicyclis (Kjellman) 
Setchell and reported these compounds as potent antioxidant agents, with eckol and 
fucofuroeckol A being the most active, presenting a stronger activity than the natural 
polyphenols kaempferol, quercetin, myricetin and chlorogenic acid (183). The 
phlorotannins eckstolonol (184) and fucodiphlorethol G (185) where reported as strong 
radical scavengers. Other compounds were reported in brown algae for their antioxidant 
activity, namely meroditerpenoids (186, 187) and monogalactosyldiacylglycerols (188). 
2.4.2. Lipid peroxidation (LPO) 
LPO is directly related to oxidative stress, since it consists in the oxidative 
degradation of lipids. Lipids are targets of many ROS and RNS and are oxidized to give a 
diverse array of products. Thus, in vivo LPO has been implicated as the underlying 
mechanism in numerous disorders and diseases, such as cardiovascular and neurological 
diseases and aging. Nevertheless, it is unclear if LPO is a cause or consequence of such 
pathological events (189). There are three basic mechanisms leading to the peroxidation of 
lipids, namely free radical-mediated oxidation, free radical-independent oxidation and 
non-enzymatic oxidation, and each mechanism requires specific antioxidants (190). Due 
to its etiology, only free radical-mediated oxidation will be discussed in this dissertation. 
In free radicals-mediated LPO, one initiating free radical can oxidize many 
molecules of lipids, which occur in biological membranes and low density lipoproteins 
(191). Different types of reactive species can be involved in this process, namely RO• and 
•OH (which can arise from the Fenton reaction of H2O2 and Fe2+, from peroxynitrite, or 
from high energy irradiation) (Figure 14). 
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Figure 14. Schematic representation of free radical-mediated lipid peroxidation. PUFA – 
polyunsaturated fatty acid; •OH – hydroxyl radical; H2O – water; O2 – oxygen. 
LPO (Figure 14) is initiated by the abstraction of hydrogen from PUFA originating 
a carbon-centered radical. This radical can undergo molecular rearrangement to form a 
more stable compound. The addition of O2 to the lipid radical originates a lipid peroxyl 
radical, which can form a hydroperoxide via the abstraction of hydrogen from the adjacent 
fatty acid, or suffer molecular rearrangement and addition of O2 to form new radicals, 
leading to the propagation of LPO. Of these reactions, the important chain propagation 
step is the abstraction of bisallylic hydrogen from lipids by lipid peroxyl radicals to give 
conjugated diene lipid hydroperoxide and new lipid radicals, which continue another 
chain reaction (192). 
2.4.2.1. LPO inhibition 
Linoleic acid (LA) has been used to study the capacity of drugs to inhibit LPO, not 
only because it is the most abundant PUFA in living organisms, but also because its 
oxidation proceeds by a straightforward mechanism and yields simple reaction products, 
which does not always happen with other PUFAs (193). 
The effect of high molecular weight phlorotannins on LPO  was evaluated by Wei 
and co-workers in mouse liver, in vivo. These authors observed that these polyphenols 
strongly inhibited the generation of malondialdehyde (a product of LPO) (194). 
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Phlorotannins isolated from three Laminarians (eckol, phlorofucofuroeckol A, dieckol and 
8,8′-bieckol) showed potent phosphoLPO inhibition in a liposome system (103). The LPO 
inhibition recorded in fish oil and LA was evaluated with an extract of Hizikia fusiformis 
(Harvey) Okamura and attributed to its polyphenolic compounds (195). In fact, some 
years before, the capacity of phlorotannins to prevent fish oil rancidity was evaluated by 
Xiaojun and colleagues, who proved that phlorotannins purified from a Sargassaceae 
presented an antioxidant capacity in this field 2.6 times higher than a 0.02% tert-butyl-4-
hydroxytoluene (BHT) solution (196). These polyphenols have also shown capacity to 
prevent the LPO reaction induced by UV radiation, suggesting that phlorotannins play a 
role in intra and extracellular protection by absorption and oxidation processes (197, 198). 
Due to their role in health and tissue homeostasis, antioxidants and LPO have been also 
taken as biomarkers of tissue damage (199). 
In addition to the health benefits provided by the inhibition of LPO, some 
researchers have mentioned that ROS and lipid oxidation in food industry can be 
controlled or minimized by the addition of commercial synthetic antioxidants or natural 
antioxidants (200). 
2.4.3. NO and Inflammation 
Inflammation can be defined as a mechanism of innate immunity by which the 
organism responds to harmful stimuli. As a complex biological response of vascular 
tissues, inflammation is mainly characterized by vasodilatation, which results, in a large 
extent, from NO-dependent processes(201, 202). 
NO is highly permeable and diffuses rapidly across the membranes. Because it is 
responsible for promoting blood vessels relaxation, it was also termed as endothelium 
relaxing factor (201). In inflammatory responses this effector molecule can modulate the 
release of a wide range of inflammatory modulators, enzymes activity, blood flow and 
adhesion of leucocytes to the vascular endothelium (202). Under normal physiological 
conditions NO produces an anti-inflammatory effect. Anyway, once over-produced, it acts 
as a pro-inflammatory mediator and induces inflammation. Having the endothelial cells as 
the main target, this molecule leads to vasodilatation in cardiovascular system and is 
involved in immune responses by cytokine-activated macrophages (203). As a 
neurotransmitter, it acts at neuron synapses and regulates apoptosis (204). Thus, under 
pathological conditions, the undesirable effects resulting from the overproduction of this 
molecule are, in a general way, related to vasodilatation, inflammation and tissue damage. 
Face to this, molecules with the capacity to suppress the overproduction of NO and avoid 
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tissue destruction, have been seen as potential anti-inflammatory agents. Both inhibitors 
of NO biosynthesis and synthetic L-arginine analogous demonstrated a successful effect on 
this field (201, 205). 
NO is produced through its precursor, L-arginine, by the action of the specific 
enzyme NOS. From the activity of NOS, by oxidation, also results the amino acid L-
citrulline (173, 174) (Figure 15).  
 
 
 
 
 
 
 
Figure 15. Schematic representation of NO production by iNOS in macrophages. LPS stimulation 
induces NF-kB, which stimulates the production of iNOS through the activation of iNOS gene in the 
nucleus. iNOS produces NO and L-citrulline through the precursor L-arginine. NO is released to 
the extracellular medium. In the phagosomes, NO interacts with O2•- originating ONOO- and HO•. 
LPS – lypopolysaccharide; TLR4 – toll like receptor 4; NF-kB –nuclear factor kappa; iNOS – 
inducible nitric oxide synthase; mRNA – messenger ribonucleic acid; O2•- - superoxide anion; 
OONO- - peroxynitrite anion; HO• - hydroxyl radical. 
 
There are three isoforms of NOS, all of them composed by an oxygenase and a 
reductase domain (homologous with cytochrome P-450 reductase). Two of the three 
isoforms of NOS were first isolated from rat neurons and bovine endothelial cells and 
named neuronal NOS (NOS I) and endothelial NOS (NOS III), respectively. These 
enzymes are constitutively expressed in cells and responsible for synthesizing NO in 
response to an increase in Ca2+ or stress stimuli (Figure 15) (206, 207). The third 
isoform, the inducible NOS (iNOS or NOS II), is constitutively expressed in some tissues 
and is typically synthesized in response to inflammatory or pro-inflammatory mediators, 
such as cytokines or endotoxins (like bacteria products) (208).  
Macrophages are a major component of the mononuclear phagocyte system and play 
a critical role in initiation, maintenance and resolution of inflammation (208). These cells 
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start the production of NO, for example, after exposure to bacterial lipopolysaccharide 
(LPS), and continue its production for several hours. The NO produced can combine with 
O2•- in the phagosomes, forming OONO- and consequently •OH, which is used by these 
cells to kill ingested bacteria (Figure 15) (209). The over-production of NO by iNOS can 
lead to septic shock, which is characterized by hypotension, inadequate tissue perfusion 
and organ failure, often resulting in death. Sepsis can be managed by drugs with the 
capacity to inhibit NO production or action (210). 
2.4.3.1. Anti-inflammatory activity 
The use of macrophage cell lines as a model for anti-inflammatory capacity 
evaluation is a common procedure. The ability of isolated compounds and extracts from a 
wide range of matrices to reduce the NO in the extracellular medium of LPS-stimulated 
macrophages is evaluated. The reduction of the NO in the culture medium is not enough, 
per se, for attributing an anti-inflammatory activity to a compound or extract. This 
happens because the decrease in NO levels can be done by simple scavenging. In order to 
attribute anti-inflammatory activity to any matrix, other complementary tests have to be 
performed, for instance, the evaluation of citrulline or the evaluation of the NO scavenging 
in a cell-free system.  
In recent years, it has been paid growing attention to the anti-inflammatory activity 
of both extracts and isolated phlorotannins from seaweeds (211-215). Perhaps because of 
their wide distribution and ecological importance, species from the genus Eisenia and 
Ecklonia have been the most studied (216). Jung and co-workers isolated five 
phlorotannins from an Eisenia species (eckol, dieckol, 7-phloroeckol, phlorofucofuroeckol 
A and dioxinodehydroeckol) and found that they dose-dependently inhibited LPS-induced 
NO production at non-toxic concentrations (212). In another work, Sugiura and co-
workers went further and studied the same seaweed species in an in vivo model for the 
first time (213). These authors tested four isolated phlorotannins and the results were as 
expected, with a good anti-inflammatory activity for the tested compounds (eckol, 8,8’-
bieckol, phlorofucofuroeckol A and B). Kim and colleagues evaluated the antioxidant and 
anti-inflammatory activity of phlorotannins isolated from a species of Ecklonia and 
concluded that phlorofucofuroeckol A significantly inhibited the LPS-induced production 
of NO and PGE2 through the down-regulation of iNOS and cyclooxygenase 2 protein 
expression (217). Other works performed with seaweeds extracts attribute their anti-
inflammatory activity to these polyphenols (218, 219). 
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Along with phlorotannins, the anti-inflammatory activity of glycerolipids has been 
studied in different cell lines. These compounds have the ability to down-regulate iNOS 
expression in cells exposed to LPS, thus exerting an anti-inflammatory action by the 
reduction of NO production (220, 221). Some structure-activity relationships have been 
established for this kind of compounds. Although the mechanism of their anti-
inflammatory action is not completely understood, it is known that glycerolipids with 
higher levels of unsaturation are more effective in inhibiting iNOS. On the same way, this 
action is also dependent on the position of the unsaturations (221). 
2.4.4. Hyaluronidase (HAase) 
Skin is the largest human organ and constitutes its first line of defense from external 
factors. As an interface with the environment, skin is particularly vulnerable to ROS, since 
it is exposed to oxidative stress from both endogenous and exogenous sources (222, 223). 
Although oxidative stress is a key factor in this process, hyaluronic acid (HA) also plays a 
significant role (223). This anionic, non-sulfated glycosaminoglycan forms the core of 
proteoglycan, which consists of heavily glycosylated proteins responsible for maintaining 
the proper volume and flexibility of the skin. The integrity of HA inside the dermal matrix 
is essential for cell integrity, mobility and proliferation (224). Under oxidative stress, 
HAase, the enzyme responsible for the depolymerization of HA, is over-activated and 
excessively breaks down HA, leading to the destruction of the proteoglycan network. This 
results in the deregulation of skin homeostasis and aggravates inflammatory and allergic 
states. Besides the easy spread of allergic and inflammatory mediators, occurring from the 
change in proteoglycan network, skin loses sustainability and gets aged appearance (224). 
2.4.4.1. HAase inhibition 
The inhibition of this enzyme can play an important role in several pathological 
states. Even though in an indirect way, HA has an important role in the propagation and 
exacerbation of allergic, inflammatory and infectious states. The prevention of HA’s 
degradation via inhibition of HAase contributes to maintain the normal skin structure, as 
well as its barrier function, reducing the spread of propagation of allergens, ROS, RNS and 
microorganisms (225). 
The effect of phlorotannins in preventing HA’s degradation via HAase inhibition is 
related not only to the prevention of skin aging, but also to the reduction of inflammatory 
states, allergy and migration of cancer cells. These compounds can effectively contribute to 
the recovery of skin homeostasis and consequently prevent the downstream events that 
physically damage the dermal matrix structure. They are not only potent ROS scavengers, 
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but have also demonstrated a huge capacity to inhibit HAase and to minimize oxidative 
stress through a synergy created by the elimination of ROS and enhancement of the 
antioxidant defense capacity (110, 111, 226). This feature, along with the potent anti-aging 
activities, is the hallmark of phlorotannins that enables effective protection from the loss 
of elasticity of aged skin (224). For these reasons, the use of natural anti-aging products 
derived from marine sources is gaining prominence over the years (157). 
2.4.5. Antimicrobial activity 
2.4.5.1. Bacteria 
Bacteria are considered the first inhabitants of earth and their number overcomes 
any other biological life form. These prokaryotic single celled microorganisms present a 
wide range of shapes (Figure 16) and can be found alone, or forming groups or arranged 
as filaments (Figure 16) (227). Bacteria live almost everywhere, from soil, water, waste, 
animals and plants to the deeper areas of earth (227, 228). 
 
 
 
 
 
Figure 16. Simplified representation of different shapes and arrangements of bacteria. 
Basically, bacteria can be divided into two main types, the Gram positive (Gram+) 
and the Gram negative (Gram─), according to their reaction to the Gram stain test. While 
Gram─ have a peptidoglycan cell wall surrounded by a second layer of LPS and 
lipoproteins, Gram+ only have a thin peptidoglycan cell wall. For this reason, and because 
of the presence of the LPS endotoxin, Gram─ bacteria are more toxic than Gram+ (227, 
229). Regarding growth, these microorganisms have four growth phases: lag (slow growth 
and adaptation to the environment), log (exponential phase of growth until nutrients 
depletion), stationary (reduce cells metabolism due to depleted nutrients) and death. Both 
types of bacteria can be cultured in laboratory using solid culture media (agar plates), 
which are the most appropriated for cultures’ isolation. The use of selective culture media 
is a common practice for bacteria isolation, since different strains have different 
Introduction 
46 
 
nutritional needs. Liquid media are used when there is a need for a large volume of cells or 
for growth measurements (230). 
Most of the bacteria are harmless and inhabit the human body without causing 
adverse effects. The great majority are found in skin and gut and most of them are 
beneficial. Nevertheless, there are also a large number of infectious bacteria capable of 
causing morbidity and mortality, especially in countries with ineffective health care 
conditions and in immunocompromised patients. Others, which seem less harmful at first 
sight, are largely responsible for nosocomial infections. Among these are, for example, 
some serotypes of Escherichia coli, a Gram─ bacteria responsible for gastroenteritis and 
urinary tract infections, and Enterococcus faecalis, a Gram+ one with high resistance to 
antibiotics, responsible for endocarditis, meningitis and urinary tract infections (229, 
231). 
2.4.5.2. Antibacterial activity 
There are a number of ways for bacteria to cause disease. In addition to superficial 
infections, bacteria can invade sterile locations, such as the bladder or blood, and through 
them invade vital organs as brain and heart. Despite the specific (immune system) and 
non-specific defenses of human body against pathogens, most of the times the organism 
cannot overcome an infection by itself and the inflammatory reaction normally arising 
from its defense process leads to fibroses and organs damage (232). In these situations, 
there is a need for the use of antibacterial agents (generally referred to as antibiotics), 
which are small molecules that interfere with normal life process of bacteria and act 
selectively towards human cells. The first antibiotic compound, penicillin, was discovered 
in 1928 by the physician Alexander Fleming, in a culture of a fungus from the genus 
Penicillium (233). Although the first antibiotics were from natural sources, most of the 
ones used today are chemical and semi-synthetic modifications of the original natural 
molecules. Some important aspects related to antibiotics effectiveness have to be 
considered, namely, their ability to directly kill the infectious organism (bactericidal or 
lethal compounds) or to slow down its growth (bacteriostatic compounds), in such a way 
that they will not represent danger to the host organism, since the immune system is 
effective in reducing the number of microorganisms in an infection, when it is residual 
(234). 
The emergence of resistance of bacteria to antibacterial drugs, and the rising side 
effects and allergic reactions to the compounds commonly used in therapeutics, lead the 
scientific community to the search for new compounds with antibacterial properties. 
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Besides this, and considering the natural products potential, natural antibiotics or 
antibacterial substances are preferred over synthetic ones. In the past few years, marine 
macroalgae have been looked as a source of antibacterial compounds (235). The 
antibacterial activity of compounds isolated from macroalgae (236-242) and of 
macroalgae extracts (243, 244) has been screened. Although in this sense more attention 
has been paid to red algae, scientists’ interest is being redirected to brown algae and their 
polyphenols. Some existing studies prove that these compounds are effective against a 
wide range of pathogenic bacteria (106, 245). Sandsdalen and co-workers isolated a 
polyhydroxylated fucophlorethol from a species of Fucus, which presented bactericidal 
activity against Gram─ and Gram+ bacteria without causing hemolytic effect (246). Other 
phlorotannins, mainly isolated from macroalgae belonging to the genus Ecklonia, have 
been proved as antibacterials: eckol, dieckol, 8, 8’-bieckol, phlorofucofuroeckol A, 
fucofuroeckol A, dioxinodehydroeckol and 7-phloroeckol (106, 108, 247-249). Although 
the mechanism by which phlorotannins exert antibacterial activity has not yet been 
defined, it is believed that, as verified for terrestrial tannins, these compounds can act by 
forming complexes with bacterial proteins and carbohydrates and inhibit extracellular 
microbial enzymes (250, 251). 
2.4.5.3. Fungi 
Fungi kingdom is composed by a wide variety of eukaryotic organisms with a diverse 
range of forms and functions. One of the main reasons for these organisms being grouped 
in a different kingdom is related to the presence of chitin in their cell walls (252). Based on 
their morphologic, physiologic and reproductive structures characteristics, fungi are 
classified into seven phyla: Microsporidia, Chytridiomycota, Blastocladiomycota, 
Neocallimastigomycota, Glomeromycota, Basidiomycota and Ascomycota (253, 254). Of 
these, Ascomycota have been isolated from the most extreme environments of earth and 
constitutes the largest, most diverse and ubiquitous phylum, occurring in a wide variety of 
ecosystems. Species belonging to this phylum are characterized by the presence of a 
specialized sac-like structure (ascus) in which meiotic spores (ascospores) are produced. 
Nevertheless, a large number of Ascomycota occur as a single celled yeast that reproduce 
by budding or binary fission (Figure 17) (255). 
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Figure 17. General representation of the two morphologies of Ascomycota. 
 
Among the great variety of species belonging to this phylum, dermatophytes 
(filamentous fungi) and yeasts have an especial importance from the health care point of 
view, since they are common causes of skin and mucosa diseases in animals and humans 
(256). 
Dermatophytes  
Dermatophytes are Ascomycota belonging to the family Arthrodermataceae (250). 
Many of these organisms are saprophytic soil fungi, without any pathogenic feature for 
humans and animals (257). Typically anthropophilic fungi do not invade living tissues and 
are known to cause superficial infections (dermatophytosis) on the keratinized stratum 
corneum of skin, hair and nails. They have the capacity to obtain nutrients from 
keratinized tissues due to the presence of keratinases, which are responsible for 
hydrolyzing keratin (258). Attending to their slow growth, infections caused by 
dermatophytes are normally lasting and difficult to treat, being particularly demanding on 
immunocompromised patients.  
The physical and chemical structure of the skin constitutes the first defense 
mechanism against dermatophytes. Nevertheless, when this barrier is compromised, an 
exacerbation of the infection can occur and the fungi can become invasive. Inflammation 
occurs together with the fungal infection, which becomes enhanced and more difficult to 
treat. A severe widespread dermatophytosis, besides being difficult to control, can present 
unusual morphologies and multiple lesions (259). As filamentous fungi, dermatophytes 
form organized hyphae, composed by glucans and chitin. Hyphae are cylindrical 
structures, septated or not, that grow at the apices. New hyphae occur by branching or 
bifurcation, leading to the development of a mycelium. They reproduce by sexual and 
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asexual means and produce spores, which morphology and pigmentation can be used for 
species identification (Figure 17) (260). 
There are three genera of pathogenic anthropophilic dermatophytes: Trichophyton, 
Microsporum and Epidermophyton. Trichophyton are related to several dermatophytosis, 
namely tinea (Tinea pedis, Tinea capitis and Tinea barbae), ringworm and 
onychomycosis. Of these, Trichophyton rubrum is the most common dermatophyte 
affecting fingers and nails. Trichophyton mentagrophytes, which can be seen as a 
zoophilic form of T. rubrum, has a wide range of animal hosts and is responsible for the 
production of scalp lesions in humans. Microsporum species are also responsible for 
causing tinea and ringworm. Pets are a recognized reservoir of some Microsporum 
species, such as Microsporum canis and Microsporum gypseum, responsible for causing 
ringworm on dogs and cats. Epidermophyton is represented by only one species, 
Epidermophyton floccosum, which is known to cause cutaneous mycosis like tinea (257, 
259). 
Yeasts  
More than 1500 yeast species have been identified, which represents only a fraction 
of yeast biodiversity on Earth (261). Yeasts are members of the phylum Ascomycota and, 
even not as widespread as bacteria, these organisms can be found in plants, animals, soil, 
water and atmosphere, and also in extreme environments (e.g. osmophilic and 
halotolerant yeasts). As non-motile organisms, yeasts rely on aerosols, animal vectors and 
human activity for their natural scatter (262). 
Morphologically different from dermatophytes, yeast cells present an ellipsoidal 
shape, which compartmentalization typifies that of eukaryotic cells, with nucleus, 
mitochondria, Golgi apparatus, vacuoles and peroxisomes. The structural organization of 
the intracellular components is maintained by a cytoskeleton. The cellular contents are 
encased by an envelope comprising plasma membrane, periplasm and cell wall (Figure 
18) (262, 263). 
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Figure 18. Schematic representation of a yeast cell. Detail of the cell membrane and cell wall 
composition. 
 
The cell wall comprises about 1/4 to 1/5 of total yeast dry mass. It is mainly 
composed by polysaccharides (mainly β-(1→3) and β-(1→6)-glucans), β-(1→3)-glucans 
being in higher amount. The cell wall has minor amounts of chitin, which can be found in 
major concentration in the bud scar (Figure 18). The amounts of chitin in yeasts are 
lower than those of filamentous fungi and some yeasts completely lack chitin. Anyway, the 
amounts of the chemical constituents of yeast cell walls vary according to the strain, cell 
age and growth conditions (262). Concerning the yeast cell membrane, in a general way, it 
is composed by a phospholipidic bilayer with proteins, enzymes and sterols (Figure 18). 
Ergosterol is a bioregulator of membrane fluidity and asymmetry and, consequently, of 
membrane integrity; cells are unable to grow in its absence (256). Due to their location, 
characteristics and function, the cell membrane and cell wall components are the main 
targets for the action of antifungal drugs (264). 
Yeasts from the genus Candida, particularly Candida albicans, are the most 
important agents causing yeast infection. This opportunistic pathogen is normally 
associated with mucosal, cutaneous and nail infections (normally known as candidiasis), 
but can cause acute or chronic invasive infections in immunocompromised or debilitated 
individuals. This yeast is part of human flora and, in most cases, infections are derived 
from the individuals own reservoir in mouth, gastrointestinal tract, lower genital tract or 
skin. Despite the mechanisms that can prevent the organism from establishing infection, 
(physical, chemical and immunological), in some situations yeasts can establish infection. 
When there are serious impairments of host defenses, life-threatening invasive infections 
can occur (256). The ability of Candida species to cause disease depends upon two main 
factors: survival and virulence. Virulence factors allow the organisms to invade new 
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Bud Pseudohyphae Hyphae/Germ tube
constriction
tissues, evading phagocytic cells and causing symptoms of infection. One of the most 
important virulence factors in Candida species is the alteration of cell morphology, i.e. 
dimorphism. Within the genus Candida, only the species C. albicans and Candida 
dubliniensis are able to undergo dimorphic transition. Dimorphism is the ability to 
produce either yeast cells (blastospores) or filamentous forms (hyphae or germ tubes and 
pseudohyphae) (265) (Figure 19). The production of germ tubes by C. albicans is 
involved in the microorganism pathogenesis, as these are responsible for the adhesion of 
yeast cells to the mucosa, turning Candida infections more difficult to overcome. In most 
cases, the inhibition of the production of the germ tube is sufficient to treat disseminated 
candidiasis (266). 
 
 
 
 
Figure 19. Morphology of a bud, pseudohyphae and hyphae/germ tube in dimorphic yeasts. 
 
Germ tubes are considered positive when they are at least as long as the diameter of 
the blastospore (mother cell), being negative when showing a constriction at the point of 
connection to the mother cell, typical of an incomplete budding and known as 
pseudohyphae (265, 267). 
2.4.5.4. Mechanism of antifungals’ action 
The study of antifungals' mechanism of action constitutes an important strategy for 
limiting the emergence of resistance to the commercially available agents, as well as to 
develop safer and more potent compounds in the future. Understanding the mechanism of 
action of antimicrobial agents is an important tool to understand the mechanism of 
microorganisms’ resistance. As referred above, the fungal membrane and cell wall 
components are the most important targets for the action of antifungal drugs (156). 
Compounds active on fungal cell membrane 
Concerning the fungal membrane, there are three main groups of antifungals acting 
in this target: azoles, polyenes and allylamines. All of them owe their antifungal action to 
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the interaction with ergosterol. This interaction can result in the depletion of ergosterol in 
the fungal membrane by affecting sterols biosynthesis, via inhibition of the enzyme 14α-
demethylase. The antifungals interaction can also occur in the early stages of ergosterol 
biosynthesis, leading to the accumulation of squalene. Compounds that act by this 
mechanism lead not only to the depletion of ergosterol, but also to the accumulation of 
sterol precursors. A direct action on the membrane ergosterol molecule can also occur, 
and some antifungals can form aqueous pores that cause alteration of cell permeability, 
leakage of vital cytoplasmic components and death (156). 
Several mechanisms are related to fungal resistance to antifungals that owe their 
action to the interaction with ergosterol, namely modifications or over-expression of target 
enzymes, production of modified sterols and cross-resistance (156). 
Compounds active on fungal cell wall 
Fungal cell wall contains compounds that are unique in fungal kingdom and 
constitute a good target for antifungal drugs. Two main groups of antifungals act on the 
cell wall: the ones inhibiting glucans and the ones inhibiting chitin synthesis. 
Antifungals responsible for the inhibition of glucans synthesis include specific 
inhibitors of β-(1→3)-glucans synthase. These compounds are fungicidal lipopeptides that 
promote cytological changes in fungi and lead them to grow as pseudohyphae, thickened 
cell wall and buds attached to mother cells (264). Chitin inhibitors include compounds 
structurally similar to N-acetylglucosamine (chitin basic units linked by β-(1→4) linkages) 
that act as competitive inhibitors of chitin synthases in pathogenic fungi and insects. 
Because of their non-toxic and easily degradable properties, chitin inhibitors are potent 
antifungal agents and insecticides in agriculture and human therapy (268). 
A drug can also owe its antimycotic effect to the interaction with the respiratory 
chain processes in mitochondria. These organelles are responsible for the generation and 
regulation of ROS, Ca2+ homeostasis, regulation of apoptosis and metabolic processes, 
being also responsible for more than 90% of cellular ATP production (269). Compounds 
with the capacity to affect mitochondrial respiratory chain can be seen as potential cell 
growth inhibitors and capable of trigger cell death (269-271). There is currently no 
antifungal drug owing its primary mechanism of action to the interference with 
mitochondria activity. Nevertheless, besides the primary mechanism of action, some 
antifungal drugs like azoles and polyenes can act in more than one target, having some 
effect on mitochondria activity (272). 
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2.4.5.5. Antifungal activity 
The antifungal activity of seaweeds extracts and isolated compounds has not been 
extensively studied, mainly because in the past few years more attention has been paid to 
pathogenic bacteria, which is, by far, more explored (155). Nevertheless, there are some 
studies concerning the antifungal activity of brown seaweeds extracts and few studies 
concerning phlorotannins. Guedes and co-workers evaluated the antifungal activity of 
different seaweeds crude extracts against dermatophytes and Candida sp., concluding that 
the dichloromethanolic, MeOH and ethanol extracts were the most active and, in a general 
way, dermatophyte were more sensitive than Candida sp. (273). Brown seaweeds from the 
Gulf of Mannar and from the Aegean Sea were also studied yielding roughly the same 
results (102, 109). Several other studies concerning the screening of antifungal activity of 
brown seaweeds extracts were developed (104, 105, 274-276). The antifungal activity of 
some brown seaweeds extracts has been attributed to phlorotannins (277, 278). Lee and 
co-workers isolated dieckol from a species of Ecklonia and tested it against T. rubrum. 
The compounds presented fungicidal activity and that effect was attributed to the loss of 
dermatophyte membrane integrity (249). To date, there are no studies concerning the 
mechanism of action of extracts or isolated phlorotannins. Despite the study of the 
mechanism of action of extracts may seem abstract due to the possibility of acting in 
multiple cell targets, it can provide an added value to therapeutic. Acting in different cell 
targets reduces the microorganisms’ resistance and can lead to better therapeutic 
responses. 
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3. AIMS OF THE DISSERTATION 
1. Characterization of seaweeds species in terms of sterols: 
1.1. Qualitative and quantitative sterols profile. 
1.2. Establishment of a relationship between the sterols profile and the 
nutritional value of the studied species. 
2. Characterization of brown seaweeds in terms of phlorotannins: 
2.1. Quantitative phlorotannins profile determination by the DMBA assay. 
2.2. Screening of the anti-inflammatory and NO scavenging capacity of 
purified phlorotannins extracts, in vitro, in cell and cell-free systems. 
2.3. Screening of the antimicrobial activity of purified phlorotannins extracts. 
3. Qualitative analysis of phlorotannins by HPLC-DAD-ESI/MSn: 
3.1 Establishment of the phlorotannins profile of the most promising bioactive 
species by HPLC-DAD-ESI/MSn. 
3.2. Determination of the antioxidant activity of purified phlorotannins 
extracts and their Haase inhibitory capacity. 
4. Approach to the mechanism of antifungal action of purified phlorotannins 
extracts: 
4.1. Determination of the antifungal action of purified phlorotannins extracts 
against a wide range of dermatohytes and yeasts. 
4.2. Approach to the mechanism of antifungal action of phlorotannins extracts 
by the evaluation of their effect on the cell wall, membrane composition and 
metabolic network of microorganisms. 
5. Compounds isolation of the most promising seaweed species: 
5.1. Isolation of compounds by chromatographic methods and structure 
elucidation. 
5.2. Evaluation of the anti-inflammatory activity of the isolated compounds.
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4. EXPERIMENTAL SECTION 
 
4.1. Standards and reagents 
Cholesterol (99%), desmosterol (87%), ergosterol (75%), fucosterol (95%), 
stigmasterol (95%), β-sitosterol (98%), campesterol (65%), phloroglucinol (98%), sodium 
pyruvate, thiazolyl blue tetrazolium bromide (MTT), β-nicotinamide adenine dinucleotide 
reduced form (NADH), sodium nitroprusside dehydrate (SNP), sulfanilamide, toluene, 
MeOH, dimethyl sulfoxide (DMSO), 2,4-dimethoxybenzaldehyde (DMBA), p-
anisaldehyde, dichloromethane (DCM), ETOAc, LPS from Salmonella enteric, trypan blue 
solution (0.4%), sodium chloride (NaCl), 3-(N-morpholino) propanesulfonic acid (MOPS), 
N-acetylglucosamine, D-(+)-glucosamine hydrochloride, rhodamine 123 (RHO), 3-
methyl-2-benzothiazolinone hydrazone hydrochloride hydrate, ammonium sulfamate 
(NH4 sulfamate), ferric chloride (FeCl3), formic acid, HAase from bovine testes (type IV-
S), HA sodium salt from Streptococcus equi, nitrotetrazolium blue chloride (NBT), 
phenazine methosulfate (PMS), L-ascorbic acid, sodium formate, trizma hydrochloride 
(Tris-HCl), bovine serum albumin (BSA), dexamethasone and curdlan from Alcaligenes 
faecalis were purchased from Sigma-Aldrich (St. Louis, MO, USA). 
Cellulose microcrystalline for thin-layer chromatography, silica gel for thin-layer 
chromatography 60 G (particle size 5–40 mm) and 60M F254, N-(1-naphthyl) 
ethylenediamine, acetone, n-hexane, acetic acid (glacial), HPLC-grade MeOH, acetonitrile, 
potassium di-hydrogen phosphate buffer, di-sodium tetraborate, iron (II) sulfate 
(FeSO4·7H2O), sodium nitrite (NaNO2), potassium hydrogen sulfate (KHSO4), n-butanol 
(BuOH) and 4-dimethylaminobenzaldehyde (DMAB) were obtained from Merck 
(Darmstadt, Germany). 
Hydrochloric acid (HCl), ortho-phosphoric acid (H3PO4), anhydrous sodium sulfate, 
ethanol, diethyl ether, KOH and sodium hydroxide (NaOH) were purchased from Panreac 
(Castellar del Valle`s, Spain).  
Dulbecco’s Modified Eagle Medium (DMEM), Dulbecco’s phosphate buffered saline 
(DPBS), heat inactivated fetal bovine serum (FBS) and Pen Strep solution (Penicillin 5000 
units/mL and Streptomycin 5000 mg/mL) were from Gibco (Invitrogen, Paisley, UK). 
Mueller Hinton broth (MHB) and Mueller Hinton agar (MHA) media were 
purchased from Liofilchem (Teramo, Italy). Sabouraud dextrose agar (SDA) was from Bio-
Mèrieux (Marcy L’Etoile, France). RPMI-1640 broth medium (with L-glutamine, without 
bicarbonate, and with the pH indicator phenol red) was purchased from Biochrom AG 
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(Berlin, Germany). Gentamicin was purchased from Appli- chem (Darmstadt, Germany) 
and fluconazole was kindly provided by Pfizer (Barcelona, Spain). Proline and aniline blue 
water soluble (C37H27N3Na2O9S3) were from Fluka (Buchs, Sankt Gallen, CH). Yeast 
nitrogen base was from Difco (New Jersey, USA). LA was from Calbiochem (San Diego, 
USA).  
The murine macrophage-like cell line RAW 264.7 was from the American Type 
Culture Collection (LGC Standards S.L.U., Spain). 
H2O was deionized using a Milli-Q water purification system (Millipore, Bedford, 
MA, USA). 
 
4.2. Seaweeds material 
Individuals of eighteen seaweeds species (ten Phaeophyta, three Chlorophyta and 
five Rhodophyta) (Figures 20 and 21) were randomly collected in the coast of Peniche 
(west Portugal) and identified by specialists from the School of Tourism and Maritime 
Technology of the Polytechnic Institute of Leiria, Portugal. Each seaweed sample 
corresponded to a mixture of 3–4 individuals in the same stage of development. With the 
exceptions of Cystoseira usneoides (Linnaeus) M. Roberts and Cystoseira nodicaulis 
(Withering) M. Roberts, collected in 2009, all samples were collected in 2008. 
Sacchorhyza polyschides (Lightfoot) Batters was collected in June, C. usneoides and C. 
nodicaulis in November and the remaining species in September. After collection, samples 
were placed on ice and immediately transported to the laboratory in insulated sealed ice-
boxes, to protect them from heat, air and light exposition. The fresh biomass was cleaned, 
in order to remove epiphytes and encrusting material, washed with NaCl aqueous solution 
(3.5% m/m) and kept at -20 ºC, prior to their lyophilization in a Labconco 4.5 Freezone 
apparatus (Kansas City, MO, USA). The dried material was powdered (<910 µm) and kept 
in the dark, in a desiccator, until preparation of the extracts for analysis.  
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4.3. Sterols profile 
4.3.1. Extraction 
All the seaweeds samples (Figures 20 and 21) were analyzed for their qualitative 
and quantitative sterols profile. In order to maximize the extraction of sterols the algae 
material was subjected to an extraction process that allowed the simultaneous 
saponification of sterols and their consequent conversion to the free form.  
The saponification process consists in the reaction of esterified sterols with a strong 
base, in order to break the ether linkages between the sterol moiety and the fatty acid. The 
most suitable conditions for extraction and saponification (or alkaline hydrolysis) were 
established by testing several combinations of KOH and n-hexane. For this, O. pinnatifida 
(the sample available in highest amounts) was processed following a described procedure 
(79). First, the powdered sample was extracted and saponified with varying volumes of 
ethanolic KOH 10% (10, 20, 30, 40, and 50 mL). After this first step, the hydrolysate was 
extracted with n-hexane, varying the number of extractions (1, 2, 3, and 4 times with 10 
mL). Best results were obtained using 40 mL of ethanolic KOH 10% for saponification and 
3 x 10 mL of n-hexane for the extractive processes. Optimal conditions were achieved on 
the basis of peak areas obtained in HPLC–DAD chromatograms. 
After optimizing the extraction/saponification conditions, 0.5 g of powdered 
lyophilized material of each seaweed species were weighed out in an Erlenmeyer flask and 
saponified with 40 mL of ethanolic KOH (10%) for 1 h, under constant shaking (1000 rpm) 
and temperature (70 ºC). The Erlenmeyer was left to cool down to room temperature and 
the mixture was centrifuged (Labofuge Ae, Heraeus Sepatech GmbH, Osterode, Germany) 
during 3 min at 5000 rpm and decanted. The mixture was extracted with 3 x 10 mL of n-
hexane, in a separation funnel, in order to remove the free sterols. The organic phase 
containing the sterols was dehydrated with anhydrous sodium sulfate, evaporated to 
dryness under reduced pressure (at 30) and kept in the freezer until analysis by HPLC-
DAD. Immediately before chromatographic analysis, the residue was dissolved in 1 mL of 
30:70 (v ⁄ v) MeOH:acetonitrile mixture and filtered through a 0.22 µm membrane 
(Millipore). 
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4.3.2. Analysis by HPLC-DAD 
The HPLC–DAD system comprised a liquid chromatographer equipped with models 
302 and 305 pumps (Gilson Medical Electronics, Villiers le Bel, France), a 20 µL loop and 
a DAD (170, Agilent, Villiers le Bel, France) controlled by Unipoint system Software 
(Gilson Medical Electronics). Separation was performed using a reversed-phase Hypersil 
ODS (20 x 0.4 cm, 5 µm particle diameter; Teknokroma, Barcelona, Spain) column. The 
elution conditions used for sample analysis were selected on the basis of preliminary trials 
to establish the most suitable ones. The temperature and flow rate were optimized in order 
to achieve the best separation of sterols. Room temperature and temperature set at 30, 35, 
and 60 ºC with a column heater (Jones-Chromatography model 7981, Mid Glamorgan, 
UK), as well as flow rates of 0.8, 1.0 and 1.2 mL/min were assayed. The best separation 
was achieved at room temperature, with a 0.8 mL/min flow. 
Several gradients using MeOH and acetonitrile were also tested. It was not possible 
to obtain a stable base line at the wavelength of detection (205 nm). For this reason, 
isocratic elution with MeOH:acetonitrile (30:70) was performed. Spectral data from all 
peaks were accumulated in the 190–400 nm range. Peak purity was checked by the 
software contrast facilities. Sterols were identified by comparing their retention times and 
UV absorption spectra with standards commercially obtained. Quantification was achieved 
by the absorbance (Abs) recorded in the chromatograms at 205 nm, except for ergosterol, 
which was determined at 280 nm. 
4.3.3. Validation of the methodology 
In order to validate the optimized methodology, calibration curves were performed 
with four different concentrations of standard solutions, selected as representative of the 
range of compounds’ concentrations in the samples: 125–1000 µg/mL for fucosterol, 71–
567 µg/mL for cholesterol, 20–128 µg/mL for desmosterol, 143–572 µg/mL for ergosterol, 
65–522 µg/mL for β-sitosterol, 125–500 µg/mL for campesterol and 125–1000 µg/mL for 
stigmasterol. The calibration plots showed a good correlation: r2 values for all sterols were 
higher than 0.99, with the exceptions of ergosterol and β-sitosterol (0.9839 and 0.9884, 
respectively). The limit of detection (LOD) (3S0 ⁄b) and the limit of quantification (LOQ) 
(10S0 ⁄b, where S0 is the standard deviation of signal-to-noise ratio and b is the slope of the 
calibration plot) for the analyzed sterols are shown in Table 1. 
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Table 1. Limit of detection (LOD)a, limit of quantification (LOQ)a, regression equations and r2 for 
the different sterols. 
Sterol LOD LOQ Regression equations r2 
Desmosterol 5.94 19.82 y = 353176374.3 x + 2799435.6 0.9987 
Ergosterol 1.39 4.63 y = 365654626.4 x + 34387743.3 0.9839 
Fucosterol 4.03 13.44 y = 87253639.0 x + 1500128.4 0.9997 
Cholesterol 4.43 14.78 y = 167654599.1 x + 8709832.1 0.9945 
Campesterol 3.94 13.12 y = 64900831.6 x – 738494.7 0.9960 
Stigmasterol 27.95 93.16 y = 252456154.9 x + 17313724.1 0.9946 
β-Sitosterol 3.39 11.28 y = 103086932.3 x + 5049720.1 0.9884 
a µg/mL. 
In order to evaluate sterols recovery, cholesterol was used, as it was the standard 
available in highest amounts and with the highest purity degree. Cholesterol was also 
found in intermediate amounts in all samples and was not co-eluting with other 
compounds. For this purpose, known amounts of cholesterol (0.1, 0.2 and 1 mg) were 
added to a sample, which was then treated under the optimized conditions. The procedure 
was repeated five times and the total recovery of cholesterol corresponded to 78, 91, and 
93%, respectively. Repeatability was checked by analyzing five times the same sample, by 
the same analyst, within the same day. The relative standard deviation (RSD) was lower 
than 8% (Table 2), indicating a good repeatability of the procedure.  
 
Table 2. Evaluation of the method precision (RSD)a. 
Sterol Intra-day Inter-day 
Desmosterol 
 
 
0.5 7.9 
Ergosterol 7.9 11.6 
Fucosterol 1.7 3.4 
Cholesterol 4.5 7.1 
Campesterol+ Stigmasterol 6.2 13.7 
β-sitosterol 0.7 15.2 
a% 
Intermediate precision on five different days (five injections a day) was also found to 
be satisfactory, since RSD varied between 3 and 15% (Table 2). Method selectivity was 
assessed by DAD (which ensured peak purity) and by authentic standards chromatograms. 
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Interferents were ruled out by verifying the absence of peaks in the retention time of the 
studied analytes. The optimization of the methodology ensured obtaining a rich sterol 
fraction, as revealed by the chromatograms, in which only peaks corresponding to 
compounds with UV spectra characteristic of sterols were noticed. The analysis of the 
same sample in different periods revealed no alteration of the chromatograms. 
4.4. Phlorotannins profile 
Once phlorotannins are exclusive of brown seaweeds, all the ten brown seaweeds 
species, belonging to the orders Fucales, Sphacelariales, Dictyotales and Tilopteridales 
(Figure 21) were used for phlorotannins quantification and screening of the anti-
inflammatory and anti-microbial activity. Of them, only the most promising species were 
selected for characterization by LC-MS and for further biological activities evaluation. 
4.4.1. Extraction 
The conditions used for phlorotannins extraction were adapted from those proposed 
by Koivikko and co-workers (118). In order to maximize the efficiency of extraction, lipids 
were removed from aliquots of 0.5 g of powdered lyophilized material of each sample. For 
this purpose, 1 mL of n-hexane was added to the powdered sample, in a falcon tube, and 
hand shacked for about 1 min. The mixture was centrifuged (5 min at 4000 rpm) in a 
Rotofix 32 A Hettich centrifuge and the supernatant removed. The n-hexane treatment 
was repeated three times.  
After n-hexane removal, the defatted material was extracted four times with 10 mL 
of a solvent mixture consisting of acetone:H2O (7:3), for 1 h at 400 rpm, followed by 
centrifugation for 5 min at 4000 rpm. The organic fractions were combined into an 
Erlenmeyer and evaporated to dryness under reduced pressure, at 30 ºC. 
4.4.2. Purification 
The conditions used for extracts purification were adapted from those proposed by 
Fairhead and colleagues (121). The dried acetone:H2O extract was resuspended in 30 mL 
of MeOH and adsorbed into cellulose (approximately 2 times the residue’s weight) by 
gentle shaking. The suspension was dried under reduced pressure, at 30 ºC, until 
complete cellulose powder detachment. After cooled to room temperature, the mixture 
was washed with aliquots of 25 mL of toluene to remove pigments, until the filtrate run 
clear. Then, cellulose was rinsed with 30 mL of acetone:H2O (7:3) to release the adhered 
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phlorotannins. After centrifugation (5 min at 4000 rpm), the supernatant was evaporated 
to dryness under reduced pressure, at 30 ºC, yielding the purified phlorotannins extract. 
4.4.3. Quantification by DMBA assay 
The methodology used for phlorotannins quantification was adapted from that 
proposed by Stern and co-workers (124). The working reagent was prepared by mixing 
equal volumes of DMBA (2%, m/v) and HCl (6%, v/v) prepared in glacial acetic acid. 
Purified phlorotannins extracts were dissolved in H2O with 10% DMSO. Aliquots of each 
extract (50 µL) were mixed with 250 µL of working reagent in a 96-wells plate. The 
reaction was conducted at room temperature, in the dark, during 60 min. After the 
incubation period, the Abs was determined at 515 nm in a Multiskan Ascent plate reader 
(Thermo Electron Corporation). 
The quantitative determination of phlorotannins was carried out using 
phloroglucinol as external standard. A series of seven phloroglucinol concentrations, 
ranging between 0.98 and 62.50 µg/mL, was used to obtain a linear calibration curve (y = 
0.0254x) presenting an r2 value of 0.9998. In order to evaluate phlorotannins recovery, 
phloroglucinol was used, as it was the only standard commercially available. Known 
amounts of phloroglucinol (0.250 and 0.500 mg) were added to the powdered lyophilized 
macroalgae material and treated under the conditions described for extraction and 
purification. The procedure was repeated 3 times and the total recovery of phloroglucinol 
ranged between 88 and 95%. 
4.4.4. Characterization by LC-MS 
Of the ten brown seaweeds samples, C. nodicaulis, C. tamariscifolia, C. usneoides 
and F. spiralis were selected for the characterization of their phlorotannins profile by LC-
MS. Chromatographic analysis were carried out on a Luna C18 column (250 × 4.6 mm, 5 
μm particle size; Phenomenex, Macclesfield, UK). The mobile phase consisted of two 
solvents: 1% formic acid in H2O (A) and acetonitrile (B). Elution was performed under the 
following gradient: 0–10 min, 0% B; 30 min, 30% B; 35 min, 80% B; 40 min, 80% B; 42 
min, 0% B; 52 min, 0% B. The flow rate was 1 mL/min and the injection volume was 20 
μL. Spectral data from all peaks were accumulated in the range 240–400 nm and 
chromatograms were recorded at 280 nm. The HPLC-DAD-ESI/MSn (n = 1–2) analysis 
were carried out in an Agilent HPLC 1100 series equipped with a diode array detector and 
mass detector in series (Agilent Technologies, Waldbronn, Germany). The HPLC consisted 
of a binary pump (model G1312A), an auto-sampler (model G1313A), a degasser (model 
G1322A) and a photodiode array detector (model G1315B). The HPLC system was 
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controlled by the ChemStation software (Agilent, v. 08.03). The mass detector was an ion 
trap spectrometer (model G2445A) equipped with an electrospray ionization interface and 
was controlled by LCMSD software (Agilent, v. 4.1). The ionization conditions were 
adjusted at 350 °C and 4 kV for capillary temperature and voltage, respectively. The 
nebulizer pressure and flow rate of nitrogen were 65.0 psi and 11 L/min, respectively. The 
full scan mass covered the range from m/z 100 up to m/z 1500. Collision-induced 
fragmentation experiments were performed in the ion trap using helium as the collision 
gas, with voltage ramping cycles from 0.3 up to 2 V. MS data were acquired in the positive 
ionization mode. 
4.5. Biological activities of purified phlorotannins extracts 
4.5.1. Anti-inflammatory activity 
The anti-inflammatory capacity and the toxicity of purified phlorotannins extracts 
was evaluated in a macrophage cell line (RAW 264.7). The amount of NO in cellular 
culture medium and in a cell-free system was measured. The metabolic activity of 
macrophages was evaluated by the MTT assay and viability was checked by measuring the 
extracellular lactate dehydrogenase (LDH).  
Purified phlorotannins extracts (dissolved in H2O with 10% DMSO) were sterilized 
by filtration through a 0.22 µm membrane before cells treatments. The serial dilutions of 
the extracts were prepared with DMEM culture medium supplemented with 10% FBS and 
2% Pen Strep solution, under aseptic conditions. 
4.5.1.1. Cell culture and treatments 
Murine macrophage RAW 264.7 cells were cultured in 75 mL cell flasks at 37 °C, in 
DMEM culture medium supplemented with 10% FBS and 2% Pen Strep solution, in a 
humidified atmosphere of 5% CO2. After confluence, cells were detached from the flask 
with a countersink and inoculated at a density of 150 000 cells/well into 48-wells plates. 
Cells were cultured until confluence under the same conditions. 
After reaching confluence (about 2 days), cells were pre-treated with 975 µL of 
different concentrations of purified phlorotannins extracts or vehicle for 1 h. After that, 25 
µL of LPS (or vehicle) was added to each well, in order to achieve a final LPS concentration 
of 1 µg/mL. Cells were further incubated for 18 h at 37 °C in a humidified atmosphere of 
5% CO2 and, after this period, assayed for cell viability and NO. The final concentration of 
DMSO in each well was 0.5%. Four independent assays were performed in duplicate. 
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4.5.1.2. Cell viability 
LDH assay 
The LDH released into the culture medium was used as an index of cell death. After 
the incubation period, the culture medium was carefully removed from each well and 
taken to determine the activity of LDH released by death cells. Briefly, after the incubation 
period an aliquot of culture medium was taken to determine the activity of LDH leaked 
through cell membranes. The culture medium was transferred to a 96-wells plate in 
aliquots of 50 µL, in triplicate. 200 µL of a 150 µg/mL NADH solution was added to each 
well. The reaction was initiated with the addition of 25 µL of a 150 µg/mL pyruvate 
solution. Both LDH and pyruvate solutions were prepared in phosphate buffer (KH2PO4 10 
mM, pH 7.4). LDH activity was determined following the oxidation of NADH during the 
conversion of pyruvate to lactate at 340 nm (Figure 22). Results are expressed as LDH 
activity in the medium of exposed cells, relative to control, without extract (279). 
 
 
 
 
Figure 22. Reaction of interconversion of pyruvate to lactate under NADH oxidation, by the action 
of LDH. 
 
MTT assay 
Contrarily to LDH, which is determined in the culture medium, the cell viability 
measured through the MTT assay is determined in the cells. After the incubation period, 
RAW 264.7 cells were washed with DPBS and then incubated for 30 min with a 0.5 
mg/mL MTT solution (prepared in DMEM culture medium). The yellow tetrazolium salt 
MTT is converted by mitochondrial dehydrogenases of metabolically active cells to an 
insoluble purple formazan product. This product was solubilized with DMSO and the 
extent of the reduction of MTT to formazan within the cells was quantified by measuring 
the Abs of the reaction product at 510 nm (Figure 23) (279). 
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Figure 23. Reaction of conversion of the yellow MTT to the purple formazan salts, by the action of 
mitochondrial dehydrogenases of metabolically active cells. 
 
4.5.1.3. NO production by RAW 264.7 cells 
After the incubation period, the nitrite accumulated in the culture medium was 
measured as an indicator of NO production (217). Based on the Griess reaction (Figure 
24), equal volumes (100 µL) of culture supernatant and Griess reagent [1:1 mixture (v/v) 
of 1% sulfanilamide and 0.1% N-(1-naphthyl) ethylenediamine in 2% H3PO4] were mixed 
and incubated for 10 min in the dark, at room temperature. 
 
 
 
 
 
Figure 24. Measurement of NO2- by the Griess reaction. 
 
The Abs of the chromophore formed during the diazotization of nitrite (NO2-) with 
sulfanilamide and subsequent coupling with naphthylethylenediamine dichloride was read 
at 562 nm. Control values were obtained in the absence of purified phlorotannins extracts 
and after addition of LPS. Four independent assays were performed in duplicate. 
 
Experimental section 
69 
 
4.5.2. Antioxidant capacity 
4.5.2.1. NO scavenging assay 
The capacity of purified phlorotannins extracts to scavenge NO was also evaluated in 
a cell-free system. NO was generated in vitro from SNP and measured by the Griess 
reaction (Figure 24) (280). SNP solution (6 mg/mL) was prepared in phosphate buffer 
(KH2PO4 100 mM, pH 7.4) and mixed with the same volume (100µL) of different 
concentrations of purified phlorotannins extracts, in a 96-wells plate. The mixture was 
further incubated at room temperature for 1 h under light. After that, 100 µL of Griess 
reagent was added and the mixture was further incubated for 10 min in the dark. The Abs 
was read at 562 nm. Control values were obtained in the absence of purified phlorotannins 
extracts. Four independent assays were performed in duplicate. 
 
4.5.2.2. Superoxide anion scavenging assay 
Superoxide radical scavenging activity was evaluated as previously described (281). 
Briefly, serial dilutions of purified phlorotannins extracts were prepared; 50 µL of each 
dilution was transferred to a 96-wells plate and mixed with the same volume of a 166 µM 
NADH solution and 150 µL of NBT (43 µM). The reaction was started by the addition of 50 
µL of PMS (2.7 µM). O2•- was generated by the NADH/PMS system. The scavenging 
activity of purified phlorotannins extracts was determined by monitoring their effect on 
the reduction of NBT induced by O2•- (Figure 25), using a plate reader working in kinetic 
function, at room temperature, for 2 min, at 562 nm. Controls (without extract) were 
included for all the assays. All reagents and samples dilutions were dissolved in phosphate 
buffer (19 mM, pH 7.4). Three independent assays were performed in triplicate. 
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Figure 25. Schematic representation of the reduction of NBT induced by O2•-, generated by the 
NADH/PMS system. 
 
 
4.5.3. Phlorotannins effects on cell components and enzymes associated 
with the spread of inflammatory and allergic mediators and aging 
The ability of purified phlorotannins extracts to act as coadjuvants in the delay of the 
aging process and in the spread of chemical mediators associated with several pathological 
states (such as inflammation and allergy) was assessed by the evaluation of their capacity 
to inhibit LPO and the enzyme HAase. The three Cystoseira species and F. spiralis were 
used in these assays. 
4.5.3.1. LPO inhibition 
Peroxidation of fatty acyl groups was modified from the methodologies proposed 
before (282, 283). The reaction was developed in test tubes. The reaction mixture 
contained 250 μL of LA (20 mM in ethanol), 150 μL of Tris-HCl (100 mM, pH 7.5), 50 μL 
of FeSO4.7H2O (4 mM in H2O) and 50 μL of serial dilutions of purified phlorotannins 
extracts prepared in distilled H2O. LA peroxidation was initiated by the addition of 50 μL 
of ascorbic acid (5 mM in H2O) and the mixture was immediately incubated for 1 h at 37 
°C. After the incubation period, 1.5 mL of ethanol:ether (3:1) mixture was added to each 
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test tube. This mixture allows the rearrangement of the double bonds, resulting in the 
formation of conjugated dienes (lipid hydroperoxides). The test tubes were then vortexed 
and the Abs was immediately measured at 233 nm in a Helios α (Unicam) 
spectrophotometer, at room temperature. Positive controls (without extract) and negative 
controls (without LA) were performed along with the samples. Three independent assays 
were performed in triplicate. 
4.5.3.2. HAase inhibition 
HAase inhibition assay was modified from that proposed by Muckenschnabela and 
co-workers (284). A stock solution of 5 mg/mL HA was prepared in H2O and stored at 4 
°C. HA stock solution (50 μL) and 100 μL of buffer (0.2 M sodium formate, 0.1 M NaCl 
and 0.2 mg/mL BSA, pH adjusted to 3.68 with formic acid) were added to 200 μL of H2O. 
Sample serial dilutions were prepared in H2O and 50 μL of each dilution was added to 
each reaction tube. The reaction was started by the addition of 50 μL of HAase (600 
U/mL, prepared in NaCl 0.9%), which begins the degradation of HA into n-
acetylglucosamine and glucuronic acid. The enzymatic reaction was stopped by adding 25 
μL of an alkaline solution consisting of di-sodium tetraborate (0.8 M in H2O) and 
subsequent heating for 3 min in a boiling water bath (Morgan-Elson reaction) (Figure 
26) (284, 285). 
 
 
 
 
 
 
 
 
Figure 26. Morgan-Elson reaction. (adapted from (284)). 
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The test tubes were cooled at room temperature and 750 μL of DMAB solution was 
added (2 g of DMAB dissolved in a mixture of 2.5 mL of 10 N HCl and 17.5 mL of glacial 
acetic acid and further diluted 1:2 with glacial acetic acid immediately before use). After 
the addition of DMAB solution, the tubes were incubated at 37 °C for 20 min. The Abs of 
the colored product (Figure 26) was measured at 560 nm in a Multiskan Ascent plate 
reader. Three independent assays were performed in triplicate. 
4.5.4. Antimicrobial activity 
The antimicrobial activity of purified phlorotannins extracts was screened against 
nine bacteria and three fungi strains (one yeast, one dermatophyte and one Aspergillus). 
Attending to the scarcity of studies concerning the antifungal activity of phlorotannins, the 
most promising extracts were further evaluated against a wider range of human and 
animal pathogenic fungi. 
4.5.4.1. Microorganisms 
The study included five Gram+ (Staphylococcus aureus ATCC 20231, 
Staphylococcus epidermidis ATCC 20044, Micrococcus luteus ATCC 20030, E. faecalis 
ATCC 20477 and Bacillus cereus ATCC 31) and four Gram─  (Salmonella typhimurium 
ATCC 439 71, Proteus mirabilis ATCC 4479, E. coli ATCC30083, Pseudomonas 
aeruginosa ATCC 50071) bacteria species.  
The fungi specimens comprised eight yeasts [four clinical strains of Candida isolated 
from recurrent cases of oral candidiasis (C. albicans D1, C. albicans D5, Candida glabrata 
D10R and Candida dubliniensis CD1) and four Candida reference strains (C. albicans 
ATCC 10231, Candida krusei ATCC 6258, Candida tropicalis ATCC 13803 and Candida 
parapsilosis ATCC 90018), three Aspergillus strains (Aspergillus niger ATCC 16404, 
Aspergillus fumigatus ATCC 46645 and Aspergillus flavus F44) and five clinical strains of 
dermatophytes isolated from nails and skin (Epidermophyton floccosum FF9, 
Trichophyton rubrum FF5, Trichophyton mentagrophytes FF7, Microsporum canis FF1 
and Microsporum gypseum FF3). 
Cultures were obtained from the Department of Microbiology, Faculty of Pharmacy, 
Porto University (Portugal). C. krusei ATCC 6258 and S. aureus ATCC 25923 were used 
for quality control in antifungal and antibacterial assays, respectively. All microorganisms 
were stored in broth medium with 20% glycerol at −70 °C and sub-cultured in SDA for 
fungi and in MHA for bacteria before each test, to ensure optimal growth conditions and 
purity. 
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4.5.4.2. Antibacterial activity 
The minimum inhibitory concentration (MIC) of each extract was determined by 
broth microdilution methods based on the Clinical an Laboratory Standards Institute 
(CLSI) guidelines, reference documents M07-A8 and M100-S19, with minor modification 
(286). Briefly, the suspensions of bacteria cultures were prepared (from a fresh overnight 
culture in MHB) in ampoules containing 2 mL of NaCl 0.85% suspension medium (Api®, 
Biomérieux, Marcy l’Étoile, France). The suspensions turbidity was adjusted to 0.5 
McFarland (using a densitometer) and then diluted in MHB till the final bacterial density 
of 1.5 x 106 colony forming units (CFU)/mL. The MIC of purified phlorotannins extracts 
was determined by two-fold serial dilution method, in sterile 96-wells plates (Figure 27). 
 
 
 
 
 
 
 
 
 
 
Figure 27. Schematic representation of the micromethod for the evaluation of the MIC and MLC 
of phlorotannins extracts, for fungi and bacteria. SCNaCl 0.85% - Sterility control of the 0.85% NaCl 
solution; SCculture medium – Sterility control of the culture medium (SDB for fungi and MHB for 
bacteria); SCculture medium with DMSO – Sterility control of the culture medium with 2.5% DMSO; SDA – 
Saboraud dextrose agar; MHA – Muller Hinton agar; MIC – minimum inhibitory concentration; 
MLC – minimum lethal concentration. 
 
The initial concentration was 31.3 mg/mL dry weight, for each tested species. 50 µL 
of the bacterial suspension was added in each well, which contained 50 µL of purified 
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phlorotannins extract dilutions (in MHB culture medium). The maximum DMSO 
concentration did not exceed 2.5% (v/v). The plates were incubated at 37 ºC in a 
humidified atmosphere, without agitation, for 18–24 h for both Gram+ and Gram─ 
bacteria. The MIC was determined as the lowest concentration of purified phlorotannins 
extracts resulting in 100% of visible growth inhibition. Gentamicin MIC for S. aureus 
ATCC 25923 was determined as quality control and the result was within the 
recommended limits (286). Sterility and positive controls in MHB medium alone and with 
2.5% of DMSO (v/v) were included. Positive control wells contained microorganisms 
without antibiotics or extract. The experiments were performed in duplicate and repeated 
independently three times. 
4.5.4.3. Antifungal activity 
Broth microdilution methods based on the CLSI reference documents M27A-3 and 
M38-A2 for yeast and filamentous fungi, respectively, with minor modifications, were 
used to determine the MIC of purified phlorotannins extracts (287, 288). Briefly, cell or 
spore suspensions were prepared from recent cultures of the different strains of fungi on 
SDA with chloramphenicol and diluted to final inoculum of 103 CFU/mL with RPMI-1640 
broth (buffered to pH 7.0 with MOPS). The MIC of purified phlorotannins extracts was 
determined by two-fold serial dilution method. Dilutions were prepared in RPMI-1640 
broth, starting from 62.5 mg/mL dry weight for each extract. The solutions and cell 
suspensions in the test medium were then distributed into sterile 96-wells plates (Figure 
27). Controls were tested along with the samples, with maximum DMSO concentrations 
not exceeding 2.5% (v/v). The plates were incubated in humid atmosphere, without 
agitation, at 35 °C (for Candida spp. and Aspergillus spp.) or 25 °C (for dermatophytes), 
during 48 h (for Candida spp.), 72 h (for Aspergillus spp.) or 5 days (for dermatophytes). 
MICs were recorded as the lowest concentrations resulting in 100% of visible growth 
inhibition. Fluconazole MIC for C. krusei ATCC 6258 was determined as quality control, 
and the result was within the recommended limits (287). Sterility and growth controls in 
RPMI-1640 medium alone and with 2.5% of DMSO (v/v) were included. 
4.5.4.4. Determination of the minimum lethal concentration (MLC) 
MLC of purified phlorotannins extracts was assessed for the tested bacteria and 
fungi. The MLC was determined after 18–24 h (for both Gram+ and Gram─ bacteria), 48 h 
(for yeasts) and 96 h (for dermatophytes) of incubation, by the subculture of an aliquot of 
each well of the 96-wells plates showing no visible growth (Figure 27). Briefly, under 
aseptic conditions, the content of each well with no visible growth was homogenized and 
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20 µL were transferred to Petri dishes containing SDA (for fungi) or MHA (for bacteria). 
The Petri dishes were incubated at 37 ºC for bacteria, at 35 ºC for yeasts and at 30 ºC for 
dermatophytes. The MLC was defined as the lowest concentration showing 100% growth 
inhibition in the Petri dish (Figure 27). 
4.5.4.5. Mechanism of antifungal action of purified phlorotannins 
extracts 
4.5.4.5.1. Influence in C. albicans virulence factors 
The inhibition of the germ tube formation in yeast and the reduction of yeasts 
adhesion to the target epithelial cells have a key role in the progression of fungal infections 
(265, 266). The capacity of purified phlorotannins extracts from the most active seaweeds 
species (C. nodicaulis, C. usneoides and F. spiralis) was studied in the reduction of both C. 
albicans virulence factors. 
Germ tube/dimorphic transition inhibition assay 
Germ tube inhibition assay was performed according to Pinto and co-workers (289), 
with minor modifications. Purified phlorotannins extracts were dissolved in H2O with 10% 
DMSO and the solution was sterilized by filtration through a 0.22 µm pore size 
membrane. 250 µL of each extract dilution was added to the same volume of yeast 
suspension, to obtain appropriate sub-inhibitory concentrations (1/2–1/256 of the MIC). 
After 3 h of incubation in NYP medium [N-acetylglucosamine (10-3 mol/L), Yeast Nitrogen 
Base (3.35 g/L) and proline (10-3 mol/L)] with NaCl (4.5 g/L, pH 6.7 ± 0.1) at 35 ºC (with 
shaking), 100 cells from each sample were counted using a hemocytometer and the 
percentage of germ tubes was determined. Germ tubes were considered positive when they 
were, at least, as long as the diameter of the blastospore and negative when showing a 
constriction at the point of connection to the mother cell, typical for pseudohyphae 
(Figure 19). The assay was performed in duplicate and repeated independently three 
times for each Candida strain. 
Adherence to epithelial cells 
Cells preparation and adherence assays were modified from those proposed by 
Lima-Neto and co-workers (290), as follows. Yeast cells were grown on SDA for 24 h at 35 
ºC and re-suspended in 2 mL of sterile DPBS (pH 6.8), washed twice by centrifugation 
(1000 rpm during 5 min, in a Rotofix 32 A Hettich centrifuge) with 2 mL of DPBS and 
finally re-suspended in NYP (2 x 107 cells/mL). Epithelial cells were donated by the author 
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via soft scraping of the cheek mucous membrane with sterile cotton swabs and gently 
stirred and washed with DPBS by centrifugation (under the same conditions as before). 
Adherence assays were developed by mixing 1 mL of each suspension in a test tube, 
followed by incubation of the mixture in the presence of the test compounds, at 35 ºC, 
under gentle stirring for 2 h. A control without test compounds and a control with 
epithelial cells pre-treated with the test compounds were performed along with the 
samples. After incubation, two drops of trypan blue solution (0.4%) were added to each 
tube and the mixture was gently shaken. Ten µL of the stained suspension were 
transferred to a Neubauer chamber and examined under light microscopy. 
4.5.4.5.2. Influence in fungal membrane and cell wall composition 
Being the main targets for the action of antifungal drugs (156), the cell wall and cell 
membrane composition was evaluated in microorganisms treated with purified 
phlorotannins extracts from the species C. nodicaulis, C. usneoides and F. spiralis. C. 
albicans ATCC 10231 and T. rubrum FF5 were used for this assay, as the model yeast and 
dermatophyte organisms, respectively. 
Quantification of the cell membrane ergosterol 
Fungi growth conditions for sterol extraction were performed according to Pinto and 
co-workers (291) with minor modifications. Cell suspensions (10 µL for yeast and 50 µL 
for dermathophyte) were inoculated in 5 mL of RPMI-1640 medium containing different 
concentrations of purified phlorotannins extracts, along with a positive control (with 
fluconazole) and a negative control (without test extract). Cultures were incubated with 
shaking at 35 ºC (for Candida species) during 48 h and at 25 ºC (for dermatophyte) 
during 5 days. After the incubation period with purified phlorotannins extracts, total 
intracellular sterols were extracted by saponification, under the same procedure used 
before for the extraction of sterols from seaweeds material (Section 4.3.1). Briefly, fungal 
cells were harvested by centrifugation (1000 rpm during 5 min), washed, dried and 
weighted. Cell pellets were transferred to borosilicate glass screw-cap tubes and 3 mL of 
25% alcoholic KOH solution were added to each tube, followed by a vigorous vortex 
agitation. Cell suspensions were incubated in a water bath at 85 ºC during 60 min. After 
cooling at room temperature, sterols were extracted with n-hexane and the organic phase 
was transferred to clean glass tubes and evaporated to dryness under nitrogen. The 
extracted sterols were redissolved in 0.5 mL of MeOH and analyzed by HPLC-DAD as 
before. Ergosterol quantification was achieved by the Abs recorded in the chromatograms, 
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relative to the external standard, at 280 nm. All the experiments were repeated 
independently three times. 
Quantification of the cell wall β-D-(1→3)-glucans 
Cell wall β-D-(1→3)-glucans content was determined using the aniline blue assay 
(292). Cell suspensions [10 µL for yeast (turbidity adjusted at 0.5 MFA) and 50 µL for 
dermathophyte (106 spores/mL in NaCl 0.85 %)] were inoculated in 10 mL of RPMI-1640 
medium containing different concentrations of purified phlorotannins extracts. Positive 
(caspofungin) and negative (without test extract) controls were assayed along with the 
samples. Cultures were incubated with shaking at 35 ºC (for Candida species) during 48 h 
and at 25 ºC (for dermatophyte) during 5 days. Hyphae and yeast cells were harvested by 
centrifugation, washed with 0.1 M NaOH and lyophilized overnight. Five milligrams of 
lyophilized material were resuspended in 250 µL of NaOH (1 M) and sonicated for 30 s. 
The mixture was incubated (30 min at 52 ºC) and then transferred to ice (5 min). 50 µL of 
each reaction tube were transferred to a 96-wells plate, in triplicate, and 185 µL of aniline 
blue solution (0.067% aniline blue, 0.35N HCl, 0.98 M glycine in NaOH 1M, adjusted to 
pH 9.5) was added to each well. The microplate was incubated (30 min at 52 ºC, under 
light protection) and then left to cool down to room temperature. Fluorescence (F) 
readings were acquired on a fluorescence reader (SynergyTM HT, Biotek Instruments, 
Winooski, USA) operated by Gen5 software, with 485/20 nm excitation (ex) and 528/20 
nm emission (em) wavelength. A standard curve was built using a β-D-(1→3)-glucan 
analog (curdlan). Results (mean ± standard deviation) are expressed as g (curdlan)/100 g 
(dry microorganism) of three independent assays performed in duplicate (equation 3). 
[Fex485/20 em528/20 (unknown) - Fex485/20em528/20 (blank)/slope] x 0.0235             (3) 
 
Quantification of the cell wall chitin 
The methodology used for cell wall chitin quantification was based on the protocol 
proposed by Fortwendel and co-workers (292). The fungal growth conditions, treatment 
and tissue harvesting were the same as those proposed for β-D-(1→3)-glucans 
quantification. Five milligrams of lyophilized material were resuspended in 3 mL of a 
saturated KOH solution and incubated for 1 h at 130 ºC. After incubation the reaction 
tubes were left to cool down to room temperature and then 8 mL of ethanol 75 % (ice cold) 
were added to each tube. The tubes were vortexed until the formation of a single layer 
(adding H2O if necessary) and incubated in ice for 15 min. 300 µL of a silica suspension 
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(13.3% in H2O) was added to each tube, followed by centrifugation (5 min at 1000 rpm). 
The supernatant was rejected and the pellet washed once with 10 mL of ice cold ethanol 
40% and twice with 10 mL of ice cold water. The pellet was ressuspended in 500 µL of 
H2O, 500 µL of a 5 % NaNO2 solution and the same volume of 5% KHSO4 (both prepared 
in H2O), shacked (3 times, for 15 min at 100 rpm) and centrifuged (5 min at 1000 rpm). 
150 µL of the supernatant were removed, in duplicate, from each tube and transferred to a 
test tube containing 450 µL of H2O. A NH4 sulfamate solution (12.5% m/v in H2O) was 
added to each tube, followed by vortexing (1 min, 5 times). 200 µL of 3-
methylbenzthiazolinone-2-hydrazone solution (5 mg/mL) were added and the mixture 
was incubated for 3 min at 130 ºC. The tubes were left to cool down to room temperature 
and then 200 µL of FeCl3 solution (0.83 % in H2O) was added to each tube, which was 
further incubated (25 min at room temperature, under light protection). 
A standard curve was built using D-(+)-glucosamine hydrochloride as the known 
glucosamine sample. The Abs was read at 630 nm on a plate reader. Chitin levels were 
reported as g (glucosamine)/100 g (dry microorganism) (equation 4). 
[½ Abs63o (unknown) – Abs630 (blank)/slope] x 0.15                                   (4) 
Final results represent the average (± standard deviation) of three independent 
experiments performed in duplicate. 
 
4.5.4.5.3. Influence in fungal metabolic activity 
The influence of purified phlorotannins extracts in the metabolic activity of fungi 
was assessed by the evaluation of the mitochondrial activity and membrane potential in 
the yeast C. albicans ATCC 10231 and in the spores of T. rubrum FF5. 
Mitochondrial dehydrogenases activity 
Mitochondrial dehydrogenase activity was evaluated by the MTT assay. Briefly, C. 
albicans ATCC 10231 cell suspensions were prepared in ampoules containing 2 mL of 
NaCl 0.85% (Api®, Biomérieux, Marcy l’É toile, France) and the turbidity was adjusted to 
0.5 MFA. Cell suspension dilutions (1:50 followed by 1:20) were prepared with RPMI 
culture medium. 500 µL of RPMI were added to the same volume of the last yeast dilution, 
in a 12-wells plate, and incubated overnight (18–24 h at 35 ºC). After the incubation 
period, cells were carefully homogenized, transferred to eppendorfs and centrifuged at 
1000 rpm for 5 min. The supernatant was removed and 1 mL of the extract serial dilutions 
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was added to each eppendorf to obtain the appropriate concentrations (MIC to 1/1024 of 
the MIC). The mixture was homogenized, transferred to 12-wells plates and exposed to the 
purified phlorotannins extract during 1 h at 35 ºC.  
For T. rubrum, spore suspensions were prepared in 0.85% NaCl solution, and 
adjusted to obtain 2.0 x 106 spores/mL. 1 mL of the suspension was centrifuged (1000 rpm 
during 5 min) and the supernatant was eliminated. 1 mL of phlorotannins serial dilutions 
was mixed with the pellet, homogenised and left incubating overnight at 25 ºC with 
shaking. After the exposure time, cell suspensions were centrifuged (1000 rpm during 5 
min), the supernatant was removed and 500 mL of MTT solution (0.5 mg/mL in RPMI, 35 
ºC) were added to the cell pellets and left incubating for 30 min at 35 ºC (for Candida) or 
25 ºC (for T. rubrum). The insoluble purple formazan product resulting from the 
conversion of MTT by mitochondrial dehydrogenases of metabolically active cells (Figure 
23) was then solubilized with 300 µL of DMSO. The extent of the reduction to formazan 
within the cells was quantified by measuring the Abs at 510 nm in a plate reader. Results 
from three independent assays performed in duplicate were expressed as the percent 
change of MTT reduction, using the untreated cells as control. 
Mitochondrial membrane potential 
The mitochondrial membrane potential was evaluated by the incorporation of the 
fluorescent dye RHO (293). Briefly, a suspension of C. albicans ATCC 10231 from an 
overnight culture in SDA was prepared in DPBS and the turbidity adjusted to 2.0 MFA. 
880 µL of the cell suspension were mixed with 120 µL of the purified phlorotannins 
extracts to the desired concentrations (MIC to 1/1024 of the MIC). For controls, purified 
phlorotannins extracts were replaced by DPBS. After the incubation period (35 ºC during 
30 min), 5 mL of 0.5 mM solution of RHO (in DMSO) were added and incubated again for 
10 minutes at 35 ºC. The exceeding RHO was removed by centrifugation, for 5 min at 
1000 rpm, and the fluorescence intensity was determined after resuspending the cell pellet 
in 1 mL of DPBS. Fluorescence intensity was determined in a fluorescence microplate 
reader equipped with Gen5 software, with excitation wavelength 485/20 nm and emission 
wavelength 528/20 nm. Results were expressed in % of fluorescence relative to control, for 
three independent assays performed in duplicate. Sodium azide (an inhibitor of the 
mitochondrial respiratory chain) at a final concentration of 20 mM was used for all the 
experiments as control. 
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4.6. Compounds isolation 
Of the studied seaweeds, the one considered as the most promising (regarding 
bioactivity and nutritional aspects) was chosen for the isolation of compounds. Due to 
constrain concerning sample amounts, F. spiralis sample used for compounds isolation 
resulted from a new harvest in September 2012. 
4.6.1. Crude extraction 
The freeze dried seaweed material (dry weight 140 g) was exhaustively extracted (1 L) 
with MeOH at room temperature, under constant shaking (250 rpm). The procedure was 
repeated 3 times and the MeOH fractions were combined and evaporated under vacuum. 
The dried methanolic extract was redissolved in MeOH with 10% H2O and subjected to 
solvent-solvent partitioning to give n-hexane, EtOAc and BuOH fractions (Figure 28). All 
the fractions were screened by HPLC-UV: analysis was performed in a Dionex UltiMate 
3400 SD apparatus with a LPG-3400SD pump coupled to a photodiode array detector 
(DAD3000RS), with routine detection wavelengths at 235, 254, 280 and 340 nm. The 
chromatographic analysis was carried out on a Eurosphere-10 C18 column (125 × 4 mm, 
Knauer), working in gradient mode of 0.02% H3PO4in H2O (A) and MeOH (B) (0–10 
min, 10% B; 35 min, 100% B; 45 min, 100% B; flow rate of 1 mL/min and injection volume 
of 40 μL). The most promising fraction (ETOAc) was chosen for compounds isolation 
(Figure 28). 
 
 
 
 
 
 
 
 
 
Figure 28. Schematic representation of compounds isolation from the crude extract of F. spiralis. 
EtOAc - ethyl acetate; BuOH – n-butanol; VLC – vacuum liquid chromatography; TLC – thin-layer 
chromatography; DCM – dichloromethane.  
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4.6.2. Vacuum liquid chromatography 
The EtOAc fraction was evaporated to dryness, yielding 15.03 g of dry mass. Of this, 
1 g was taken and was subjected to C18 reversed VLC (with silica gel 60 M), using a step 
gradient starting with H2O:MeOH (80:20 v/v), followed by a final elution with 100% 
MeOH. This procedure was repeated 3 times, resulting in a VLC separation of a total of 3 g 
of the ETOAc fraction. The fractions resulting from the VLC were monitored by TLC under 
UV light and by spraying the plates with p-anisaldehyde reagent (freshly prepared 0.5 mL 
of p-anisaldehyde in 50 mL of glacial acetic acid and 1 mL of 97 % sulfuric acid, followed 
by heating at 105 ºC until maximum visualization of spots). 
4.6.3. Isolation by silica gel chromatography  
The non-polar fraction (100% MeOH) was taken and the best mobile phase was 
chosen using TLC plates pre-coated with silica gel 60 M F254. After selecting the best 
mobile phase to separate the spots obtained, the 100% MeOH fraction was submitted to 
consecutive silica gel 60 M column chromatography with the optimized mobile phase 
DCM:MeOH (95:5 v/v). The isolation by silica yielded 6.09 mg of an isolated compound 
and 50.14 mg of an inseparable mixture of two compounds with the approximate ratio of 
1:1. Both fractions were evaluated for their anti-inflammatory activity in RAW 264.7 cells, 
following the procedure proposed for purified phlorotannins extracts (Section 4.5.1) and 
using the anti-inflammatory drug dexamethasone as control. 
4.7. Statistical analysis 
Data were analyzed by GraphPad Prism software (version 5.02 for Windows), using 
the one way analysis of variance (ANOVA).  
Bonferroni’s multiple comparison test was carried out for sterols, on data obtained 
from triplicate determinations of each sample, at P<0.05, P<0.01 and P<0.001. Dunnett 
Multiple Comparison test was carried out for the determination of phlorotannins and 
glycerolipids anti-inflammatory activity, being used in the analysis of NO concentration in 
cell culture medium and in the cell-free system, and for the determination of 
phlorotannins toxicity by the MTT and LDH assays, from data obtained from four assays 
performed in duplicate for each sample, at P<0.05, P<0.01 and P<0.001. The same test, 
with the same levels of significance, was used for the determination of ergosterol, β-D-
(1→3)-glucans and chitin on yeasts and dermatophytes, and on the determination of the 
microorganisms metabolic activity by the MTT, LHD and RHO assays, on data obtained 
from three independent assays performed in duplicate for each sample LPO, O2•- and 
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HAase inhibition data obtained with purified phlorotannins extracts were analyzed by 
Turkey’s multiple comparison test, from triplicate determinations of each sample, at 
P<0.05. 
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5. RESULTS AND DISCUSSION 
5.1. Sterols profile of seaweeds samples 
5.1.1. Analysis by HPLC-DAD 
Most of the existing methodologies for sterols analysis deals with complex methods, 
including purification or isolation and derivatization of the samples for GC analysis (78). 
The present procedure was based on an alkaline hydrolysis of the lyophilized biomass, 
followed by extraction and concentration for HPLC-DAD analysis. As demonstrated 
herein, the proposed method is sensitive, gives good repeatability and is short in analysis 
time, as all the compounds are determined in less than 20 min. (Figure 29). 
 
 
 
 
 
Figure 29. HPLC-DAD chromatogram of the Phaeophyta Stypocaulon scoparium (detection at 
205 nm). Peaks: desmosterol (1), ergosterol (2), fucosterol (3), cholesterol (4), campesterol (5), 
stigmasterol (6) and β-sitosterol (7) (294). 
The HPLC-DAD analysis of the non-saponifiable fraction of macroalgae samples 
allowed the determination of 7 compounds: desmosterol, ergosterol, fucosterol, 
cholesterol, campesterol, stigmasterol and β-sitosterol (294). In a general way, and 
according to previous works (295), C29 sterols (campesterol, ergosterol 
fucosterol/isofucosterol, β-sitosterol and stigmasterol) were the major group in 
Phaeophyta and Chlorophyta. On the other hand, C27 sterols (cholesterol and desmosterol) 
constituted the majority in Rhodophyta (Figure 30). 
Contrarily to what happens in brown and red seaweeds, green seaweeds are 
characterized by the asymmetry of C-24 (24S configuration) which, being a characteristic 
of this phylum, difficults the sterols identification (54). Codium tomentosum Stackhouse 
and Codium adhaerens C. Agardh have been reported to contain 28-isofucosterol (54). As 
it happens in Codium spp., species of the Ulvaceae family almost always have 28-
isofucosterol as the major phytosterol, while fucosterol, when present, appears in trace 
concentrations (48). In the present work the HPLC-DAD chromatograms of Chlorophyta 
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species showed an important peak with the same retention time and UV spectra of 
fucosterol which, according to the above mentioned, was tentatively identified as 28-
isofucosterol. 
 
 
 
 
 
 
Figure 30. Sterols profile of Chlorophyta, Phaeophyta and Rhodophyta from the Portuguese west 
coast. Results are presented as percentage of each sterol for the species corresponding to each 
seaweed group (294). 
Seaweeds are able to biosynthesize sterols with similar structure to that of 
cholesterol, but containing a methyl or ethyl group at C-24. The qualitative and 
quantitative sterols composition of the studied seaweeds varied between the different 
phyla and within the same phylum (Figure 30). In each phylum the species with highest 
sterols amounts were C. adhaerens, O. pinnatifida and C. tamariscifolia, this last species 
being the one with the highest content of sterols among all of the studied samples (294) 
(Table 3). 
The sterols composition of seaweeds can be useful in taxonomic classification. 
Fucosterol is the dominant sterol of Phaeophyta (54), which is in agreement with the 
results of this study, in which all Phaeophyta contained more than 70% of fucosterol 
(Figure 30, Table 3) (294). In this phylum, the ratio fucosterol:cholesterol is usually 
high, although some exceptions can occur (296). Data on the chemical composition of 
Padina spp. reflect different phytosterols profiles within the genus. Although fucosterol is 
the main phytosterol in P. pavonica (297), some differences in the ratio of fucosterol to 
cholesterol can occur. In the analyzed sample (from the Atlantic Ocean) this ratio was 7:1, 
while in previous studies with a sample from the Aegean Sea (298) it was 0.3:1, 0.7:1 in a 
sample from the Adriatic Sea (297) and 16:1 in another from the French Mediterranean 
Sea (299). As expected due to its proximity, the ratio found in this study for P. pavonica 
from the Atlantic Sea is more similar to that of the algae from the Mediterranean Sea. In 
canned S. polyshides fucosterol content has been reported to be around 88% (79), while in 
our sample it represented 85%. The case of fucosterol in S. Polyshides is a valuable 
indicator of a kind of processing that does not affect the metabolites profile. 
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Several factors can contribute to the different sterols profiles within the same 
seaweeds species, namely, the ecological differences, geographical origin and 
developmental stage of the collected organism. In particular, it has been reported that the 
salinity and temperature of sea water probably influence the differences in the phytosterol 
profile of Ulvaceae family (48). U. lactuca has been characterized by the presence mainly 
of 28-isofucosterol and cholesterol and lower amounts of other sterols (48). The ratio 28-
isofucosterol:cholesterol was 10.8:1 in a sample from the Senegalese coast (300), 10.1:1 in 
a sample from the Mediterranean Sea (301) and 0.76:1 in another from the Adriatic Sea 
(48). In our sample this ratio was 5.8:1, thus being more close to that of the Mediterranean 
sample, which is in agreement with the geographical proximity with Atlantic Ocean (294). 
Among the 18 studied algae fucosterol/isofucosterol ranged from 4 to 95% of total 
sterols contents, C. usneoides being the species with the higher relative content (Table 3). 
C. tamariscifolia presented the highest amount of fucosterol (Table 3). In Phaeophyta 
and Chlorophyta the content of these compounds was significantly higher than that found 
in Rhodophyta (Figure 30, Table 3) (294). 
Rhodophyta are reported to primarily contain cholesterol, although several species 
exhibit large amounts of desmosterol (54). This is in marked contrast with the sterols in 
other algae (Chlorophyta and Phaeophyta) and in higher plants, which usually mainly 
contain C28 and/or C29 phytosterols (53). In our work cholesterol was the main compound 
in Rhodophyta, with the exception of Sphaerococcus coronopifolius Stackhouse, in which 
the pair campesterol+stigmasterol was predominant (Table 3) (294). 
Cholesterol in Rhodophyta represented 34-88% of total sterols, O. pinnatifida being 
the species with higher amounts (Table 3) and Schizymenia dubyi (Chauvin ex Duby) J. 
Agardh the species with higher relative content. The relative amount of cholesterol in 
seaweeds belonging to this phylum was significantly higher than that of the other phyla. S. 
polyshides and C. usneoides were the species with lower cholesterol content (Table 3) 
(294).  
The campesterol+stigmasterol content revealed large differences among the 18 algae 
species. This pair was not detected in only three species: C. usneoides (Phaeophyta), and 
A. armata and S. dubyi (Rhodophyta) (Table 3). C. tamariscifolia contained the highest 
amount of this pair of sterols (294). 
Desmosterol, ergosterol and β-sitosterol were generally minor compounds. 
Desmosterol represented less than 5% of total sterols, with the exception of A. armata, in 
which it reached 13% (294). Although it has been previously published that S. dubyi 
contained a desmosterol to cholesterol ratio of 2.0:1 (302), in our sample cholesterol 
Results and discussion 
89 
 
largely predominates (0.02:1). According to literature, in Rhodophyta the quantities of 
desmosterol, a precursor of cholesterol, can change from almost pure desmosterol in 
spring to 100% cholesterol in autumn (303). As our samples were collected in the 
beginning of autumn, it was expected that cholesterol predominated relatively to 
desmosterol. The relative amount of desmosterol in Rhodophyta was significantly superior 
to that of the Phaeophyta (294). 
Ergosterol was detected in all Chlorophyta, which can be a characteristic of this 
phylum. C. adhaerens clearly contained the highest amount of this compound (Table 3). 
Ergosterol was also detected in four Phaeophyta species (Table 3) and was absent in 
Rhodophyta. When present, β-sitosterol accounted for less than 8% of total phytosterols. 
S. polyshides exhibited the highest content of this sterol (Table 3) (294). 
5.1.2. Sterols profile variations with seaweeds development 
The macroalgae life cycle and the algae development stage at the time they are 
collected can be particularly important for the sterols profile. There are considerable 
variations in growth during the course of the seasons. Each algae phylum has got a 
favorable period for vegetative growth and reproduction, the accumulation of sterols 
probably corresponding to the rapid phase of cell growth (42). Rhodophyta achieves their 
maximum biomass production from March to June, levelling off in the period from June 
to September (304, 305). As our samples were collected in September, it could be expected 
a low phytosterol content in Rhodophyta algae, as these species would be in a decreasing 
phase of biomass production. In fact, the analyzed Rhodophyta species exhibited the 
lowest sterols content (Table 3). On the other hand, Phaeophyta and Chlorophyta achieve 
their maximum biomass production in summer, which can be an explanation for the 
higher amounts of sterols determined in the species belonging to these phyla (306). As far 
as we know, with the exceptions of U. lactuca (48, 307, 308), F. spiralis (50), P. pavonica 
(297), A. armata (309) and S. polyshides (79), the sterols profile of the remaining 13 
species was achieved for the first time. As for the others, it was proved that environmental 
conditions can influence the chemical composition. 
5.1.3. Seaweeds sterols as potential health promoters 
Phytosterols are recognized as an important component of healthy diets and of diets 
designed to reduce hypercholesterolemia. Chlorophyta and Phaeophyta might be 
beneficial as food ingredients or dietary supplements to increase phytosterols intake and, 
thereby, lower cholesterol absorption. As supplement, phytosterols need to be formulated 
in order to achieve biological activity because they are inherently hydrophobic. A common 
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used method consists in an esterification with long chain fatty acids to increase their 
solubility in foods (67). 
To take advantage of the cholesterol lowering effect, an increasing number of 
products with added phytosterols have become available in European Union. An intake of 
1 to 3 g per day of added phytosterols lowers LDLc blood levels in about 5 to 15%. Besides 
phytosterols benefits, the market share for plant sterol enriched products in any product 
category is lower than 10%. As according to the World Health Organization, 60% of 
coronary heart disease and 40% of strokes are due to elevated cholesterol levels, 
phytosterols rich matrices can be explored in order to reduce the incidence of these 
diseases (72). 
Although in Portugal O. pinnatifida is regularly consumed, taking into account the 
high phytosterols content of C. tamariscifolia and Fucales, in general, it might be 
interesting to consider these species to be used as supplement or in enriched phytosterols 
foods for individuals with high cholesterol levels. 
 
5.2. Phlorotannins 
5.2.1. Determination of total phlorotannins content 
The extractive process used to obtain a rich purified phlorotannins extract 
guarantees the extraction of almost all free phlorotannins present in the samples (118, 
121). 
The unique structure of phlorotannins, not found in terrestrial plants, allows their 
quantification in the purified extracts by the DMBA colorimetric method, via the 
formation of triphenylmethane pigments after electrophilic substitution (124, 310). The 
indirect measurement of phlorotannins content, with good repeatability and high 
precision, is time and temperature dependent, reason for what these factors have to be 
strictly controlled (310). 
The analyzed seaweeds presented a variable amount of phlorotannins, both among 
genus and among species of the same genus (Figure 31). 
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C. spongiosus
81.64 (1.57)
C. nodicaulis
516.24 (3.15)
C. tamariscifolia
815.82 (17.46)
C. usneoides
288.2 (8.01)
F. spiralis
968.57 (10.89)
H. filicina
101.97 (1.57)
P. pavonica
53.31 (1.57)
S. polyschides
36.68 (1.82)
S. vulgare
74.96 (7.76)
S. scoparium
126.73 (0.91)
 
 
 
 
 
 
 
Figure 31. Phlorotannins content of brown seaweeds (mg/kg dry weight). Results are expressed as 
mean (standard deviation) of three determinations, expressed as phloroglucinol units (311). 
S. polyshides contained the lowest amount of phlorotannins and F. spiralis the 
highest one (Figure 31) (311). 
Previous studies confirmed that the amount of phlorotannins can be largely variable 
among species and may constitute up to 15 % of the dry weight of brown seaweeds (83, 84, 
312). The amounts found in this work were considerably lower (<0.1 %, dry weight). The 
amount of cell-wall bound phlorotannins is usually much lower than the amount of 
soluble/free phlorotannins (118). The determination of phlorotannins content was 
performed in the soluble fraction of the algal matrix after an exhaustive purification 
technique, thus only free ones were determined in our work. However, the species and 
geographic origin of the samples can also explain these results: it is known that the total 
amount of phenolic substances in brown seaweeds in temperate seas is lower than in 
tropical ones (313). In the same work, the authors found that P. pavonica collected in the 
Canary Islands contained 0.69% phenolic substances, while F. spiralis presented 2.17% 
(313). Another species, F. vesiculosus, contained 14.5% of phlorotannins in ethanolic 
crude extract using the DMBA method (310). 
In this survey, the phlorotannins amounts of Sargassaceae family (represented by C. 
nodicaulis, C. usneoides, C. tamariscifolia and S. vulgare) widely varied, S. vulgare being 
the one containing lower amounts of phlorotannins when compared with the remaining 
species. Phlorotannins belonging to fuhalols and fucophlorethols classes are described as 
the main components of this family (314). In this work the total phlorotannins amount 
found in the purified extracts of each family was assessed for the first time and revealed to 
be significantly different: the Fucaceae rank on the top while the Phyllariaceae rank at the 
bottom (311). 
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5.2.2. Anti-inflammatory potential of purified phlorotannins extracts 
The anti-inflammatory potential of purified phlorotannins extracts was evaluated on 
the macrophage cell line RAW 264.7. Prior to testing the samples for their anti-
inflammatory activities the cytotoxicity of purified phlorotannins extracts was assessed by 
using MTT and LDH assays. The anti-inflammatory activity of phlorotannins was screened 
by the determination of the extracts capacity to reduce the NO present in the supernatant 
of the cell culture medium. 
5.2.2.1. Cytotoxicity of phlorotannins extracts 
Purified phlorotannins extracts did not reveal cytotoxicity under the tested 
concentrations (0.5 to 8.35 mg/mL, dry weight) (311). Being non-toxic in cell systems, it is 
leaved opened the possibility of using these extracts in topic pharmacological formulations 
with anti-inflammatory properties. 
The reduction of MTT varied between 92 and 107% of control (data not shown), 
evidencing that cells were metabolically active. LDH assay indicated cells viability between 
89 and 107% (data not shown). Cells maintained their normal size and shape before and 
after the incubation period with the extracts. The effect of F. spiralis extract could not be 
evaluated in this cell system under the experimental conditions, due to the precipitation of 
the extract (solubility below 0.52 mg/mL). In fact, in order to test the same concentrations 
for all seaweeds, F. spiralis extract needed the addition of high percentages of DMSO to 
completely solubilize. High concentrations of DMSO are not advisable in cell systems 
(maximum 0.5%). In order to obey this requirement, the sample had to be much diluted 
and, under those conditions, no effect was observed (311). 
Previous works have evaluated the effect of phlorotannins from Fucales on different 
cell lines. Phlorotannins rich extracts of F. vesiculosus were shown to lack relevant toxic 
effects in a rat model (113). Phlorotannins isolated from Ecklonia cava Kjellman (7-
phloroeckol, 6,6′-bieckol, phloroglucinol, eckol, fucodiphlorethol, phlorofucofuroeckol A 
and dieckol) also proved to have no cytotoxicity up to 100 µM in different cell lines (MRC-
5, RAW264.7 and HL-60) (315). 
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5.2.2.2. Effect on NO in cell culture 
Purified phlorotannins extracts of most of the tested species were able to 
significantly reduce the levels of NO in LPS-exposed macrophage cells, at non-cytotoxic 
concentrations; P. pavonica and S. vulgare did not significantly reduce NO levels in 
comparison with control cells (Figure 32) (311). 
Figure 32. Effect of purified phlorotannins extracts on LPS-induced NO production in RAW 264.7 
cells. Values of each group are expressed as % of LPS-only exposed cells (mean ± SEM of 4 
independent assays). *P<0.05, **P<0.01, ***P<0.001 (311). 
 
C. tamariscifolia displayed a remarkable potential for reducing NO production 
(Figure 32). At the highest concentration, NO production was reduced to 25% (P<0.001) 
of control cells. C. nodicaulis, Halopteris filicina (Grateloup) Kützing and S. scoparium 
were the species with highest activity: C. nodicaulis and H. filicina lead to a decrease of 
NO production to 55% and S. scoparium to 61% for the highest concentration (P<0.001) 
(Figure 32). These results may turn seaweeds phlorotannins extracts attractive potential 
anti-inflammatory agents or co-adjuvants in the treatment of inflammatory states. The 
inhibitory effect of the extracts on NO production cannot be attributed to cytotoxic effects, 
since they did not decrease cell viability, as discussed above (311). 
Brown seaweeds can exert anti-inflammatory activity by diverse processes, not 
necessarily related to the decrease of NO production. For example, anti-inflammatory 
effect via the arachidonic dependent pathway (down regulation of prostaglandin E2 
generation) was observed for a phlorotannins extract of E. cava (112). Isolated 
phlorotannins have also shown to inhibit lipoxygenases and phospholipase A2 activity 
(114). In another assay moderate Cox-1 inhibition by several phlorotannins was observed, 
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which may contribute for their anti-inflammatory capacity (211). Phlorotannins can affect 
NO levels by direct scavenging and/or by decreasing NO production through the action in 
the inflammatory signaling cascade or by inhibiting the enzymes involved in NO 
production (111, 112). 
The differences observed in the anti-inflammatory activity can be related, at least 
partially, with the total amount of phlorotannins present in the seaweeds extracts. In what 
concerns to extracts of the same species but with different phlorotannins contents, the 
work by Zaragozá and colleagues with F. vesiculosus extracts (113) showed that the 
potential to reduce NO is proportional to the phlorotannins content. Considering the 
probable similarity of the qualitative composition of the three Cystoseira species studied 
herein, the results seem to be in agreement with those of Zaragozá and co-workers, as the 
capacity of these species to reduce NO in the culture medium was proportional to their 
phlorotannins content (Figures 31 and 32). However, the qualitative composition of the 
extracts may not be excluded, as species with similar phlorotannins content presented 
different activities (316). S. polyschides and P. pavonica are example of this: the first 
displayed a much higer capacity to reduce NO levels, even presenting a lower 
phlorotannins content (311). 
5.2.2.3. Effect of NO in a cell-free system 
The decrease of NO concentration can be due to the interference with NO 
production by LPS-stimulated macrophages or to the scavenging of the produced NO. In 
order to test the later hypothesis, a cell-free assay with a NO donor was performed. The 
concentrations of purified phlorotannins extracts tested on the cell free system were the 
same as those used for macrophage cells. Under these conditions, Cladostephus 
spongiosus (Hudson) C. Agardh, H. filicina, S. polyschydes and P. pavonica had no 
activity. As a first approach, it seems that phlorotannins can act by reducing NO by, at 
least, two different mechanisms. As far as we know, the NO scavenging activity of purified 
phlorotannins extracts for the ten brown seaweeds under study had not been previously 
assessed. 
Five of the brown seaweed species (the three Cystoseira, S. vulgare and F. spiralis) 
showed significant NO scavenging activity, in a dose-dependent manner (Figure 33) 
(311). 
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Figure 33. Effect of purified phlorotannins extracts on SNP-generated NO in a cell-free system. 
Values of each group are expressed as % of control (mean ± SEM of 4 independent assays). 
*P<0.05, **P<0.01, ***P<0.001 (311). 
 
The decrease of NO seen in the cellular system may be partially attributed to the 
direct NO scavenging, as the purified phlorotannins extracts of these species decreased the 
amount of nitrite generated from the decomposition of SNP. In contrast to the cellular 
assays, in which C. tamariscifolia showed the highest potential to reduce NO, in the cell-
free system F. spiralis and C. nodicaulis exhibited the highest capacity for NO radical 
scavenging, leading to a reduction of about 40% when compared with the control (Figure 
33) (311). On the other hand, the extracts of H. filicina, S. polyschides and S. scoparium 
reduced the levels of NO on cells stimulated by LPS, having no activity in the cell-free 
system. The differences observed between the cellular and non-cellular assays suggest that 
phlorotannins can reduce NO by different mechanisms. The evaluation of NO scavenging 
capacity of phlorotannins in the cell-free system evidences that these compounds have the 
capacity to sequester NO. On the other hand, the reduction on NO levels in the culture 
medium of cells treated with C. spongiosus, H. filicina, S. polyschydes and P. pavonica 
(which have no capacity to reduce NO generated from SNP) demonstrates that there are 
other mechanisms responsible for NO reduction, besides scavenging. These mechanisms 
of decreasing NO that may be involved in the cellular assay, can be, for example, those 
related to the several inflammatory cascade steps (111, 112, 317). As so, the scavenging 
effect observed in the cell-free system with C. nodicaulis, C. tamariscifolia, C. usneoides 
and S. vulgare can contribute to the decrease of NO noticed in the cellular system with 
these species. 
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5.2.3. Screening of the antimicrobial activity of purified phlorotannins 
extracts 
5.2.3.1. Antibacterial activity 
The antibacterial activity of purified phlorotannins extracts of the studied species 
was investigated in vitro for the first time herein. The results obtained highlight how the 
species variability and their phlorotannins content can influence the antibacterial 
properties.  
Purified extracts from the ten seaweeds were tested against several Gram+ and 
Gram─ bacterial strains (311). The values of MIC and MLC were determined and are 
displayed in Table 4. Gram+ bacteria were more sensitive to phlorotannins than Gram─. 
The purified phlorotannins extracts showed bacteriostatic activity against all the studied 
strains and bactericidal activity against five of them (S. epidermidis, M. luteus, E. faecalis, 
B. cereus and E. coli). There was no considerable variation in the MLC found among the 
different studied bacteria, with the exception of M. luteus treated with F. spiralis extract, 
which revealed to be the most lethal agent (Table 4). S. epidermidis was the most 
susceptible species among Gram+, the inhibitory effect of C. nodicaulis extract on its 
growth being directly proportional to the phlorotannins extract concentration and lethal at 
31.3 mg/mL (Table 4). In a general way, and according to the results, F. spiralis and C. 
nodicaulis were the most promising seaweeds (Table 4) (311). 
Gram+ bacteria 
In a general way, Cystoseira species and F. spiralis were the most active against 
Staphylococcus. Of them, S. epidermidis was the most sensitive species, with the lowest 
MIC and MLC values for treatment with F. spiralis (Table 4, Figure 34) and C. 
nodicaulis (Table 4). S. aureus was also more sensitive to C. nodicaulis and F. spiralis 
(MIC=7.8 mg/mL) (311). These Gram+ cocci are members of the Micrococcaceae family, 
and are more often associated with human infection, S. aureus being the major cause of 
morbidity and mortality. Among the more common infections caused by S. aureus are 
boils, folliculitis, cellulitis and impetigo, which can be a risk in immunocompromised 
individuals. This strain is also capable of producing food poisoning. On the other hand, S. 
epidermidis is recognized as the leading cause of nosocomial infections, being responsible 
for a subtle and sub-acute clinical presentation. This strain also presents the ability to 
form biofilms, which can be a risk in intravenous drug users (318). 
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A B C
Of the studied seaweeds, F. spiralis presented the best activity against M. luteus 
(MIC=2.0 mg/mL) (Table 4). This seaweed also presented the highest bactericidal 
activity, being capable of killing M. luteus at 15.6 mg/mL (Table 4, Figure 34) (311). M. 
luteus has been implicated in a variety of infections, including meningitis, endocarditis, 
septic arthritis and central nervous system infections in immunocompromised hosts (318). 
 
 
 
 
 
Figure 34. Minimum lethal concentration (MLC) of F. spiralis against M. luteus (A), S. 
epidermidis (B) and E. faecalis (C). Arrows point the area of growth inhibition corresponding to the 
MLC. (Photographs of Graciliana Lopes). 
 
The species belonging to the genus Cystoseira and Fucus were the only ones active 
against B. cereus, with F.spiralis also presenting bactericidal activity (Table 4). B. cereus 
is an important pathogen responsible for food-borne illness, causing intoxication or 
infection in humans (318).  
E. faecalis, which commonly colonizes gastrointestinal and genital tracts of humans, 
was the most resistant among Gram+ bacteria. Only F. spiralis and S. vulgare were active 
against this microorganism and only F. spiralis showed bactericidal activity (Table 4, 
Figure 34). In general, species belonging to the genus Cystoseira and F. spiralis were the 
ones with highest bacteriostatic and bactericidal activity, which can be related with their 
high content in phlorotannins (311). 
Gram─ bacteria 
Phlorotannins purified extracts evidenced lower activity against Gram─ strains 
(Table 4). C. nodicaulis was the only seaweed with ability to inhibit S. typhimurium 
growth (Table 4). Most infections with Salmonella are caused by contaminated food and 
water. Of concern are Salmonella infections that are resistant to several antimicrobial 
agents, in which the serotype Typhimurium is included (318). 
F. spiralis and C. nodicaulis extracts were the only ones active against P. aeruginosa 
(Table 4), a bacterium responsible for a wide range of infections, especially prevalent 
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among patients with burn wounds, cystic fibrosis, acute leukemia, organ transplants and 
intravenous drug addiction. It also causes urinary tract and lower respiratory tract 
infections, particularly severe and even life-threatening in immunosuppressed hosts (318). 
P. mirabilis was the most sensitive strain studied. It was inhibited by five of the 
tested extracts between 15.6-31.3 mg/mL (Table 4) (311). C. nodicaulis was the most 
effective seaweed against this bacterium, which is normally found in human 
gastrointestinal tract and can cause urinary tract and wound infections and septicemia. It 
is also often associated with nosocomial infections (318) . 
C. nodicaulis was the only seaweed capable of inhibiting E. coli growth, being also 
lethal for this bacterium at the same extract concentration (31.3 mg/mL) (Table 4) (311). 
E. coli is the most common member of Escherichia genus, normally found in the 
gastrointestinal tract of humans and animals. It causes gastrointestinal and extra 
intestinal infections and is spread by fecal-oral route or by improperly cooked or 
contaminated food and drinks (318) . 
The physical differences between Gram─ and Gram+ bacteria can be the basis of the 
observed behavior of phlorotannins extracts. Gram─ bacteria are surrounded by an 
external membrane with high lipopolysaccharide content. This membrane, in addition to 
other mechanisms, confers bacteria the capacity to resist to several antibiotics and, 
consequently, to the action of many natural extracts. Having this in mind, it is expectable 
Gram+ strains to be more sensitive and, consequently, infections caused by them easier to 
overcome. 
Nagayama and co-workers (106) concluded that the antibacterial effects of 
phlorotannins tend to increase with the polymerization of phloroglucinol. S. aureus and B. 
cereus were the only Gram+ strains studied by this group. S. aureus was more sensitive 
than B. cereus, which is in accordance with our results. Taking this into account, it is 
expectable that species belonging to the genus Cystoseira and Fucus are probably the ones 
with phlorotannins of higher molecular weight, as they are the ones presenting lower 
MICs for all the studied bacteria. On the other hand, and according to the tannic 
compounds ability of reacting with amine groups of proteins by their free OH groups 
(250), it is also probable that those species with phlorotannins with a higher degree of 
polymerization have more free OH groups capable of reacting with the amine groups of 
proteins from the bacterial surface. Although the mechanism of action of phlorotannins 
with bacteriostatic and bactericidal activities is not yet elucidated, it is possible that there 
is some relation with the action of these compounds on the microorganisms surface (251). 
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In fact, it is thought that the interactions between bacterial proteins and phlorotannins 
play an important role in the bactericidal action of these compounds (251). 
Concerning Cystoseira genus, although C. tamariscifolia presented the highest 
phlorotannins amount (Figure 31), the extract was less effective against bacteria than 
that of C. nodicaulis and C. usneoides. Thus, it is possible that polyphenols present in C. 
tamariscifolia exhibit lower molecular weight or fewer OH groups free to react when 
compared with those in C. nodicaulis and C. usneoides (311). 
The available studies concerning the antibacterial activity of phlorotannins are, in 
their majority, related to phlorotannins isolated from seaweeds of the genus Ecklonia and 
Eisenia. Compounds like eckol, 8,8’-Bieckol, dieckol, dieckoldioxinodehydroeckol, 
fucofuroeckol-A, 7-phloroeckol and phlorofucofuroeckol-A have been shown to have 
antimicrobial activity against several bacterial strains, such as S. aureus, methicillin-
resistant S. aureus (MRSA), Salmonella spp., Bacillus spp., Campylobacter jejuni and E. 
coli, among others (106, 108, 247, 248). The effect of phlorotannins on bacterial growth 
inhibition has been compared to that of catechins from green tea, used as positive control, 
and their activity was equal or superior to that (108). 
Considering the pathogenic capability of Gram─ bacteria and the emerging 
multidrug resistance, especially against third and fourth-generation cephalosporins and 
quinolones antibiotics, it becomes important the development of new antimicrobial drugs 
(229). Taking into account the MIC values obtained for F. spiralis and C. nodicaulis, these 
species appear to be promising for a future antimicrobial approach. 
 
5.2.3.2. Antifungal activity 
Results of the antifungal screening of phlorotannins extracts against the yeast C. 
albicans, the filamentous fungi A. fumigatus and the dermatophyte T. rubrum are shown 
in Table 5. Phlorotannins extracts seemed to be less effective against fungi than bacteria, 
in the tested concentrations. The purified extracts displayed antifungal properties against 
two fungi strains: T. rubrum and C. albicans, being inactive against Aspergillus (311). 
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Table 5. MIC and MLC of purified phlorotannins extracts against selected fungi (311). 
1mg/mL (dry weight) 
Of the studied fungi, T. rubrum was the most sensitive to the purified phlorotannins 
extracts. F. spiralis and C. nodicaulis were the most effective species (MIC=3.9 mg/mL), 
followed by C. usneoides and S. vulgare (MIC=7.8 mg/mL) and C. tamariscifolia (31.3 
mg/mL). All the other seaweed extracts were inactive under the tested concentrations 
(Table 5). The MLC was also assessed against T. rubrum. Best results were obtained with 
C. nodicaulis, being lethal for the fungi at 7.8 mg/mL (311). These results point C. 
nodicaulis as very promising for the future development of antimycotic drugs, since the 
tested phlorotannins extract acted as fungicidal (MLC=MIC or MLC=MIC-1 dilution). The 
importance of C. nodicaulis against T. rubrum takes a key role if one considers the therapy 
abandonment by patients, due to the extent of the treatment period.  
Only four species displayed activity against C. albicans under the tested 
concentrations, C. nodicaulis being the most effective one (Table 5). Under the tested 
concentrations none of the studied species was lethal for C. albicans (MLC>31.3 mg/mL) 
(311). Nevertheless, the active seaweeds can be considered as an alternative for the 
treatment of disseminated candidiasis, in combined therapy with other antifungal agents. 
Candida cells can establish disease by disseminating from mucosa and gut, which is in the 
origin of invasive infections, particularly serious in individuals with weakened immune 
defenses. Since phlorotannins extracts did not reveal toxicity to mammalian cells, they can 
be especially interesting for the treatment of fungal infections in immunocompromised 
 Fungi 
 
 
 
Seaweed Extract1 C. albicans A. fumigatus T. rubrum 
 MIC MLC MIC MLC MIC MLC 
C. spongiosus >31.3 - >31.3 - >31.3 - 
C. nodicaulis 7.8 >31.3 >31.3 - 3.9 7.8 
C. tamariscifolia >31.3 - >31.3 - 31.3 >31.3 
C. usneoides 31.3 >31.3 >31.3 - 7.8 31.3 
F. spiralis 31.3 >31.3 >31.3 - 3.9 31.3 
H. filicina >31.3 - >31.3 - >31.3 - 
P. pavonica >31.3 - >31.3 - >31.3 - 
S. polyschides >31.3 - >31.3 - >31.3 - 
S. vulgare 15.6-31.3 >31.3 >31.3 - 7.8 31.3 
S. scoparium >31.3 - >31.3 - >31.3 - 
Results and discussion 
 
102 
 
patients, as the side effects related to the antifungal drug will be, in this situation, less 
expected. 
In a general way, C. nodicaulis revealed to be the most effective species against the 
studied fungi. Although it was not lethal for C. albicans under the tested concentrations, it 
presented the lowest MICs for both C. albicans and T. rubrum, being also lethal for the 
dermatophyte (311). 
According to these results, purified phlorotannins extracts can be pointed to act as 
antimicrobial, antioxidant and anti-inflammatory agents. Species belonging to the genus 
Cystoseira and F. spiralis revealed potential for the development of medicines with anti-
inflammatory and antimicrobial activities, especially against Gram+ strains and 
dermatophytes, which showed to be more sensitive to them. Additionally, the NO 
scavenging capacity observed in cell-free systems confirms the antioxidant potential of 
phlorotannins, which can contribute to the overall beneficial effects. These results point 
phlorotannins extracts as potential pharmaceutical resources for combating infections 
with multi etiological causes, as the same extract can cover a wide range of 
microorganisms and has the potential to act on inflammatory states and oxidative 
environment, commonly associated with microbial infections. 
Taking into account the importance of the mechanism of action on therapeutic 
effectiveness of antifungals, and considering the relative scarcity of antifungal drugs 
comparatively to antibacterial ones and the potentialities of phlorotannins, these 
compounds were further evaluated on this field. 
5.2.4. Mechanism of antifungal action of phlorotannins 
Whereas the medicinal properties of herbs have been recognized since ancient times, 
there has been a resurgence of interest in the antimicrobial properties of marine organisms, 
particularly seaweeds. With this in mind, phlorotannins extracts from the seaweeds 
species that have shown most promising antifungal activity in the first screening, namely 
C. nodicaulis, C. usneoides and F. spiralis, were used for the study of the mechanism of 
antifungal action. 
On a first approach, it has been made a screening of the antifungal activity of the 
phlorotannins extracts on a broader range of fungi (Table 6). 
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The tested extracts displayed antifungal properties against six yeast strains (C. 
albicans ATCC 10231, C. krusei ATCC 6258, C. parapsilosis ATCC 90018, C. albicans D1, 
C. albicans D5 and C. dubliniensis), C. albicans ATCC 10231 being the most sensitive. It 
was also possible to determine the MIC50 for C. glabrata in the tested concentrations 
(Table 6) (319). With the exception of M. gypseum that was resistant to C. usneoides, all 
of the studied dermatophytes were sensitive to the purified phlorotannins extracts, with 
fungistatic and fungicidal activity. T. rubrum and E. floccosum were the most sensitive, 
being inhibited by all the purified phlorotannins extracts. C. nodicaulis presented the 
lowest MIC and MLC value for both species, followed by F. spiralis (Table 6). Under the 
tested conditions, all of the studied Aspergillus species were resistant to the tested 
extracts at the concentration of 62.5 mg/mL (Table 6). Contrarily to Candida species, 
and with the exception of M. gypseum, purified phlorotannins extracts presented 
fungicidal activity against almost all of the studied dermatophyte strains (with MLC=MIC 
or MLC= at least one dilution before MIC) (319). Considering this, phlorotannins can be 
promising antifungals, both individually and in combined therapy. 
According to the displayed antifungal activity, the purified phlorotannins extracts 
were object of further investigation, in an attempt to elucidate the mechanism underlying 
their antifungal action. The effects on the dimorphic transition and adherence (in C. 
albicans), on the fungal cell wall and membrane composition and on the mitochondrial 
function were addressed. 
5.2.4.1. Effect on C. albicans virulence factors 
The dimorphic transition of C. albicans, i.e., the ability to produce a germ tube, is 
involved in the microorganism pathogenesis. The inhibition of the germ tube production is 
sometimes sufficient to treat disseminated candidiasis, as this structure is responsible for 
the adhesion of Candida cells to the mucosa, which turns these infections more difficult to 
overcome (265, 266). The ability to produce a germ tube is characteristic of C. albicans 
species and represents a good tool for the presumptive identification of clinical isolates 
(267). With the purpose of evaluating the effect of phlorotannins on the dissemination of 
Candida cells, the study of the dimorphic transition and adherence of these cells was 
performed in the presence of the purified phlorotannins extracts.  
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5.2.4.1.1. Dimorphic transition 
Of the genus Candida, only the species C. albicans and C. dubliniensis display the 
capability to undergo dimorphic transition (265, 267). In order to evaluate the effect of 
purified phlorotannins extracts in yeast dimorphic transition, and taking into account that 
C. dubliniensis does not produce a germ tube in vivo, three C. albicans were selected: one 
type strain (ATCC 10231) and two clinical isolates (D1 and D5). Purified phlorotannins 
extracts of species from the genus Cystoseira did not inhibit the germ tube formation in 
the tested C. albicans strains. However, purified phlorotannins extracts from F. spiralis 
inhibited similarly the dimorphic transition in the three C. albicans strains studied 
(Figure 35). More than 90% of the yeast cells treated with sublethal concentrations of 
purified phlorotannins extracts from F. spiralis (from MIC to MIC/32) presented 
pseudohyphae instead of germ tubes (Figure 35 B1), pointing this species as a potential 
inhibitor of Candida infection dissemination (265). MIC/32 was the lowest concentration 
for which more than 90% of yeast cells presented pseudohyphae (Figure 35 C). For 
MIC/64, the percentage of yeast cells with pseudohyphae was reduced to values around 
70% and, for the lowest concentrations tested (MIC/128 and MIC/256), pseudohyphae 
represented less than 10%, the production of germ tubes being no longer inhibited 
(Figure 35 C). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 35. Effect of purified phlorotannins extracts from F. spiralis in the dimorphic transition of 
C. albicans ATCC 10231 (Untreated control cells - A1; cells treated with extract at MIC/32 – B1), in 
the adherence of the yeast to the epithelial cells (Untreated control cells – A2; cells treated with 
extract at MIC/32 - B2) and in the germ tube formation (C). Arrows show a constriction resulting 
from an incomplete budding, where the bud remains attached to the mother cell, originating 
pseudohyphae. Levels of magnification are as shown: Bars, 50 µm (A1 and B1) and 250 µm (A2 and 
B2). Results are expressed as mean (±SD) of three independent assays. * P<0.05, ** P<0.01, 
***P<0.001 (C) (319). 
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The results demonstrate that phlorotannins of F. spiralis inhibit the dimorphic 
transition of Candida cells by causing an incomplete budding, where the bud is not 
detached from the mother cell, originating pseudohyphae. 
5.2.4.1.2. Adherence to epithelial cells 
The adherence assay with epithelial cells was performed to clarify if pseudohyphae 
formation could affect the adherence of Candida to the mucosal cells. Figure 35 shows 
the effect of purified phlorotannins extracts in the dimorphic transition of C. albicans 
ATCC 10231 and in the adherence of the yeast to epithelial cells, for the lowest F. spiralis 
concentration capable of inhibiting the dimorphic transition in more than 90% of yeast. A 
common distribution pattern was observed in control yeast cells and in yeast cells treated 
with phlorotannins. C. albicans treated with F. spiralis phlorotannins presented a 
widespread distribution through the culture medium, with few or no adherence to 
epithelial cells (Figure 35 B2). Contrarily, in control cells, yeast appeared adhered to 
epithelial cells and few yeast where found free in the culture medium (Figure 35 A2). 
These observations confirm the adherence capacity of C. albicans germ tubes and the lack 
of adherence for pseudohyphae, emphasizing the potential of F. spiralis to reduce the 
virulence factor in Candida species. This effect can be the cause of phlorotannins 
fungistatic activity and is also an important target concerning the virulence of these 
microorganisms, as this species can significantly inhibit germination until MIC/64 
(Figure 35 C). 
Hereupon, phlorotannins of F. spiralis seem to be promising for association with 
existing antifungals, possibly being beneficial for the treatment of invasive candidiasis. 
5.2.4.2. Effect on the cell membrane and cell wall composition 
The cell membrane and cell wall of fungi are the most important targets for 
antifungal drugs. These physical and chemical barriers are responsible for the 
communication with the environment, for maintaining fungal structure and normal cell 
growth and, therefore, have a key role in metabolic processes (256, 264). Face to this, the 
effect of purified phlorotannins extracts on fungal cell wall composition was evaluated by 
measuring the amount of β-D-(1→3)-glucans and chitin in yeasts and dermatophytes. 
5.2.4.2.1. Cell membrane ergosterol 
As referred above, ergosterol is responsible for the maintenance of cell membrane 
structure and functions (156). The effect of purified phlorotannins extracts on fungal 
membrane composition was evaluated by determining ergosterol by HPLC-DAD, after 
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fungal treatment with sub-inhibitory extracts concentrations (1/2 to 1/8 of the MIC). With 
the exception of C. nodicaulis and C. usneoides that significantly reduced the ergosterol 
amount in yeast and dermatophyte, respectively, the influence in the cell membrane 
composition does not seem to be the primary mechanism of phlorotannins antifungal 
action (Figure 36). 
 
 
 
Figure 36. Ergosterol concentration in C. albicans ATCC 10231 (A) and T. rubrum FF5 (B) cells 
treated with purified phlorotannins extracts (1/2 to 1/8 of the MIC). Results are expressed as mean 
(±SD) of three independent assays. *P<0.05, **P<0.01, ***P<0.001 (319). 
For both yeast and dermatophyte, the species C. nodicaulis and C. usneoides, 
respectively, reduced the ergosterol amount similarly to fluconazole. This behavior can be 
related to the seaweeds phlorotannins composition. On one hand, it would be expectable 
the Cystoseira species to act in a similar manner due to genus similarities. On the other 
hand, regarding the differences related to the phlorotannins amounts and composition of 
these two species (311, 320), some differences can occur. C. nodicaulis has got more 
phlorotannins than C. usneoides; however, C. usneoides phlorotannins tend to be of lower 
molecular weight. Thus, it is possible that phlorotannins with lower molecular weight are 
more efficient on inhibiting ergosterol biosynthesis in the dermatophyte. Regarding the 
yeast, it seems that both molecular weight and phlorotannins amount are related to the 
inhibition of ergosterol biosynthesis. F. spiralis is the species with higher phlorotannins 
amount and, at the same time, the species with higher molecular weight phlorotannins 
(Figures 31 and 39, Table 7). No activity was observed for this species. The 
phlorotannins molecular weight among Cystoseira species is closer and, among them, C. 
nodicaulis presented more activity, having also a higher phlorotannins concentration. 
 
 
Results and discussion 
 
108 
 
5.2.4.2.2. Cell wall β-D-(1→3)-glucans and chitin 
The effect of purified phlorotannins extracts on fungal cell wall composition was 
evaluated by measuring the amount of β-D-(1→3)-glucans and chitin (data not shown), 
which are essential components of the fungal cell wall, responsible for maintaining fungal 
structure and normal cell growth. 
β-D-(1→3)-Glucans levels were quantified by a fluorescence assay after 
microorganisms’ treatment with sub-inhibitory concentrations of purified phlorotannins 
extracts (1/2 to 1/16 of the MIC). Caspofungin, an inhibitor of glucans synthesis, was used 
as control and the β-D-(1→3)-glucans levels on treated cells were compared with 
untreated control cells. Chitin levels were determined spectrophotometrically. 
Of the studied seaweeds, only F. spiralis purified phlorotannins extract significantly 
reduced the amount of chitin in the dermatophyte T. rubrum (P<0.05). None of the tested 
seaweeds extracts affected the β-D-(1→3)-glucans composition of the studied 
microorganisms. In what concerns to chitin, a much lower amount in yeast than in 
dermatophyte was expected, as it constitutes only 1-10% of Candida cell wall in yeast form 
(321). However, as this yeast undergoes dimorphic transition in RPMI medium, after the 
incubation period it is not in the yeast form, rather presents branching filaments, for 
which chitin composition is similar to that of dermatophytes. 
5.2.4.3. Effect on the microorganisms metabolic network 
Mitochondria are present in most eukaryotic cells and comprise the respiratory 
chain. These organelles play several important roles, including generation and regulation 
of ROS, Ca2+ homeostasis, regulation of apoptosis and metabolic processes, being also 
responsible for more than 90% of cellular ATP production (269). Compounds with the 
capacity to affect mitochondrial respiratory chain can be seen as potential cell growth 
inhibitors and capable of trigger cell death (269, 270, 322). With this purpose, the activity 
of purified phlorotannins extracts was evaluated on the mitochondrial metabolic activity 
of C. albicans. Currently, no antifungal drug primary acts by affecting mitochondria 
activity. 
5.2.4.3.1. Mitochondrial dehydrogenases activity 
In order to check whether the phlorotannins could affect the mitochondrial function, 
the MTT reduction assay was performed with purified phlorotannins extracts 
concentrations ranging from MIC to MIC/1024 (Figure 37A). Surprisingly, Candida cells 
treated with purified phlorotannins extracts presented significantly higher mitochondrial 
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activity than the control cells, being about 2.5 times higher in cells treated with C. 
nodicaulis extract MIC (Figure 37 A). For lower concentrations of extracts, the 
mitochondrial activity equaled the value of control cells (Figure 37 A). Cells were 
observed under light microscopy and the ones treated with the extracts presented a higher 
density of formazan salts (Figure 37 B and C). For T. rubrum spores, the MTT 
conversion rate decreased with increasing phloro annins concentrations, which was the 
expected behavior, being in accordance with MIC (data not shown). 
 
 
 
Figure 37. Mitochondrial activity of C. albicans ATCC 10231 cells treated with different 
concentrations of purified phlorotannins extracts. Results are expressed as the percent change of 
MTT reduction using the non-treated cells as control (mean (±SD) of three independent assays 
performed in duplicate). For concentrations lower than MIC/1024 the mitochondrial activity was 
similar to that of the untreated cells. Arrows show the formazan salts produced by C. albicans 
mitochondria. *P<0.05, **P<0.01, ***P<0.001 (319). 
 
Yeast respiratory chain involves complex and flexible pathways not fully elucidated. 
C. albicans mitochondria contain three respiratory chains: the classical respiratory chain 
(CRC), a secondary parallel chain (PAR) and an alternative oxidative pathway (AOX). CRC 
capacity was verified to be twice as large as AOX, while PAR capacity, which was only 
efficient when both CRC and AOX were blocked, represented only one tenth of the 
maximal oxygen consumption rate (265, 323). 
 
A large proportion of cellular dehydrogenases, namely succinate, NADH, glycerol 
3P-dehydrogenase and LDH, which are part of the CRC, are responsible for the reduction 
of MTT to formazan salts (318, 323). MTT reduction assay, which is commonly used to 
assess cell viability by means of the mitochondrial function evaluation, is also used to 
confirm and determine MIC values. Tetrazolium salts have become some of the most 
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widely used tools in cell biology for measuring the metabolic activity of cells ranging from 
mammalian to microbial origin. These salts are cleaved by mitochondrial dehydrogenases 
to form its purple formazan derivatives, which can be measured and reported to 
mitochondrial activity (324). 
Attending to the results obtained (Figure 37 A), and after cells observation under 
light microscopy (Figure 37 B and 37 C), we can assume a possible stimulation of 
cellular dehydrogenases, which presented the capacity to convert MTT at a much higher 
rate than the untreated cells. According to these observations, it can be supposed that the 
fungistatic activity of phlorotannins on Candida cells can be related to toxic effects due to 
increased ROS production, which follows from the respiratory rate increment (322). 
During normal respiration, small amounts of toxic intermediate species are generated by 
partial reduction of O2, including O2•-, H2O2 and HO•. Although cells have several 
enzymatic (superoxide dismutase, GPx and CAT) and non-enzymatic (endogenous and 
exogenous antioxidants) systems contributing for free radicals inactivation, the reactive 
species can accumulate and cause cell damage (322, 325). As it is possible that purified 
phlorotannins extracts increase the mitochondrial respiratory rate by stimulating the 
activity of yeast dehydrogenases (Figure 37 A and C), we can assume that these 
compounds trigger an increased production of ROS. Once the mitochondrial 
dehydrogenases activity on cells treated with phlorotannins purified extracts was 
significantly higher (P<0.001) than that of control cells, it is possible that the cell’s free 
radical inactivation systems were not able to intercept all of the ROS formed during the 
respiration process, leading to toxic effects, which inhibit cell division (322). 
5.2.4.3.2. Mitochondrial membrane potential 
The mitochondrial membrane potential reflects the pumping of hydrogen ions 
across the inner membrane during the process of electron transport and oxidative 
phosphorylation, being, together with the mitochondrial dehydrogenases function, a key 
indicator of cellular viability. The change in fluorescence intensity is related to the inner 
mitochondrial membrane depolarization, namely to the loss of membrane potential. In 
this case, mitochondrion loses the ability to sequester Ca2+, resulting in a loss of selectivity 
of the inner membrane and leading to a mitochondrial membrane permeability transition 
dependent of Ca2+. This change of permeability is involved in the process of injury and cell 
death (326, 327). RHO is a fluorescent probe commonly used for the evaluation of 
mitochondrial membrane potential (293). 
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The mitochondrial membrane potential was evaluated by measuring the 
incorporation of the fluorescent probe RHO by Candida cells after treatment with purified 
phlorotannins extracts (Figure 38). The amount of RHO incorporated by treated cells 
was significantly superior to the control for almost all the tested concentrations, 
increasing from MIC to MIC/8 and decreasing from MIC/16 to MIC/1024 (Figure 38). 
The fluorescence intensity for MIC/1024 equaled the values of untreated cells. 
 
 
 
 
 
 
 
Figure 38. Percentage of Rhodamine 123 fluorescence of C. albicans ATCC 10231 cells treated 
with different concentrations of purified phlorotannins extracts, relative to control. For 
concentrations lower than MIC/1024 the percentage of fluorescence was similar to that of 
untreated cells. Results are expressed as mean (±SD) of three independent assays performed in 
duplicate. *P<0.05, **P<0.01, ***P<0.001 (319). 
Face to the results, it appears that purified phlorotannins extracts have a dual 
mechanism for regulating the mitochondrial membrane potential (Figure 38). The 
fluorescence intensity was superior to that of untreated cells for almost all extracts 
concentrations, leading to the assumption that a hyperpolarization state of the 
mitochondrial membrane could occur (328). Although the increase of fluorescence 
intensity observed from MIC to MIC/8 was more unexpected, it can be associated with 
cellular defense mechanisms against apoptosis (329). Taking into account that several cell 
proteins are responsible for regulating programmed cell death and mitochondria integrity, 
anti-apoptotic proteins can block cell death by reducing the oxidative stress in cases of 
severe cellular injury. The expression of these proteins is able to stabilize the 
mitochondrial membrane potential (329). The mechanism by which membrane 
polarization occurs is still obscure, although it is known that the loss of mitochondrial 
membrane potential constitutes an early event during apoptosis in some systems (330-
332). As so, a biphasic change in membrane potential can occur for higher concentrations 
of tested compounds, with an early hyperpolarization followed by depolarization (331). 
According to this, it could be hypothesized that at the highest concentration (MIC) there is 
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increased expression of anti-apoptotic proteins by the cell, in a tentative to resist apoptosis 
and, therefore, a quicker stabilization of the membrane potential takes place. As the 
concentration of phlorotannins decreases (from MIC to MIC/8), the cellular injury and the 
expression of anti-apoptotic proteins is reduced, so that the membrane potential is not 
established as soon. 
The second mechanism by which phlorotannins seem to affect the membrane 
potential is not probably related to anti-apoptotic defenses. The accumulation of ROS 
inside cells can lead to alterations in cell membranes permeability, leading to the increase 
of cytosolic Ca2+ concentrations, both by the release of Ca2+ from the intracellular stores 
and by the increased influx over the cytoplasmic membrane (322). As soon as the 
phlorotannins concentration lowers (from MIC/8 to MIC/1024), the membrane potential 
may be gradually replaced. The cell recovers from the hyperpolarization state, the 
mitochondrion recovers the membrane potential and the fluorescence value equals the 
control. 
Taking into account such hypotheses, there seems to be two possible mechanisms to 
explain the behavior of mitochondria in C. albicans ATCC 10231 when exposed to 
phlorotannins. The mechanism taking place for higher phlorotannins concentrations 
(from MIC to MIC/8) can be regulated by anti-apoptotic proteins expression, once cells 
are undergoing a major aggression that puts at risk their viability. For lower phlorotannins 
concentrations (from MIC/16 to MIC/1024) cellular aggression will not be sufficient to 
trigger anti-apoptotic defense mechanisms and a mechanism related to the change in Ca2+ 
permeability can take place. 
The study of the metabolic network of the yeast C. albicans revealed a hyperactivity 
of mitochondrial dehydrogenases caused by phlorotannins. This alteration in 
mitochondrial activity can lead to the accumulation of ROS and Ca2+, which, in turn, may 
result in membrane hyperpolarization, incompatible with normal cell metabolism. In 
order to clarify these observations, the study of the mechanism of antifungal action of 
phlorotannins needs further investigation, namely in what concerns to their action over 
some important cell enzymes like proteases and lipases, which play an important role in 
cell metabolism (333, 334). 
This work evidenced the antifungal capacity of phlorotannins against a wide range of 
yeast and filamentous fungi. In a general way, C. nodicaulis revealed to be the most 
effective species against the studied fungi. Despite not being lethal for Candida species 
under the tested concentrations, this seaweed presented the lowest MIC/MLC for both 
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yeast and dermatophytes, being also lethal for the last ones. Although the mechanism of 
action of these compounds was not completely elucidated, there are evidences pointing to 
some effect on ergosterol and chitin composition in filamentous fungi, and on ergosterol 
and respiration in yeast. Nevertheless, the main role of phlorotannins seems to be related 
to their capacity to reduce the virulence factor in C. albicans, by inhibiting the dimorphic 
transition. 
The increment in combining antifungal medications with different mechanisms of 
action can lead to better therapeutic responses. Contrary to what happens with some 
commercially available antifungal drugs, the effect on yeast mitochondria activity can be 
the primary mechanism of action of phlorotannins. Thus, the challenge remains to 
associate compounds from natural matrices with existing antifungal drugs for which there 
is some resistance. There are some data indicating that phlorotannins do not act similarly 
in the mitochondria of mammalian and yeast (311). In this sense, searching for differences 
between mammalian and fungi mitochondria, in the classical and alternative components 
of the mitochondrial respiratory chain, may provide new potential therapeutic targets in 
treating pathogenic fungal infections. 
Given the high biological potential of phlorotannins and the scarce information 
concerning the species under study, the evaluation of the biological potential of 
phlorotannins extracts of the most promising species was further extended. As so, the 
three Cystoseira species and F. spiralis were considered for the phlorotannins profiling by 
LC-MS. The antioxidant potential of these species and their activity on specific enzymes 
was further studied. 
5.2.5. HPLC-DAD-ESI/MSn phlorotannins analysis 
Phlorotannins extracts from the three Cystoseira species and F. spiralis were 
chromatographically separated and their mass was analyzed following ESI ionization. The 
Extracted Ion Chromatogram (EIC) of protonated molecular ions ([M+H]+) from the most 
common phlorotannins found in literature (dioxinodehydroeckol (MW 371), eckol (MW 
373), fucophlorethol (MW 375), 7-phloroeckol (MW 497), fucodiphlorethol (MW 499), 
phlorofucofuroeckol (MW 603), fucotriphlorethol (MW 623), dieckol (MW 743) and 
fucophlorethols with six (MW 747), seven (MW 871) and eight units of phloroglucinol 
(MW 995)) was used for the study of phlorotannins by HPLC-DAD-ESI/MSn. The MS 
fragmentations of other peaks observed in the UV chromatogram were studied. The 
compounds were numbered following elution order, starting by F. spiralis (1-8), and 
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followed to C. usneoides (9-12), C. tamariscifolia (13-14) and C. nodicaulis (15-22) 
(Figure 34, Table 6) (320). 
In the EIC of F. spiralis and of C. usneoides it could be noticed the presence of well-
defined and abundant ions, 1-8 and 9-12, respectively, which can correspond to 
phlorotannins. On the other hand, in the EIC of C. tamariscifolia and C. nodicaulis, the 
ions were found in trace amounts and appear co-eluting with other compounds (Figure 
39) (320).  
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Figure 39. Extracted Ion Chromatogram (EIC) of purified phlorotannins extracts of F. spiralis, C. 
usneoides, C. tamariscifolia and C. nodicaulis. [M + H]+ (m/z): 1, 499; 2, 747; 3-5, 871; 6-8, 995; 9 
and 11, 375; 10, 499; 12, 623; 13, 499; 14, 497; 15-17, 499; 18-19, 497; 20-21, 603; 22, 743 (320). 
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The UV chromatograms of the four studied species extracts were recorded at 280 
nm and exhibited some abundant peaks that do not correspond to any of the studied ions 
(Figure 40). Ions corresponding to the compounds tentatively identified as 
phlorotannins are not abundant in the chromatograms of C. tamariscifolia and C. 
nodicaulis. 
Figure 40. UV chromatograms of the purified phlorotannins extracts of F. spiralis, C. usneoides, 
C. tamariscifolia and C. nodicaulis, recorded at 280 nm. Identity of compounds as in Figure 39 
(320). 
The MS study of the ions of possible phlorotannins allowed the detection of two 
isomers, 9 and 11, in C. usneoides, which protonated molecular ions ([M+H]+) at m/z 375 
correspond to fucophlorethol isomers (Figure 41). 
 
 
 
 
 
 
 
 
Figure 41. Hypothetical structure of the identified phlorotannins: identity of compounds as in 
Figure 39. 
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These compounds present a similar fragmentation, with losses of 1 and 2 molecules 
of H2O (-18 and -36, respectively), phloroglucinol (-126), as well as the protonated 
molecular ion of phloroglucinol (m/z 127), base peak being the ion resulting from the loss 
of phloroglucinol and methyl (m/z 235, -126-14) (Figure 42 B, Table 7). In fact, isomers 
of fucophlorethols with the same molecular ion can occur, depending on the position of 
the aryl linkage (141). There were also observed isomers with [M+H]+ at m/z 499, 
phlorotannins tetramers, compounds 1 in F. spiralis and 10 in C. usneoides, which can 
correspond to tetrafucol and/or fucodiphlorethol (Figure 41). Their MS2 shows losses 
similar to those listed above (-18, -126/-127, among others) and the base peak in both is 
the ion at m/z 355 (-126-18). These losses were also detected in the other compounds, 
which protonated molecular ions indicated them as polymers with several phloroglucinol 
units. Thus, in C. usneoides compound 12 (with protonated molecular ion at m/z 623) was 
suggested to be a polyphenolic compound composed by five phloroglucinol units, possibly 
a fucotriphlorethol (Figure 41). In F. spiralis compound 2 ([M+H]+ at m/z 747) can be a 
polyphenolic compound composed of six units of phloroglucinol. Three isomers 
(compounds 3-5) with m/z 871, corresponding to seven phloroglucinol units, and other 
three (compounds 6-8) with m/z 995 (eight units of phloroglucinol) were also detected in 
this species (Figure 42 A, Table 7) (320). 
 
 
 
 
 
 
 
 
 
 
 
Figure 42. MS2[M+H]+ analysis of compound 6 from F. spiralis (A) and compound 9 from C. 
usneoides (B) (320). 
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Species belonging to the order Fucales (119, 211, 314, 322) and Laminariales (103, 
335) have been the subject of many studies, allowing the identification of several 
phlorotannins structures, such as eckol, dieckol, 8,8’ dieckol, 6,6’ bieckol, 8,8’ bieckol, 
phlorofucofuroeckol-A and B, fucofuroeckol-A, dioxinodehydroeckol, 2-phloroeckol, 7-
phloroeckol, fucodiphlorethol-G and triphlorethol. Thus, in the present work 22 different 
phlorotannins belonging to eckol and fucophlorethol main groups were characterized in 
the studied seaweeds: 8 in C. nodicaulis, 2 in C. tamariscifolia, 4 in C. usneoides and 8 in 
F. spiralis) (Figures 39 and 40, Table 7) (320). 
More recently, Tierney and co-workers profiled F. spiralis phlorotannins by UPLC-
MS, starting from cold H2O and ethanol:H2O extracts (336). On the cold H2O extract those 
authors detected ions corresponding to 498, 746, 870 and 994 g/mol. In the ethanol:H2O 
extract, ions with 746, 870 and 994 g/mol were observed. Those authors also identified 
phlorotannins with a higher degree of polymerization that may be explained by the use of 
UPLC, which allows an increased efficiency in separation than HPLC. Our results are in 
agreement with those authors in what concerns to the molecular weight of phlorotannins 
of the cold H2O extract. Nevertheless, and even highlighting the degree of polymerization 
of phlorotannins, those authors have not made an approach to the chemical phlorotannin 
group. Anyway, the complexity of these molecules remains a challenge in terms of 
chromatographic separation and chemical characterization. Thus, with the exception of 
fucols and fucophlorethols groups identified in F. spiralis (316), and bifuhalol and 
diphlorethol identified in C. tamariscifolia (322), none of the compounds described 
herein was previously reported in these species.  
Concerning the mode of action of phlorotannins, there is also a recent survey 
conducted by Hierholtzer and co-workers, where a crude phlorotannins extract with 
known concentration was tested against mixed anaerobic microbial cultures (337). The 
authors concluded that the bactericidal activity of phlorotannins was function of the level 
of polymerization of the compounds present in the extract. They also observed that 
microorganisms presented a higher energy consumption for survival, which resulted from 
the stress induced by phlorotannins (337). 
5.2.6. Antioxidant Activity 
The antioxidant potential of purified phlorotannins extracts from the three 
Cystoseira species and F. spiralis was checked against O2-• and LPO. A concentration-
dependent pattern was observed for both assays. C. nodicaulis and F. spiralis were the 
species with the highest radical scavenging capacity, presenting IC50 values of 0.93 and 
1.30 mg/mL (dry weight), respectively (Figure 43 A, Table 8). The IC50 found for these 
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two species was significantly lower than those obtained for C. tamariscifolia and C. 
usneoides (P<0.0001). Concerning LPO inhibition, F. spiralis was the most effective, 
displaying an IC50 value (2.32 mg/mL, dry weight) significantly lower than those found for 
both C. nodicaulis and C. tamariscifolia (P<0.0001) (Figure 43 B, Table 8). The 
protective activity of C. usneoides against LPO was not higher than 15% for the highest 
concentration tested (9.1 mg/mL dry weight, Table 8). 
 
 
 
 
 
 
 
 
Figure 43. Activity of purified phlorotannins extracts against superoxide radical (A) and lipid 
peroxidation (B). Results are expressed as percentage relative to control (mean ± standard 
deviation of three independent assays) (320). 
 
Table 8. Antioxidant activity and HAase inhibition of purified phlorotannins extracts a (320). 
 
 Assays 
Superoxide 
radical 
scavenging 
Lipid 
peroxidation 
inhibition 
HAase 
inhibition 
Samples 
 
C. nodicaulis  0.93 (0.11) 8.52 (0.08) 1.34 (0.04) 
     
C. tamariscifolia  2.73 (0.30) 7.55 (0.02) 3.3 (0.12) 
     
C. usneoides  4.02 (0.68) > 9.10  2.51 (0.22) 
     
F. spiralis  1.30 (0.04) 2.32 (0.08) 0.73 (0.06) 
a IC50 values (mg/mL, dry weight) represented as mean (standard deviation) of 
three assays, performed in triplicate. 
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The peroxidation of lipids is one of the inevitable causes of oxidative stress, because 
the derived products lead to the spread of free radical reactions (222, 338). As so, the anti-
radical activity is of extreme importance to establish a balance between pro-
oxidants/antioxidants. The role of antioxidants takes a crucial importance when the 
subject is the skin. This physical and chemical barrier is subjected to a wide kind of 
aggressions during life, which are reflected in the loss of its integrity and properties, 
resulting in diverse situations, among which aging can be highlighted. Skin aging has been 
associated with the increased peroxidation of skin lipids, namely of squalene, which 
constitutes the main component of skin surface polyunsaturated lipids and is easily 
peroxided. Peroxidation of fatty acyl groups of membrane phospholipids is one of the 
major outcomes of free radical-mediated injury to tissue, leading to cell damage by 
continuous chain reactions. In addition, LPO may be responsible for the activation of 
phospholipase A2, production of many mediators by arachidonate, deactivation of 
adenylate cyclase and activation of guanilate cyclase, leading to the decrease of 
cAMP/cGMP ratio, responsible for epidermal proliferation. Thus, the physicochemical 
properties of the membrane lipid bilayers can be greatly altered, resulting in severe 
cellular dysfunction (338). 
Several works have concerned the antioxidant activity of phlorotannins crude 
extracts and isolated compounds. Zubia and co-workers assessed the antioxidant capacity 
of 10 brown seaweeds from the Brittany coast (339). Species belonging to the order 
Fucales, mainly those of the genus Fucus and Cystoseira, displayed the strongest activity, 
which was positively correlated with their phenolics content. Similar results were obtained 
by Shibata and colleagues with phlorotannins isolated from Laminariaceous (103). These 
authors found that the increase of molecular weight of the isolated phlorotannins leads to 
a decrease of the antioxidant activity. According to these previous reports, it is possible to 
establish a correlation between phlorotannins composition and biological activity. Thus, F. 
spiralis is the species displaying the lowest IC50 regarding LPO inhibition and C. 
nodicaulis the one showing best superoxide scavenging capacity, but almost no activity 
against LPO (Figure 43, Table 8). It seems that extracts with lower molecular weight 
phlorotannins are more effective as superoxide radical scavengers, while those with higher 
molecular weight are better in inhibiting LPO (Tables 7 and 8). Anyway, the mode of 
action of these molecules and the phlorotannins groups responsible for each activity are 
not easy to point, moreover dealing with an extract instead of isolated compounds. Thus, 
synergistic and antagonic effects can be behind the main molecules and affect the results. 
Recent studies have demonstrated that the protective effect against oxidative stress 
induced by ROS and UV radiation was connected to the number and position of hydrogen-
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donating OH groups on the aromatic ring of the phenolic molecules, being also affected by 
other factors, such as other hydrogen donating groups (-NH, -SH) (340). A recent review 
about cosmeceuticals derived from marine seaweeds highlighted the importance of marine 
polyphenols, particularly phlorotannins, because of their antioxidant activity, stronger 
than that of many other polyphenols, which may be related, in part, to their molecular 
arrangement (341). 
Kang and co-workers have recently studied the effect of the pre-treatment with 
dieckol on the LPO observed in mice liver. These authors concluded that dieckol, a low 
molecular weight phlorotannin, dramatically reduces LPO induced by ethanol (342). With 
the same purpose, another research group (197) proved that phlorotannins can reduce the 
LPO induced by UV radiation. Since skin is always exposed to UV radiation and 
environmental pollutants, it is a main target of oxidative stress. The overexposure of skin 
to UV radiation is associated with abnormal cutaneous reactions, such as epidermal 
hyperplasia, accelerated breakdown of collagen and inflammatory responses. The effect of 
UV radiation has a strong oxidative component and photo-oxidative stress has been 
directly linked to the onset of skin photodamage. Thus, regular skin treatments with 
products containing antioxidant ingredients can be useful for the prevention and 
reduction of damage induced by UV radiation (343, 344). 
As it has been seen before, despite their capacity to inhibit LPO and their 
antioxidant activity against O2•-, F. spiralis and C. nodicaulis phlorotannins extracts have 
demonstrated the highest capacity for NO scavenging. Since NO reacts rapidly with 
superoxide radical to form peroxynitrite (ONOO-), the studied species can prevent the 
generation of ONOO-, a strong oxidant with a lethal effects on many cells (280). 
 
5.2.7. Inhibitory Effect on HAase  
HAase, an enzyme responsible for the depolymerization of HA (a polysaccharide 
present in the extracellular matrix of the connective tissue and in body fluids), is known to 
be involved in allergic effects, migration of cancer and inflammation, increasing the 
permeability of the vascular system. As so, potent HAase inhibitors might have anti-
allergic, anticancer and anti-aging activities, becoming leading compounds in the 
development of new drugs (223, 317, 345). Of the species studied herein, F. spiralis 
demonstrated the highest capacity to inhibit HAase (IC50=0.73 mg/mL dry weight), C. 
tamariscifolia being the less effective (Figure 44, Table 8). All of the IC50 values found 
were significantly different (P<0.0001). 
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Figure 44. Inhibitory activity of purified phlorotannins extracts on hyaluronidase. Results are 
expressed as percentage of hyaluronidase inhibition relative to control (mean ± standard deviation 
of three independent assays) (320). 
 
Phlorotannins are reported as anti-allergic and potential anti-aging agents, owing to 
their strong inhibitory effect on HAase. Sugiura and co-workers performed a bioguided 
fractionation of a MeOH:chloroform extract of the brown seaweed Eisenia arborea 
Areschoug and identified six phlorotannins, phlorofucofuroeckol-B showing the strongest 
activity (335). HAase inhibition assay was also performed with crude phlorotannins 
extracted from five brown seaweeds from Pakistan and China (346). A positive correlation 
between the extracts activity and the total phlorotannins content was observed. 
Sargassum tennerimum J. Agardh was the most active species, exhibiting an IC50 value 
lower than that of disodium cromoglycate, a natural inhibitor of HAase. In addition, 
Shibata and colleagues observed that phlorotannins like eckol, phlorofucofuroeckol A, 
dieckol, and 8,8’-bieckol exert a stronger inhibition of HAase than well-known inhibitors, 
such as catechin and sodium cromoglycate, and that phlorotannins with higher molecular 
weight are more effective (110). The inhibition on HAase is more than one strategy to 
reduce the progression of allergy and inflammation. The inhibition of this enzyme is the 
first step for the preservation of the HA structure and, thus, the maintenance of the skin 
framework. Thus, the activity of phlorotannins can be further explored concerning not 
only inflammatory and allergic diseases, but also skin aging which, more than fashionable, 
is a matter of self-esteem. 
 
Our findings seem to be in good agreement with previous reports. In fact, the best 
results obtained with F. spiralis extract are not surprising, as this species possesses the 
highest total phlorotannins content (311). Furthermore, it also contains the ones with 
higher molecular weight, as demonstrated herein (Figure 39, Table 7). However, the 
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structure of phlorotannins appears to be more important than its amount. The genus 
Cystoseira is a good example: despite having a much lower phlorotannins content than C. 
tamariscifolia (311), C. nodicaulis and C. usneoides presented significantly lower IC50 
values for HAase inhibition (Figure 44, Table 8). 
 
5.3. Further exploration of F. spiralis bioactive compounds 
The recognition of F. spiralis as nutritionally and pharmacologically promising, and 
considering its high content of bioactive compounds, stimulated us to go further in terms 
of compounds’ isolation and determination of their biological activities. With this purpose, 
the lyophilized seaweed material was exhaustively extracted with MeOH and the resulting 
MeOH extract was subjected to solvent-solvent partitioning to give n-hexane, EtOAc and 
BuOH fractions. The HPLC-UV monitorization of the compounds present in each solvent 
revealed the EtOAc as the richest one, as its chromatogram presented a higher amount 
and intensity of peaks. Thus, EtOAc fraction was chosen for further analysis. 
5.3.1. Isolation of monoacylglycerol and MGDGs 
The EtOAc fraction was partitioned as outlined in the experimental section to yield 
one monoacylglycerol featuring oleic acid (C18:1 Ω9) (compound 1) and a 1:1 mixture of 
two MGDGs containing EPA (C20:5 Ω3) combined with octadecatetraenoic acid (C18:4 
Ω3) (compound 2) and LNA (C18:3 Ω3) (compound 3), respectively (Figure 45). Their 
structures and the regiochemical attachments of the acyl chains to the glycerol moiety 
were unambiguously elucidated on the basis of extensive NMR spectroscopic analysis and 
MS and by comparison with data reported in the literature (217, 347, 348).  
 
 
 
 
 
 
 
 
 
 
 
Results and discussion 
125 
 
R1=
R2=
Glyceride
Compound 2
C47H72O10
Compound 3
C47H74O1020’
19’
18’17’
16’
15’14’
13’
12’11’
10’
9’8’
7’
6’5’
4’
3’
2’
1’
18’’
17’’
16’’15’’
14’’
13’’12’’
11’’
10’’9’’
8’’
7’’
6’’
5’’
4’’
3’’
2’’
1’’
20’
19’
18’17’
16’
15’14’
13’
12’11’
10’
9’8’
7’
6’5’
4’
3’
2’
1’
18’’
17’’
16’’15’’
14’’
13’’12’’
11’’
10’’9’’
8’’
7’’6’’
5’’
4’’
3’’
2’’
1’’
R3=
R1=
R2=
R3=
R1=
R2 = R3= H
Compound 1
C21H40O4
3
2
1
6’’’
2’’’ 1’’’
6’’’
2’’’ 1’’’
C18:1Ω9
C18:4Ω3
C20:5Ω3
C18:3Ω3
C20:5Ω3
Galactose
Galactose
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 45. Structures of the monoacylglycerol (compound 1) and the MGDGs (compounds 2 and 
3) isolated from F.spiralis. 
 
Previous reports also include the isolation of compounds 2 and 3 from the fresh 
water dinoflagellate Glenodinium sanguineum Marchesoni (349) and their detection in 
glaucocystophytes (350). 
5.3.2. Spectrometric data of isolated compounds 
The spectrometric data of the monoacylglycerol (compound 1 – Figure 45) were 
previously reported by Hirao and co-workers in the brown seaweed Ishige sinicola 
(Setchell & N. L. Gardner) Chihara (347) and are in agreement with the data obtained in 
this work with F. spiralis, in which this compound was reported for the first time: 
Compound 1 (Figure 45): 1H NMR (500 Mz, CDCl3): 5.35 (2H, m), 4.19 (1H, dd, J 
= 11.7, 4.5 Hz), 4.13 (1H, dd, J = 11.7, 6.0 Hz), 3.91 (1H, m), 3.68 (1H, dd, J = 11.7, 4.0 Hz), 
3.58 (1H, dd, J = 11.7, 6.0 Hz), 2.33 (2H, t, J = 7.6 Hz), 2.01 (4H, m), 1.61 (2H, m), 1.29 
(22H, m), 0.86 (3H, t, J = 6.9 Hz); ESIMS positive m/z 357 [M+H]+ (100), 735 [2M+Na]+ 
(5) (Figure 46); in accordance with literature (347). 
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Figure 46. Positive mode ESI - Full mass spectrum [100.00-1000.00] of compound 1. 
 
Data related to the MGDGs was also previously reported in the brown seaweed 
Sargassum thunbergii (Mertens ex Roth) Kuntze (188) and later in the diatom 
Phaeodactylum tricornutum Bohlin (348): 
Compounds 2 and 3 (Figure 45): 1H NMR (CDCl3, 500 Mz) of glycerol and sugar 
parts, common to both compounds: 4.38 (1H, dd, 12.0, 3.3, H-1a), 4.19 (1H, dd, 12.0, 6.4, 
H-1b), 5.30 (1H, m, H-2), 3.89 (1H, dd, 11.0, 5.6, H-3a), 3.73 (1H, dd, 11.0, 6.4, H-3b), 4.26 
(1H, d, 7.4, H-1’’’), 3.63,(1H, dd, 9.5, 7.4, H-2’’’), 3.58 (1H, dd, 9.5, 2.5, H-3’’’), 3.99 (1H, 
brd, 2.5, H-4’’’), 3.53 (1H, brt, 4.6, H-5’’’), 3.96 (1H, dd, 12.5, 5.8, H-6a’’’), 3.85 (1H, dd, 
12.5, 4.6, H-6b’’’); 13C NMR (CDCl3, 500 Mz): 63.1 (C-1), 70.4 (C-2), 68.5 (C-3), 104.2 (C-
1’’’), 71.8 (C-2’’’), 73.6 (C-3’’’), 69.5 (C-4’’’), 74.7 (C-5’’’), 62.7 (C-6’’’); in accordance with 
literature (188, 348). 
Compound 2 (Figure 45): 1H NMR (CDCl3, 500 Mz): 5.36 (18H, m, H-5’, 6’, 8’, 9’, 
11’, 12’, 14’, 15’, 17’, 18’, 6’’, 7’’, 9’’, 10’’, 12’’, 13’’, 15’’, 16’’), 2.80 (14H, m, HC-7’, 10’, 13’, 16’, 
8’’, 11’’, 14’’), 2.31 (4H, m, H-2’, 2’’), 2.08 (2H, m, H-4’), 2.05 (6H, m, H-5’’, 17’’, 19’), 1.67 
(2H, m, H-3’), 1.61 (2H, m, H-3’’), 1.37 (2H, m, H-4’’), 0.96 (6H, t, J = 7.5, H-18’’, 20’) and 
13C NMR (CDCl3, 500 Mz): 174.1 (C-1’), 173.5 (C-1’’), 33.7 (C-2’), 34.4 (C-2’’), 25.1 (C-3’, 
3’’), 26.7 (C-4’), 29.4 (C-4’’), 129.2 (C-5’), 27.1 (C-5’’), 128.1-129.0 (C-6’, 8’, 9’, 11’, 12’, 14’, 
15’, 7’’, 9’’, 10’’, 12’’, 13’’), 129.8 (C-6’’), 25.8 (C-7’, 10’, 13’, 16’, 8’’, 11’’, 14’’), 127.2 (C-17’, 
15’’), 132.2 (C-18’, 16’’), 20.7 (C-19’, 17’’), 14.3 (C-20’, 18’’); ESIMS positive m/z 819 
[M+Na]+ (10), 797 [M+H]+ (100), 635 [M+H-C6H10O5]+ (24), 617 [M+H-C6H12O6]+ (1), 333 
[C17H28CO + 74]+ (3), 285 [C19H29CO]+ (0.5) (Figure 47); in accordance with literature 
(188, 348). 
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Figure 47. Positive mode ESI - Full mass spectrum [100.00-1000.00] of compound 2. 
Compound 3 (Figure 45): 1H NMR (CDCl3, 500 Mz): 5.36 (16H, m, H-5’, 6’, 8’, 9’, 
11’, 12’, 14’, 15’, 17’, 18’, 9’’, 10’’, 12’’, 13’’, 15’’, 16’’), 2.80 (12H, m, H-7’, 10’, 13’, 16’, 11’’, 14’’), 
2.31 (4H, m, H-2’, 2’’), 2.08 (2H, m, H-4’), 2.05 (4H, m, H-19’,17’’), 2.04 (2H, m, H-8’’), 
1.67 (2H, m, H-3’), 1.59 (2H, m, H-3’’), 1.31 (8H, m, H-4’’, 5’’, 6’’, 7’’), 0.96 (6H, t, J = 7.5, 
H-18’’, 20’’); 13C NMR (CDCl3, 500 Mz): 173.8 (C-1’), 173.5 (C-1’’), 33.7 (C-2’), 34.4 (C-2’’), 
25.1 (C-3’), 24.9 (C-3’’), 26.7 (C-4’), 29.3 (C-4’’), 129.2 (C-5’), 29.5 (C-5’’), 128.1-129.0 (C-
6’, 8’, 9’, 11’, 12’, 14’, 15’, 10’’, 12’’, 13’’), 29.8 (C-6’’), 25.8 (C-7’, 10’, 13’, 16’, 11’’, 14’’), 29.9 
(C-7’’), 27.4 (C-8’’), 130.2 (C-9’’), 127.2 (C-17’, 15’’), 132.2 (C-18’, 16’’), 20.7 (C-19’, 17’’), 
14.3 (C-20’, 18’’); ESIMS positive m/z 821 [M+Na]+ (9), 799 [M+H]+ (100), 637 [M+H-
C6H10O5]+ (23), 619 [M+H-C6H12O6]+ (1), 335 [C17H30CO + 74]+ (2), 285 [C19H29CO]+ (0.6) 
(Figure 48); in accordance with literature (188, 348). 
 
 
 
 
 
Figure 48. Positive mode ESI - Full mass spectrum [100.00-1000.00] of compound 3. 
 
5.3.3. Anti-inflammatory activity 
The anti-inflammatory activity of this kind of compounds has been studied in 
diferent cell lines and more extensively on cells from articular cartilage (351, 352). 
Nevertheless, to our knowledge, there were no reports concerning the anti-inflammatory 
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activity of the glycerolipids isolated from F. spiralis. Thus, the anti-inflammatory capacity 
of the isolated compounds was assessed in the macrophage cell line RAW 264.7. 
5.3.3.1. Cell viability 
The viability of RAW 264.7 macrophages was evaluated using non-treated cells, in 
order to assess the effect of 18 h of exposure to 1 µg/mL LPS. Cell viability, as evaluated by 
the LDH and MTT assays, was not significantly different from that of non-exposed control 
cells (Figure 49). 
 
 
 
 
 
Figure 49. Influence of LPS in cell viability. RAW 264.7 macrophages were exposed to 1 µg/mL of 
LPS during 18 h and cell viability was assessed by LDH and MTT assays. Results are expressed in 
percentage of control (mean ± SEM of four independent assays performed in duplicate). 
The cytotoxicity of the monoacylglycerol (compound 1) and of the fraction 
containing MGDGs (compounds 2 and 3), in a ratio of 1:1, isolated from F. spiralis was 
also evaluated by the MTT and LDH assays, prior to testing them for their anti-
inflammatory activity, following the same procedure as for purified phlorotannins extracts 
(Figure 50). 
 
 
 
 
 
 
 
 
Figure 50. Influence of the monoacylglycerol (A) and of MGDGs (B) on cell viability and on NO 
released by macrophages. After pre-exposure with the tested compounds and stimulation with LPS, 
the viability of RAW 264.7 cells was assessed by the LDH and MTT assays and the NO production 
was quantified. Results are expressed as percentage of control (mean ±SEM of four independent 
assays performed in duplicate). **P<0.01, ***P<0.001. 
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Concerning the monoacylglycerol, exposure to LPS had no effect on cell viability at 
the tested concentrations (6.25 – 100 µg/mL). There was no statistical difference relative 
to control for both MTT and LDH assays (Figure 50A) and the microscopic evaluation 
revealed normal size and shape of the cells. The same pattern was observed in control 
cells, treated with the monoacylglycerol but without LPS (data not shown).  
On the other hand, cells treated with the highest concentration of the MGDGs 
fraction (500 µg/mL) suffered a decrease of cell viability to 33.06 ± 3.68%, relative to 
control, in MTT assay (P<0.001) (Figure 50B). This assay, which provides information 
about the mitochondrial function of the cells by evaluating succinate dehydrogenase 
activity, proves that there was a drastic loss of viability (353). Curiously, this effect was not 
confirmed with the LDH assay, which presented values around 100% relative to control 
for all the tested concentrations (Figure 50B). As so, the lack of LDH in the extracellular 
medium indicates that there was no cell membrane damage. 
In order to confirm these results, cells were observed under light microscopy, 
immediately before starting with the treatment (this is, before pre-exposing the cells for 1 
h to the tested compounds) and after the established incubation period (1 h exposure to 
the tested compounds followed by 18 h incubation with both compounds and LPS). This 
allowed us to observe that before exposure to test compounds and 1 h after exposure, 
macrophages presented normal size and shape. After 18 h of co-treatment with LPS, cells 
exhibited severe modifications of size, shape and density (data not shown) for the highest 
concentration of MGDGs tested (500µg/mL). 
According to these observations, we may consider that, at the cytotoxic 
concentration of 500 µg/mL, the tested MGDGs promoted the death of the majority of the 
cells. This observation is not supported by the results of the LDH assay (which indicate 
cell viability per se), but was previously observed and confirmed by other authors using 
the same cell line, treated in a similar manner (354): while assessing the anti-
inflammatory potential of plumbagin on LPS-stimulated Raw 264.7 macrophage cells 
Pinho and colleagues verified that the LDH could be released from macrophages in an 
early stage of cells treatment and then degraded during the incubation period, reaching 
values close to control (354). Moreover, the culture medium DMEM retained its color very 
close to the initial one, which did not happen in the other wells. DMEM has a pH indicator 
that changes from red to yellow by acidification, the pH decrease being characteristic of 
cell metabolism. The fact that no change of the color of the culture medium was observed 
is another indicative of cell death or metabolic disability. 
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5.3.3.2. NO released by RAW 264.7 macrophages 
The isolated compounds were screened for their ability to affect NO released by LPS-
stimulated RAW 264.7 macrophages. All of them showed a dose-dependent NO inhibitory 
activity. The monoacylglycerol (compound 1, Figure 45) demonstrated lower capacity to 
inhibit NO production by macrophages than the 1:1 mixture of the MGDGs (compounds 2 
and 3, Figure 45) (IC50=65.70 µg/mL vs 60.06 µg/mL). The anti-inflammatory reference 
drug dexamethasone was used as positive control, as inhibitor of NO production by 
macrophages (Figure 51). Macrophage cells were treated with dexamethasone along with 
the isolated compounds. Like the isolated compounds, the reference anti-inflammatory 
drug was able to inhibit NO production in a dose-dependent manner (IC50 = 34.60 µg/mL) 
(Figure 51). 
 
 
 
 
 
 
Figure 51. Dexamethasone effect on NO release. Quantification of NO produced by RAW 264.7 
cells exposed to dexamethasone and stimulated with 1 µg/mL of LPS for 18 h. Results are expressed 
in percentage of control with LPS (mean ±SEM of four independent assays performed in duplicate). 
 
According to previous studies (220, 221), galactolipids are able to down-regulate the 
iNOS protein levels in LPS-stimulated RAW 264.7 cells, suggesting that the decrease in 
NO production observed with these compounds is related to the down regulation of iNOS 
expression (220, 221). In these studies it was evaluated the capacity of two MGDGs 
composed of hexadecatetraenoic acid (C16:4 Ω3) combined with octadecatetraenoic 
(C18:4 Ω3) and linolenic (C18:3 Ω3) acids to reduce NO production in RAW 264.7 cells 
and concluded that the compound with more double bonds presented a lower IC50, 
proving that the levels of unsaturation are related to the anti-inflammatory activity. The 
same research group reported the NO inhibitory capacity of two MGDGs composed by one 
glycerol unit linked to a fatty acid and one molecule of galactose. With this study they 
concluded that the position of the double bonds was more crucial for the bioactivity than 
the number of double bonds, since compounds with Ω6 fatty acids were more active than 
Ω3 fatty acids (even having more double bonds) (220, 221). 
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These findings are in accordance with our results, as both the monoacylglycerol and 
the MGDGs showed the capacity to reduce NO release in a dose-dependent manner. 
According to the previous findings (221), the difference between the IC50 values of MGDGs 
fraction and of the monoacylglycerol can be justified by the position of the double bond in 
the monoacylglycerol at Ω9. 
Although the IC50 values of our compounds are higher than that of the reference 
drug, the potential of the monoacylglycerol and the MGDGs as anti-inflammatory agents 
cannot be set aside. Glucocorticoids are commonly prescribed for the treatment of several 
inflammatory disorders; nevertheless, there are plenty of undesirable side effects 
associated with both acute and long term treatments (355). For this reason, glycerolipids 
and MGDGs may constitute an alternative to common anti-inflammatory drugs, as they 
present a good therapeutic activity without known side effects. MGDGs have shown a 
potent anti-inflammatory activity in in vitro cultured articular chondrocytes and also the 
ability to prevent cell proliferation, without affecting cell viability, in osteoarthritic 
cartilage degeneration (351, 352). Maeda and colleagues went further and investigated the 
action of MGDGs on colon tumor in mice after an oral administration, demonstrating that 
these compounds were safe and had a potent antitumor effect (356). These compounds 
also prove to be able to inhibit croton-oil-induced ear edema in the mouse, with a better 
IC50 than the reference drug (151). 
A combination of our study with previous investigations involving similar naturally 
occurring glyceroglycolipids (151, 221, 352) highlights their anti-inflammatory capacity 
over different types of cell lines. This contributes to promote their use as potential 
naturally occurring templates for future drug development. 
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6. CONCLUSIONS 
 
The work carried out under the subject of this dissertation allowed reaching to the 
following conclusions: 
Seaweeds species under study presented a widely variable sterols profile. The ones of 
Chlorophyta and Phaeophyta phyla are clearly marked by the abundance of C28 and C29 
sterols, while the ones belonging to Rhodophyta are mainly characterized by their 
abundance of C27 sterols, cholesterol being predominant. 
From a health and nutritional point of view, and considering the health effects of C28 
and C29 sterols, Chlorophyta and Phaeophyta are preferred over Rhodophyta. In what 
concerns to total C28 and C29 sterols amount, species belonging to Fucales seem to be 
greatly promising for both introduction in human diets and development of functional 
foods and additives with cholesterol lowering properties and capacity to reduce and 
prevent CHD. 
Phaeophyta species, particularly F. spiralis and the three Cystoseira species, 
revealed substantial concentrations of bioactive phlorotannins.  
The purified phlorotannins extracts demonstrated anti-inflammatory activity on 
RAW 264.7 cells by the reduction of NO, which seems to happen by two different 
mechanisms: scavenging and inhibition of iNOS. 
Purified phlorotannins extracts demonstrated antimicrobial activity over a wide 
range of pathogenic bacteria and fungi. The extracts were more active against Gram+ 
bacteria and, among fungi, more active against dermatophytes. The extracts also revealed 
bactericidal and fungicidal (for dermatophytes) activity, being only fungistatic for yeasts. 
Phlorotannins revealed a marked antioxidant activity against NO, O2•-, being also 
capable of inhibiting LPO and the degradation of HA by the inhibition of HAase. 
The isolation of compounds from F. spiralis allowed obtaining two MGDGs and a 
monoacylglycerol, which demonstrated anti-inflammatory properties by the inhibition of 
NO production by RAW 264.7 cells. 
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6.1. Practical applications for further research 
According to the exposed, phlorotannins demonstrate a huge potential to be used in 
cosmeceutical preparations with both anti-inflammatory, anti-aging, anti-bacterial and 
antifungal properties, constituting an alternative to the existing pharmaceutical formulas 
with undesirable side effects. 
Bacteria and inflammation - Acnes vulgaris 
Thus, and being aware of the need for further studies, a combination of F. spiralis 
and C. tamariscifolia extracts could be interesting for an anti-acne formulation, since it 
would be possible to combine the anti-bacterial effect of F. spiralis with the anti-
inflammatory effect of C. tamariscifolia, taking into account the inflammatory conditions 
associated with acne. 
Fungi – superficial dermatophytosis and disseminated infections 
On the same direction, a C. nodicaulis based formulation would be interesting for 
the treatment of dermatophytosis, considering its fungicidal effect. On the other hand, F. 
spiralis could be an alternative for the treatment of disseminated candidiasis, considering 
its ability to reduce C. albicans virulence factor. 
Enzymes and oxidants - Aging 
Considering its capacity to radicals scavenging, for LPO inhibition and HA break 
prevention by the inhibition of HAase, all common reactions in the aging process, F. 
spiralis seems to be a powerful matrix for the development of an anti-aging formula. 
Nevertheless, and considering that aged skins are more sensitive and reactive, frequently 
presenting allergic reactions, this matrix could have a dual effect and prevent the allergic 
reactions via HAase inhibition. 
Glycerolipids - Anti-inflammatory drugs development 
The MGDGs and the monoacylglycerol isolated from F. spiralis demonstrated anti-
inflammatory capacity. Despite not being better than the reference drug dexamethasone, it 
is still encouraging, considering the undesirable side effects of corticoids. Additionally, the 
isolated molecules can constitute a starting point for molecular design, in order to reach 
new molecules with a powerful anti-inflammatory activity and irrelevant side effects. 
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